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Abstract

BEHAVIORAL AND GENOMIC CHARACTERIZATION OF SCHEDULED ETHANOL
DEPRIVATION
By Jonathan A. Warner, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2013
Major Director: Michael F. Miles, M.D., Ph.D., Professor, Department of Pharmacology and
Toxicology

Alcoholism is a persistent substance abuse disorder that is associated with negative health,
social, and economic outcomes. Treatment strategies for alcohol use disorders are limited, and
only three drugs have been approved by the FDA for treatment. Although behavioral therapy and
drug combination strategies improve abstinence outcomes, the majority of those in treatment will
not achieve long-term abstinence. Therefore, better treatment strategies are needed.
While much progress has been made toward understanding the neurobiology of alcoholism, this
knowledge has not been effectively translated into treatment strategies. Animal models of
alcohol drinking have been crucial to this research effort, but until recently there have been few
procedures that effectively model alcoholism by producing binge-like drinking, withdrawal, and
relapse behavior. In the last five years the intermittent alcohol access (IAA) model, which uses
repeated cycles of scheduled alcohol deprivation and reinstatement to elevate drinking, has been

established as such a procedure, with substantial evidence that escalation of drinking produced
by IAA is mediated by similar mechanisms as in human alcoholics, which include transcriptional
regulation that alters functioning of mesolimbocortical reward pathways. The IAA model.
The studies reported herein characterize changes in gene expression in mesolimbocortical brain
regions associated with development of maladaptive binge-like alcohol drinking due to
scheduled abstinence, particularly in the nucleus accumbens, which regulates motivated
behavior. Furthermore the IAA model is characterized with regard to effectiveness in 2 ethanolpreferring C57BL/6 inbred mouse strains, and the influence of concurrent access to multiple
alcohol concentrations is examined. Finally, the potential of naltrexone and novel mu-opioid
receptor-selective antagonist NAQ to modulate alcohol drinking under continuous access and
intermittent access procedures is reported.
Microarray analysis is used to analyze the transcriptome in prefrontal cortex, nucleus accumbens,
and ventral midbrain of C57BL/6NCrl mice after alcohol deprivation, and to identify
differentially expressed genes and gene co-expression networks in C57BL/6J mice during
continuous access, as well as after six cycles of IAA. Differentially expressed genes, network
hub genes, and regulation mechanisms represent high priority targets for further study in bingelike drinking behavior, with the goal of translating this knowledge to treatment strategies for
alcoholism.

Chapter 1. Introduction

Alcoholism is a persistent substance abuse disorder with a high rate of relapse for patients in
therapy and potentially fatal withdrawal symptoms caused by abstinence from ethanol (Powell,
1999). Ethanol is a small molecule that interacts with a diverse set of molecular targets in
neurons and glia, including glutamate, GABA, and serotonin receptors. These actions at the cell
surface initiate changes in cell signaling and gene expression, which are associated with altered
behavior toward drugs and other rewarding and aversive stimuli. The nature of these changes
varies among individuals and between brain regions, which are effected by ethanol according to
their respective target abundance and composition, which in turn are dependent on
environmental history and genetic background (Kalsi et al., 2009; Vengeliene et al., 2009).
Persistent exposure to ethanol alters protein composition and function, which regulates cellular
processes, leading to changes in function and the transition to a dependent state, in which ethanol
is required for normal functioning. From this point, absence of ethanol leads to physiological and
psychological withdrawal symptoms, which include desire for ethanol and severe seizures that
may lead to death (Valdez et al., 2002; Vilpoux et al., 2009). The transition to dependence is
gradual, as continued ethanol exposure over time alters mRNA transcription and protein
translation through diverse signaling networks, leading to changes in brain function and
behavior. Neuroplasticity induced by ethanol exposure over time is not well-understood, but
many of the signaling pathways and genes have been identified in recent years through
1

behavioral study in animal models (Kerns, 2005; Koob and Volkow, 2009). The goal of studying
alcohol in animal models is to develop effective treatments for alcoholism through better
understanding of the behavior and neurobiology of alcohol abuse.
The complexity of the effects of alcohol and variation among individuals have impeded the
development of effective pharmacological therapeutic tools for the treatment of alcoholism. As
of 2013 only 3 drugs are approved by the FDA for reduction of relapse in abstinent alcoholics:
naltrexone, acamprosate, and disulfiram. These drugs do not share a direct mechanism of action,
have rarely been shown to be effective for maintaining long-term abstinence, and are not
effective for all alcoholics (Garbutt, 2009; Krampe et al., 2006). The variation in effectiveness of
drugs used to prevent relapse shows that the physiological nature of dependence differs among
individuals. Thus, detailed study is needed to identify common disease factors, which can be
exploited to produce targeted therapeutic strategies that are effective in a significant subset of
alcoholics (George and Koob, 2010). However, this endeavor is particularly complex in the case
of ethanol because of the large number of primary targets and the diverse signaling mechanisms
involved (Pignataro et al., 2009). Interaction with these targets produces myriad effects on the
cell depending on abundance and function, which depend on environment and genotype
(Spanagel, 2009).
Furthermore, alcohol intake shows extreme individual variation even within inbred rodent strains
of identical genetic background, which indicates that differences in transcriptional regulation,
which are modulated by epigenetic processes, are likely major factors that contribute to drinking
behavior (Wolstenholme et al., 2011). Ethanol causes histone hyperacetylation, and in the
amygdala this is accompanied by elevated expression of cAMP response element-binding protein
(CREB) and Neuropeptide Y (NPY), which are known to play a role in addictive behavior and
2

alcohol dependence (Robison and Nestler, 2011; Sorensen et al., 2013). Withdrawal from alcohol
produces anxiety-like behavior and deficits in histone acetylation, which are reversed by histone
deacetylase inhibitors (Pandey et al., 2008). Transcriptional regulation in the brain caused by
ethanol is complex, largely region-specific, and often correlated with ethanol-related behavior
(Ahmadiantehrani et al., 2013; Kerns, 2005).
To better understand the role of transcriptional regulation in the transition to dependence,
regional genomic analysis is used, which identifies changes in mRNA in brain regions associated
with particular aspects of ethanol-related behavior. Genomic methods measure the abundance of
tens of thousands of transcripts in a single sample from a single region of the brain, and can be
applied to identify significant differentially expressed genes across experimental groups (Kerns
and Miles, 2008; Miles and Williams, 2007a). Targets of interest need not be specified before the
experiment, so it can be used to discover transcripts regulated by the model without known
behavioral significance, rather than merely confirm changes in abundance for transcripts with
known relevance to ethanol-related behavior. Thus, experimenter bias is minimized and the
potential for novel discovery is maximized.
Transcripts found to be regulated by experimental manipulation can be correlated with
differences in acute and chronic ethanol-related behavior, such as ethanol consumption and
preference over water, sensitivity, and tolerance (Costin et al., 2013b; Iancu et al., 2013;
Mulligan et al., 2011; Osterndorff-Kahanek et al., 2013; Repunte-Canonigo et al., 2010; Wolen
and Miles, 2012; Wolen et al., 2012; Wolstenholme et al., 2011). Further analysis of regulated
transcripts co-expression and functional networks provides biochemical context through gene
ontology, as well as important hub genes and regulation mechanisms, such as transcription
factors and miRNAs (Chen et al., 2009b; Ho Sui et al., 2005; Kaimal et al., 2010; Vadigepalli et
3

al., 2003). Identified genes and pathways represent potential pharmacological or genetic
therapeutic targets for alcoholism that warrant further study (Tabakoff et al., 2009; Wang et al.,
2010). Selective ligands, RNAi, and knock-out mice can be used to verify the functional
relevance of particular targets (Bhutada et al., 2010; Choi et al., 2002; Cortínez et al., 2009).
Indeed, perturbation of targets selected by our laboratory based on microarray analysis of diverse
ethanol-related behavioral models for adeno-associated virus-mediated regional overexpression
in murine prefrontal cortex (PFC) (Clic4, Sgk1, Gsk3b) have been generally successful in
altering ethanol-related behaviors, including locomotor stimulation and sensitization produced by
low ethanol doses, loss of righting reflex produced by high ethanol doses, drinking behavior, and
withdrawal-induced anxiety-like behavior.
Recent years have seen the development of animal models of the transition to alcoholism that
rely on voluntary ethanol self-administration combined with scheduled abstinence of varying
lengths, which are known as the ethanol deprivation effect (EDE) and intermittent alcohol access
(IAA) models, respectively (Khisti et al., 2006a; Simms et al., 2008). These methods produce
escalation in alcohol consumption and preference at concentrations ranging from 3% to over
30%, which are similar to those typically consumed by humans, without sucrose fading or other
procedures designed to facilitate drinking. Naltrexone and acamprosate attenuate escalation of
drinking behavior produced by both models which indicates some shared physiological
foundation for the EDE, IAA, and alcoholism (Heyser et al., 2003; Li et al., 2010a; Sabino et al.,
2013). After several weeks or months of IAA the procedure produces behavior in rodents that
resembles drinking in human alcoholics: binge-drinking, inflexible intake, and seizures upon
withdrawal (Hopf et al., 2010; Hwa et al., 2011).
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Ethanol deprivation on particular schedules significantly increases ethanol consumption,
preference for ethanol over water, and operant responses for ethanol in mice (Sparta et al., 2009).
Repeated deprivation in animals allowed concurrent access to multiple concentrations of ethanol
causes a significant shift in preference to the highest ethanol concentration offered (30% w/v)
(Melendez et al., 2006a), and near-total preference for ethanol over water (Warner, in
preparation). Escalation of intake due to deprivation and IAA varies with animal strain, ethanol
concentration, and access schedule, but 50% to 100% increases in ethanol consumption and
significant increases in preference for ethanol over water occur immediately under most
conditions (Hwa et al., 2013; Khisti et al., 2006a; Melendez, 2011; Melendez et al., 2006a;
Rosenwasser et al., 2013). Extended IAA often produces 3- to 4-fold increases, and produces
near-total ethanol preference over several weeks, without the use of multiple alcohol
concentrations to boost intake (Hargreaves et al., 2009b; Wise, 1973). The IAA model has been
associated with changes in ΔFosB abundance and enhanced excitatory synaptic strength in the
ventral tegmental area, and its effect is decreased by glial cell line-derived neurotrophic factor
(GDNF), which alters gene expression and promotes neuronal survival (Carnicella et al., 2009b;
He, 2005; Li et al., 2010a; Stuber et al., 2008).
The need for better treatments for alcoholism can only be met by the careful use of valid animal
models that represent the condition in humans. Scheduled abstinence models meet this criteria by
allowing for detailed study of the molecular basis of the development of increased ethanol
consumption and preference over time, using a schedule similar to human patterns of alcohol use
during adolescence and early adulthood, when alcoholic behavioral patterns are usually
established (Moss et al., 2010). Indeed, several candidate ligands have been tested using
scheduled deprivation in recent years, showing that the IAA model is a useful initial screen to
5

identify compounds that alter craving during abstinence and merit further study in the context of
alcohol-related behavior (Hopf et al., 2011; Li et al., 2011a; Li et al., 2012a; Moorman and
Aston-Jones, 2009a; Wen et al., 2012; Yardley et al., 2012).
Interestingly, in IAA naltrexone reduces binge-like drinking and reverses accumulation of
transcription factor deltaFosB, and the efficacy of naltrexone to reduce binge-like drinking is
controlled by early life experience, during which epigenetic programming of gene expression is
occurring (Daoura and Nylander, 2011; Li et al., 2010b; Meaney et al., 2007; Renthal et al.,
2007; Siegmund et al., 2009). These results show that transcriptional regulation may be
important for the behavioral changes induced by the model, both downstream of the mu opioid
receptor, which is known to mediate changes in gene expression (Befort et al., 2008; Oliva and
Manzanares, 2006; Yu et al., 2010), and upstream of the receptor, where epigenetic processes
determine the expression of it and other genes (Hwang et al., 2010; Lin et al., 2008). Thus,
transcriptional regulation induced by cycles of ethanol intake and abstinence contributes to the
plasticity that leads to alcohol dependence, and a better understanding of the way genetics and
gene expression influence this process will drive the study of alcohol and of other drugs of abuse
and identify novel therapeutic targets for the treatment of alcoholism. Therefore, the author here
reports studies performed toward this end, with the guiding hypothesis that scheduled abstinence
in mice produces regional changes in gene expression in the brain, which mediate changes in
alcohol drinking behavior over time. Experiments were performed with the following aims:
1. To determine the environmental and genetic factors that regulate escalation of drinking
behavior produced by scheduled abstinence in mice.
2. To determine the nature of transcriptional regulation associated with scheduled
abstinence in areas of the mesolimbic reward pathway.
6

3. To determine the functional relevance to IAA behavior of targets identified by genomic
analysis of transcriptional regulation using in vivo pharmacological manipulation.

7

Chapter 2. Background and significance

Alcoholism and alcohol use disorders
Alcoholism is a persistent disorder with significant costs to the afflicted individual and to
society. In the United States approximately 80,000 deaths each year are attributable to excessive
alcohol use, which the Centers for Disease Control and Prevention ranks as the third-leading
lifestyle-related cause of death (Mokdad et al., 2004). The average potential life lost for each
individual for whom excessive drinking contributed to death was nearly 30 years, and in 2006
the economic cost of this behavior was estimated at $223.5 billion (Bouchery et al., 2011).
Furthermore, alcohol use disorders (AUDs) are associated with negative employment outcomes
and low marriage quality (Booth and Feng, 2002; Leonard and Rothbard, 1999). People drink
despite this physical and economic damage because alcohol produces rewarding psychoactive
effects, such as euphoria and anxiolysis, and the aversive effects associated with heavy use and
withdrawal are not always sufficient to moderate consumption (Spanagel, 2009; Valdez and
Koob, 2004).
The motivation of an organism to consume alcohol is influenced by dynamic neurobiological and
environmental factors that modulate the rewarding and aversive effects of the drug. Initiation and
regulation of alcohol consumption is controlled by memories of previous experiences with the
drug, associations of these experiences with environmental context and cues, genetic and
biological factors, and social influences (Barr et al., 2008; Behrendt et al., 2008; Goltz et al.,
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2009; Pawlak et al., 2008; Siegmund et al., 2005b; Spanagel et al., 2005; Vengeliene et al.,
2009). The influence and interplay of these factors varies from one individual to another, and
with their respective stage of development and of alcohol addiction. Approximately 25% of
Americans develop an alcohol use disorder at some point in their lives, and for some it becomes
an overwhelming negative influence that results in uncontrolled drinking and disruption of
normal life (DSM-IV-TR, A.P.A., 2000; Haeny et al., 2013).
Until 2013 the American Psychiatric Association listed defined criteria for two alcohol use
disorders (AUD) in the Diagnostic and Statistical Manual (DSM-IV): alcohol abuse and alcohol
dependence. Alcohol abuse was characterized by drinking despite social, occupational, and legal
problems that are associated with impairment and stress, but not with physical dependence.
Alcohol dependence reflected neurobiological adaptations to the long-term presence of alcohol,
and had several defining characteristics: tolerance, withdrawal, drinking more than intended,
unsuccessful attempts to quit or reduce drinking, interference with other life activities, and
continued use despite knowledge of negative physical and psychological problems that are likely
caused by drinking. For a diagnosis of alcohol dependence there must have existed a maladaptive
pattern of drinking behavior that lead to clinically significant impairment or distress
accompanied by at least 3 of the above symptoms in a 12-month period (A.P.A., 2000). Studies
have shown that alcohol dependence was the more valid and reliable of these two diagnoses
(Bucholz et al., 1994; Canino et al., 1999; Chatterji et al., 1997), and in 2013 the definitions for
AUDs were revised for the 5th edition of the DSM (DSM-V). Instead of two distinct constructs,
the DSM-V defines a single construct with moderate and severe diagnoses based on the number
of criteria displayed by the patient, with the previous criteria for alcohol abuse and dependence
remaining largely unchanged, but combined into a single list. A moderate AUD is a pattern of
9

maladaptive drinking behavior with 2-3 of the listed criteria, while a diagnosis of severe AUD
requires 4 or more of these criteria (Kopak et al., 2013).

Neurobiology and treatment of alcoholism in humans
It is clear from the persistent cost of alcoholism to individuals and society that the disorder is not
well understood and thus not well controlled. Alcohol use disorders are particularly difficult to
manage due to the complexity of the biological and environmental factors that motivate drinking.
Alcohol is widely available in the United States, where the drug may be purchased legally by
persons over the age of 21 in most of the country, with the exception of some dry counties.
Behavioral and pharmacological treatment strategies have not proven effective in the long-term
for the majority of patients, although there is evidence to suggest that a combination of these
strategies is more effective than either alone (Feeney et al., 2006; Garbutt, 2009; Krampe et al.,
2006; McKay, 2006; Soyka and Rosner, 2008). Much has been learned in recent years about the
neurobiology of ethanol exposure, with the goal of developing more effective treatment
strategies.
Alcohol produces psychoactive effects through action at more molecular targets than is typical
for an abused substance (Vengeliene et al., 2009). In the CNS, ethanol interacts with receptors
for glutamate, GABA, glycine, acetylcholine, and serotonin, and inhibits ion channels for
potassium and calcium. Several other neurotransmitters are known to modulate aspects of
alcohol drinking behavior, including dopamine, serotonin, endogenous opioids,
endocannabinoids, corticotrophin releasing factor, and neuropeptide Y. Due to this complexity of
action the FDA has been able to approve only three drugs for the management of alcoholism as
of 2013: disulfiram, acamprosate, and two forms of naltrexone. Although drugs approved to treat
alcoholism show limited effectiveness, much can be learned about alcoholism and alcohol10

related behavior from study of the behavioral changes they produce in animal models and their
mechanisms of action.
Disulfiram inhibits the action of the acetaldehyde dehydrogenase enzyme, which increases levels
of acetaldehyde 5- to 10-fold (Faiman et al., 2013). Acetaldehyde is an alcohol metabolite that
mediates some of the aversive effects of alcohol consumption, and genetic differences that
reduce acetaldehyde dehydrogenase function are associated with reduced ethanol intake (Faiman
et al., 2013). High levels of circulating acetaldehyde cause flushing of the skin, tachycardia,
nausea, vomiting, headache, and other unpleasant symptoms (Bae et al., 2012). Disulfiram is
relatively effective when patients are compliant, with some evidence for abstinence rates of
about 50% over a 9-year study when combined with calcium carbimide, which is an ethanolsensitizing agent (Krampe et al., 2006).Unfortunately, disulfiram does not reduce craving for
ethanol and patient compliance is a major obstacle to successful therapy. A study of disulfiram
treatment in cooperation with the U.S. Veterans Administration found patient compliance at
20%, which precluded any statistically significant effect of disulfiram treatment combined with
therapy compared to disulfiram alone (Fuller et al., 1986).
Acamprosate and naltrexone both address more directly the psychological aspects of alcohol
addiction by acting at a pharmacodynamic level to interfere with the neurobiological
underpinnings of ethanol reward and craving (Soyka, 2013). When given in conjunction with
cognitive behavioral therapy, each of these drugs has been shown to produce abstinence in the
majority of patients over a 3-month period. There is some evidence that the combination of the
two drugs is more effective than either alone, although naltrexone produced nearly the same
proportion of abstinent patients alone as when combined with acamprosate (Anton et al., 2006;
Feeney et al., 2006). Until 2013 it was thought that acamprosate attenuates the hyperactive
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neuronal state associated with withdrawal, which is characterized by hyperactive NMDA
glutamate receptors and hypoactive GABAA receptors. By acting as a partial agonist at GABAA
receptors and inhibiting NMDA receptor activity, acamprosate would reduce hyperexcitability
and negative aspects of withdrawal and reduces alcohol consumption (Kurokawa et al., 2013;
Oka et al., 2013).
There is also some evidence in vitro for neuroprotective effects of acamprosate that reduce
neuronal death caused by excitotoxicity induced by withdrawal and glutamate release, which
could mitigate long-term deficits caused by cycles of alcohol abuse and withdrawal (al Qatari et
al., 2001). However, a recent landmark Neuropsychopharmacology study shows that all of the
actions of acamprosate (calcium-bis-N-acetylhomotaurinate) can be attributed to calcium, and
that N-acetylhomotaurine is a biologically inactive molecule (Spanagel et al., 2013).
Naltrexone is a non-selective competitive antagonist at the three main subtypes of opioid
receptor: mu, kappa, and delta. It is available in oral and injectable forms for prevention of
relapse for heavy-drinking alcoholics and patients dependent on opioids. Naltrexone interferes
with the reinforcing effects of alcohol by preventing activation of opioid receptors by
endogenous opioid peptides, which is accompanied by reduced release of dopamine in the
ventral tegmental area (VTA) of the midbrain (Soyka and Rosner, 2008).
The VTA is the site of origin for dopaminergic neurons that project forward to the nucleus
accumbens (NAc) in the mesolimbic reward pathway, as well as efferents that project to the
prefrontal cortex (PFC) in the mesocortical dopamine pathway. These two dopamine pathways
are not independent, and the functioning of one may be affected by altering the other. Although
differences in opinion exist as the function and extent of these regions and pathways, there is
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general consensus that together with closely connected regions, they act to regulate behavior in
response to drugs of abuse and other potentially rewarding stimuli. Other areas of the brain
involved in these behaviors through connections with these pathways include the amygdala and
the hippocampus. The mesocortical pathway is thought to be involved in attention and
motivation, emotional response, decision making, and other functions associated with the frontal
lobe of the cerebral cortex. The mesolimbic pathway is thought to be involved in reward, desire,
and motivated behavior. There is some evidence that activity in this pathway is particularly
associated with incentive salience, which is the ability of a stimulus to induce craving or wanting
in an organism, as opposed to pleasure or euphoric feelings (Berridge, 2012). Study of the effects
of drugs known to be useful for management of alcoholism in the context of these neural
pathways and regions may point the way toward better therapeutic strategies, with respect to
molecular targets and method of administration.

Animal models of excessive alcohol consumption
Better drugs are needed for the management of alcoholism, but experimentation toward this goal
has been hindered by the impracticality of extensive study of neurobiological factors and
response to novel compounds in humans. Thus, reliable and valid animal models of alcoholism
are necessary for better understanding of the disease and the development of new treatment
strategies.
The study of alcohol-related behavior in animals has been hindered by the low propensity of
most rodents to self-administer the drug (Amit et al., 1970; Crabbe et al., 2012; Wise, 1973,
1974). Mice and rats do not typically drink alcohol in a manner that produces measurable signs
of intoxication or significantly elevates blood alcohol content above 1.0% by volume, which is
approximately the legal limit for motor vehicle operation in most states. However, animal
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models have been developed for the study of alcohol abuse and dependence that reflect particular
sets of their respective defining characteristics, with the aim of elucidating the biological and
environmental factors that influence maladaptive excessive drinking behavior. Models of
escalating alcohol self-administration are also useful for the identification and testing of potential
therapeutic strategies, and for more basic study of the nature of reward processes.
Experimental strategies for producing high-level alcohol self-administration in rodents may be
grouped into several categories that reflect different aspects of alcohol-related behavior (Becker,
2013): scheduled brief access to alcohol (drinking-in-the-dark, DID), ethanol deprivation
following a baseline consumption period (alcohol deprivation effect, ADE/EDE), intermittent
alcohol access (IAA), schedule-induced polydipsia, and induction of dependence and withdrawal
via ethanol vapor or diet (chronic intermittent ethanol, CIE). Each of these models produces
effects on drinking behavior that are mediated by distinct neuromolecular substrates, and depend
greatly on the strain of rodent used. Much progress has been made in recent years toward
illumating the behavioral and neuromolecular characterization of these models, but results have
varied among laboratories with regard to the major players involved. The CIE and IAA models
are thought to be particularly reliable and valid representations of the transition to alcoholism in
humans, and have received much research attention in recent years.

Chronic intermittent ethanol vapor (CIE)
Induction of dependence with ethanol vapor is a well-established experimental method in
rodents. A typical procedure consists of 12-14 hour sessions of ethanol vapor exposure that
induce binge-like BEC levels of 100 mg% and greater (Criado and Ehlers, 2013; Griffin et al.,
2009; Lopez et al., 2011; Repunte-Canonigo et al., 2013). Vapor sessions are interspersed with
periods of withdrawal followed by home-cage drinking, and voluntary intake gradually increases
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with repeated cycles of dependence and withdrawal. This type of CIE vapor treatment increases
voluntary consumption and preference for alcohol by approximately 40-50%, but methodological
concerns limit the validity of the model for representing alcoholism. High BECs are achieved
through the use of the alcohol dehydrogenase inhibitor pyrazole, which is not used by human
drinkers and may itself alter drinking behavior over time. Furthermore, vapor exposure is an
involuntary method of ethanol intake, and involuntary drug use is known to produce
neurobiological changes that are different from those produced by voluntary use
(Ahmadiantehrani et al., 2013; Fernandez-Castillo et al., 2012; Tapocik et al., 2013).
Nevertheless, the CIE model has been used to study the neuromolecular consequences of
repeated alcohol exposure and withdrawal, which have been difficult to model in rodents.
Diverse molecular targets in several brain regions have been implicated in the production of
increased voluntary ethanol intake by CIE vapor exposure. GABAB agonist Baclofen decreased
operant ethanol self-administration following CIE (Walker and Koob, 2007), while the
benzodiazepine lorazepam and glutamate receptor antagonist MK-801 reduced signs of seizure
during the withdrawal phase of CIE, suggesting involvement of GABA and NMDA receptor
subunits (Veatch and Becker, 2005). CIE altered NMDAR subunit expression (NR1, NR2A,
NR2B) and excitability in the bed nucleus of the stria terminalis (BNST) (Kash et al., 2009) and
hippocampus (Nelson et al., 2005; Pian et al., 2010). Hippocampal LTP was transiently blocked
after 1 day of withdrawal from CIE, but recovered after 5 days (Roberto et al., 2002). These
changes in hippocampal LTP have been shown to involve changes in MAPK activity and sigmareceptor-dependent mechanisms (Roberto et al., 2003; Sabeti and Gruol, 2008).
CIE has also been shown to alter expression and function of thalamic T-type voltage-gated
calcium channels (Graef et al., 2010) and to interfere with synaptic plasticity and in nucleus
15

accumbens (NAC) (Jeanes et al., 2010). Administration of neuropeptide Y (NPY) or antagonists
for corticotrophin releasing factor (CRF) receptor or mu opioid receptor attenuated increased
drinking following CIE (Gilpin et al., 2008a; Gilpin et al., 2008b). Increased immobility in the
forced swim test (FST) produced by CIE was correlated with CRF levels in amygdala and
decreased NPY in frontal cortex (Walker et al., 2010). Genomic studies of mice following CIE
have shown changes in expression of genes regulated by protein kinase A (PKA), including
NPY, in medial prefrontal cortex, NAC, and amygdala, and have demonstrated alterations in
transcript abundance that likely affect the insulin/PI3K, NF-KB, and JAK/STAT pathways
(Repunte-Canonigo et al., 2007; Repunte-Canonigo et al., 2010). Lesion of the BNST or central
nucleus of the amygdala did not prevent increased voluntary ethanol drinking due to CIE
(Dhaher et al., 2008), suggesting that multiple brain regions are involved in the behavior.
The CIE model, despite its limitations, has been effectively used to study alcohol dependence
processes, and molecular results have fit well with what is known of the neurobiological
underpinnings of alcoholism, in addition to providing insight into heretofore unknown players.
However, the model is expensive and time-consuming to use, and experimental design is
complicated by the number of control groups often needed: air-exposed and home-cage drinkers,
as well as vehicle controls when the effects of a drug are studied. In particular the stress of long
periods in the vapor chamber must be considered, which is difficult given the inconsistent effects
of stress on drinking behavior. Perhaps the most important limitation of the model is the
involuntary nature of alcohol exposure, which produces distinct regional activation and
transcriptional regulation compared to voluntary exposure. Thus, better animal models of the
transition to alcohol dependence are needed.

Intermittent alcohol access (IAA)
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In recent years, abstinence-based procedures for producing increased craving for alcohol in 2bottle voluntary self-administration models have progressed substantially and have been adopted
by several laboratories. Scheduled abstinence models have several advantages in validity and
experimental utility compared to other methods for producing high or binge-like alcohol
consumption in rodents. With this type of model, drinking is voluntary and occurs in the home
cage, and water and food are always available. No enzyme inhibitors are required to achieve high
blood ethanol concentrations, and the only experimental manipulations performed are single
housing and scheduled abstinence. Thus, IAA has significant advantages in validity and
feasibility compared to other procedures used to produce increased ethanol craving and
dependence-like phenotypes, including vapor-chamber models that make use of enzyme
inhibitors and complex experimental designs, experimenter-administered ethanol injections that
are stressful to the subjects, and forced consumption through ethanol diet or lack of water
availability.
The scientific lineage of intermittent access (IA) models is complex. Multiple lines of
investigation have converged in recent years, although significant design differences remain in
access schedules, ethanol concentrations offered, and use of baseline access periods. In 2008
Simms and colleagues (Simms et al., 2008) resurrected the IAA model pioneered by Roy Wise
decades earlier in rats, and this every-other-day, single-concentration (20% v/v), no-baseline
model has been well-characterized in recent years, and extended to mice (Melendez, 2011; Wise,
1973). A further line of research originated in the study of the so-called alcohol deprivation
effect (ADE), a well-characterized single-deprivation model, which was extended to a multiple
deprivation or intermittent access model in mice in 2006 by Melendez and colleagues, who
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allowed simultaneous access to multiple alcohol concentrations for one day per week, after an
initial baseline access period (Khisti et al., 2006a; Melendez et al., 2006a).
In ADE studies deprivation occurs after a baseline continuous access period, and elevated intake
is transient upon resumption of continuous access. A consensus model has begun to emerge, and
studies published in the last 5 years utilizing these types of models have tended to use a single
ethanol concentration between 15 and 20% v/v, offer access with water for 24 hours on 3 nonconsecutive days per week, do not compare levels to a baseline access period, and make use of a
continuous access (CA) group as a time-matched control. Due to experimental limitations
rodents are always housed one animal per cage, which has been shown to induce stress and may
contribute to the effects produced by intermittent access. It is surprising that concurrent access to
multiple alcohol concentrations is rarely used, given the high levels of drinking it produces, and
the obvious similarity to human drinking (Bell et al., 2004b; Holter et al., 1998; Melendez et al.,
2006a; Obara et al., 2009b; Wolffgramm and Heyne, 1995).
The intermittent alcohol access (IAA) procedure increases ethanol consumption and preference
for ethanol over water in a manner thought to model the early stages of the transition from
controlled to uncontrolled alcohol consumption that occurs in human alcoholics (Melendez et
al., 2006a; Simms et al., 2008; Wise, 1973). Alternating periods of voluntary oral ethanol selfadministration and abstinence produce two-fold increases in ethanol consumption and significant
increases in preference for ethanol over water in as little as 1 week, which increase over
subsequent weeks of IAA to reach binge-like levels of consumption (> 20 g/kg/day) and BEC (>
80 mg/dl). The magnitude of escalation produced by IAA depends on animal strain, ethanol
concentrations offered, and access schedule (Crabbe et al., 2012; Khisti et al., 2006a; Simms et
al., 2008). Changes indicative of dependence-like phenotypes have been shown after months of
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IAA: increased handling-induced convulsions during withdrawal (Hwa et al., 2011) and
resistance to decreased alcohol consumption produced by quinine adulteration (Hopf et al.,
2011).

Influence of age, genetics, and environment on IAA
The degree to which intermittent access produces binge-like drinking behavior depends on
environmental and genetic factors, as well as the developmental stage of the animal utilized.
Drinking during adolescence is characterized by binge consumption, which may interfere with
brain development (Maldonado-Devincci et al., 2010; Silveri, 2012; Spear, 2000). Interestingly,
the IAA model produces greater binge-drinking in adolescent rodents than in adult rodents, but
these differences tend to disappear by adulthood. Group-housed adolescent rats drank beer on an
IA schedule and achieved high drinking levels of consumption (approximately 8 g/kg/day),
which gradually declined as the rats aged, and by postnatal day 55 mean consumption was
approximately 4 g/kg/day, and did not differ from intake in adult rats with continuous access.
Adolescent rats under intermittent access conditions drank more beer than adolescents with
continuous access, and more than adult rats under intermittent access (Hargreaves et al., 2009b).
Adolescent C57BL/6J mice under IA conditions increased intake more quickly and by a greater
relative amount, compared to adult mice (Melendez, 2011). Adolescent mice displayed
significantly decreased water intake from session 2, whereas adult mice did not show this effect
until session 5. This effect seems to be a later consequence of intermittent alcohol access that
reflects a loss of interest in fluids that do not contain alcohol. More study is needed to determine
the role of adolescent IAA in adult drinking behavior, to determine the extent of similarity
between binge-drinking in rodents and humans, and thus the utility of the model for study of
early intervention to prevent the development of AUDs. Differences in the effects of adolescent
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binge-drinking on drinking in adulthood are likely caused by social and cognitive factors that
may be difficult or impossible to model in rodents, such as peer pressure.
Few studies have examined the role of stress and anxiety in the IAA model, despite the
established role of CRF signaling in IAA drinking behavior, and the utility of CRF antagonists to
reduce binge-like consumption in dependent and non-dependent animals (Finn et al., 2007; Hwa
et al., 2011). Furthermore, AUDs have shown significant comorbidity with anxiety disorders
such as post-traumatic stress disorder (PTSD) in epidemiological studies, and alcohol is used by
humans as an anxiolytic (Coffey et al., 2010). In rodents, foot-shock procedures induce anxietylike behavior such as conditioned freezing and reduced exploration. Stress induced by foot-shock
in Long-Evans rats produced elevated drinking behavior in the IAA model, but only when given
prior to the start of drinking. Shocked rats showed elevated drinking for the initial 70-day IAA
period, and for a further 20 days following a 40 day withdrawal period (Meyer et al., 2013). Thus
there seems to be a direct relationship between certain stressors and binge-like drinking behavior
produced by IA, but the fact that stress did not alter previously established drinking patterns
produced by IA is intriguing. This lack of effect suggests that behavior produced by IAA is
relatively inflexible, which is a characteristic of drinking in human alcoholics, who drink despite
negative consequences and have difficulty moderating intake.
Juvenile social isolation is also known to increase anxiety-like behaviors and ethanol
consumption. Social isolation in rats during adolescence increased anxiety-like behavior in the
elevated plus maze, and increased drinking in the IAA model, compared to group-housed rats
(Chappell et al., 2013). Furthermore, these measures were significantly correlated across
individual animals in the socially isolated group and in group-housed rats. Maternal separation is
an early life stressor with lasting neurobiological and behavioral consequences that include
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altered opioid signaling, increased alcohol consumption, and altered dopamine D2 receptor
density in the VTA (Cruz et al., 2008; Li et al., 2013). Maternal separation during the period
from postnatal day 1 to 20 has been shown to decrease the escalation of 5% alcohol consumption
in adult Wistar rats (Daoura et al., 2011), but the use of a low alcohol concentration, and the lack
of effect in rats with normal upbringing, may limit generalization to other versions of the model.
Maternal separation also influences the efficacy of naltrexone for reducing binge-drinking during
adulthood (Daoura and Nylander, 2011). Naltrexone had no effect in rats reared under normal
conditions, and dose-dependently decreased intake of 5% and 20% alcohol in rats with extensive
maternal separation. Interestingly, in rats with shorter periods of maternal separation naltrexone
reduced intake of 5% alcohol, but increased preference for 20% alcohol. These results suggest a
complex link between early life stress, opioidergic neurotransmission, and adult binge-drinking
behavior that should be further explored, and the results of which could inform current treatment
strategies in humans.
Inbred animal strains of the type used for nearly all behavioral research display a wide range
phenotypes for drinking and other alcohol-related behaviors. Alcohol consumption varies from
strain to strain under the influence of genetics, and among individuals under the influence of
epigenetics and environment (Crabbe et al., 2012; Crabbe et al., 2009; Khisti et al., 2006a;
Metten et al., 2010; Wise, 1974; Wolstenholme et al., 2011). Much effort has been devoted to
study of the influence of genetic background on drinking behavior induced by intermittent
access, with the goal of correlating differences in alcohol intake to genetic, epigenetic, and
phenotypic factors. In IAA behavior the animal supplier used for drinking studies has been
shown to affect drinking behavior. In Wistar rats from 5 suppliers, significant differences in
drinking for 5% ethanol, with fewer differences for 20% ethanol were observed; response to
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intermittent access varied greatly across the strains, and no strain displayed the elevated intake
typically produced by IAA in other strains (Palm et al., 2011).
Intermittent access has been shown to increase alcohol consumption and preference in several
strains of mice, although the magnitude of the effect varies. Interestingly, the IAA procedure
produced similar escalation in drinking behavior across mouse strains bred for divergent ethanolrelated behavior (Rosenwasser et al., 2013). Mice bred for binge-drinking and sensitivity to
withdrawal-related seizures showed no difference compared to their respective genetic
background strains. IAA using a shortened 4-hour access period did not produce elevated ethanol
intake in C57BL/6J or HDID (High Drinking-In-the-Dark) mice, and a 24-hour access period
produced this effect in C57BL/6J mice only (Crabbe et al., 2012). It is surprising that the IAA
model seems to represent an aspect of alcohol-related behavior controlled by distinct genetic
mediators as compared to withdrawal sensitivity and binge-drinking, when it is a model that
produces precisely these effects in mice. However, the preponderance of evidence shows that
binge-like drinking behavior may be altered by a wide range of pharmacological and genetic
manipulations. Any of the molecular targets of these manipulations, or genes with as yet
unknown relationships to alcohol behavior, could be responsible for the trait produced in the
selectively-bred mice. That is, selective breeding for a trait may produce a phenotype through
genetic mediators with no similarity to those that produce the trait in uncontrolled settings, and it
is thus important to be skeptical regarding neurobiological and behavioral conclusions drawn
through its use.
Ethanol drinking behavior in rodents is extremely sensitive to environmental change, and
particularly to changes in the personnel attending to the animals. A recent IAA study in the Miles
laboratory (unpublished) examined drinking behavior in 7 strains chosen from the Hybrid Mouse
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Diversity Panel group, which were selected to represent a wide range of CA drinking behavior.
In this study a change in personnel was found to decrease combined group mean alcohol intake
more than did the initial intra-peritoneal saline injections given by the new experimenter (Miles
lab, unpublished data). The initial change in drinking was due only to indirect interaction with
the mice; the experimenter did not handle the mice until 1 week after initial exposure, when
saline injections were begun.
Although IAA immediately elevates alcohol intake, there is mounting evidence that after weeks
or months the procedure causes further behavioral and molecular changes that reflect the
transition to alcohol dependence. These changes suggest a loss of interest in alternative
reinforcers and the development of compulsive and inflexible drinking behavior, which are
characteristics of human alcoholics. Six weeks of IA to 20% alcohol led to maintained
consumption despite quinine adulteration, and this effect was not shown by CA animals.
Furthermore, long-term IA caused impairment in the Rota-rod task compared to CA animals (Loi
et al., 2010). Three to four months, but not 1.5 months, of IA using a hybrid model with operant
self-administration and home-cage intermittent procedures prevented reduction of progressive
ratio breakpoints by quinine adulteration (Hopf et al., 2010). Extended IAA also reduced the
effect of quinine adulteration on home-cage drinking, and motivation for sucrose adulterated by
quinine was not altered. Furthermore, quinine taste preference was not altered by extended IAA,
which showed that this procedure did not seem to alter taste preference for bitter solutions.
Significant differences from continuous access rats were only observed for the first 8 weeks in
alcohol-preferring Indiana University P rats offered concurrent access to 15% and 30% alcohol
on an intermittent schedule (Obara et al., 2009a). However, IA rats drank significantly less water
than CA rats after the 5th week, and showed differences in abundance of several proteins
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involved in glutamatergic signaling in the nucleus accumbens and central amygdala. Protein
levels of mGluR5 in NAc core were elevated by 24h withdrawal in IA and CA rats, but after 4
weeks of withdrawal this protein remained elevated in IA rats, and had returned to normal in CA
rats. In CeA mGluR5 is upregulated after 24h withdrawal in IA rats, but not at any withdrawal
time point in CA rats. These results suggest that in NAc and CeA alcohol alters glutamatergic
signaling via NMDA receptors similarly in IA and CA rats, but that long-term IA causes
persistent regulation of metabotropic glutamate receptor signaling in a manner distinct from CA.
Thus long-term IAA seems to engender a second set behavioral and neurobiological changes
distinct from the immediate increase in drinking, and these changes, which include inflexible
behavior and alterations in glutamatergic signaling, are consistent with the transition to
alcoholism in humans.

Neurobiology of Intermittent Alcohol Access
Escalation induced by IAA is attenuated by naltrexone and acamprosate, and thus seems to
represent a valid model for the study of other compounds with potential to treat AUDs (Simms et
al., 2008). A large number of studies in recent years have focused on study of the
neuromolecular systems altered by IAA, changes in which are associated with increased craving
and binge-like drinking. Typical experimental strategies toward this end are the use of ligands
and knockout mice to alter IAA behavior, and use of molecular methods to study the effects of
IAA on neurotransmission, neuronal excitability, mRNA transcription, and protein abundance.
The most extensively studied molecular mediators of the effects of IAA on behavior are the
transcription factor deltaFosB, glial cell line-derived neurotrophic factor (GDNF) and the
corticotropin-releasing factor/hormone (CRF/CRH) system, but perturbation of other
neurotransmitter systems has been shown to modulate effects of IAA. In recent years several
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laboratories have explored a diverse array of ligands for the potential to alter binge-like drinking
behavior, and each of these compounds represents a potential treatment vector for AUDs
(Ahmadiantehrani et al., 2013; Carnicella et al., 2009a; Hopf et al., 2011; Hwa et al., 2013; Li et
al., 2011a; Moorman and Aston-Jones, 2009a; Sabino et al., 2013; Sajja and Rahman, 2013; Wen
et al., 2012; Yardley et al., 2012). Some of the drugs effective in reducing IAA are already
approved by the FDA for use in humans, and further study is needed to determine which vectors
represent the most high priority targets for further preclinical and clinical research.
Recent studies do not agree on the role of CRF in binge-like drinking behavior. CRF is produced
by the paraventricular nucleus (PVN) of the hypothalamus in response to stress, and is trafficked
to the pituitary gland, where it causes the release of adrenocorticotropic hormone (ACTH),
which stimulates glucorticoid release from the adrenal glands. CRF acts at 2 subtypes of CRF
receptor: CRHR1 and CRHR2. The observation that CRF-R1 antagonists attenuate elevated
ethanol consumption produced by chronic ethanol vapor exposure led to its study in IAA. Taken
together the data thus far indicate that CRHR1 antagonism attenuates binge-like drinking
behavior produced by IAA, but this effect may be dependent on strain and age.
Crucially, significant differences have been observed regarding the role of the CRF system in
animals on IA and CA alcohol drinking schedules, suggesting that the system mediates
maladaptive drinking in a manner distinct from controlled drinking, and is thus a promising
therapeutic candidate. The CRF-R1 antagonist CP-376395 reduced consumption of 20% ethanol
in Long-Evans rats on an intermittent schedule, but had no effect on rats offered continuous
access. CRF-mediated signaling in the hypothalamus of IA rats was decreased compared to CA
rats, which suggested that CP-376395 effects on drinking behavior are mediated by
extrahypothalamic mechanisms (Simms et al., 2013).
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The CRHR1 antagonist antalarmin reduced alcohol consumption for 20% ethanol under
intermittent and continuous access schedules, but reduced consumption of 10% ethanol under the
intermittent schedule only (Cippitelli et al., 2012). In Sardinian alcohol-preferring rats, bingelike drinking produced by IAA was suppressed by naltrexone and dopamine D1 receptor
antagonist SCH 39166, but not by CRF1 antagonist R121919. Thus in sP rats, the effects of IAA
appear to be mediated by the opioid and dopamine neurotransmitter systems, but not by the
action of corticotropin releasing factor on CRF1R (Sabino et al., 2013). This result underscores
the fact that alcohol preference and high levels of consumption may be mediated by distinct
genetic factors across strains, and that study of IAA in multiple animal models is important.
The effects of CRHR1 on binge-like drinking are likely mediated by the VTA, but other regions
may be involved (Hwa et al., 2011). In Long-Evans rats and C57BL/6J mice intra-VTA CRHR1
antagonism selectively decreased alcohol intake elevated by IAA, and intra-DRN CP-154,526
administration reduced intake of ethanol and water. Individual animals with relatively high
alcohol intake were more severely affected by CRHR1 antagonism than animals with relatively
low intake. Effectiveness in the VTA, but not the dorsal raphe nucleus, implied that
dopaminergic inputs to the nucleus accumbens were more involved in maintenance of IAA
behavior than were serotonergic projections from DRN to amygdala and striatum. In adolescent
rats, a hybrid operant self-administration IAA model reduced CRF cell counts in the central
amygdala and increased adult drinking during intermittent access to alcohol, but not constant
access to alcohol. Rats with a history of binge drinking in adolescence also showed decreased
anxiety-like behavior in the elevated plus maze, but this difference was abolished by a history of
dependence induction with ethanol vapor (Gilpin et al., 2012). Thus, the CRF system appears to
be regulated by IAA and to mediate some aspects of IAA drinking behavior.
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DeltaFosB (ΔFosB),a persistent form of the Fos family of transcription factors that is associated
with addictive behavior (Krasnova et al., 2013; McClung and Nestler, 2003; Pitchers et al.,
2013). ΔFosB accumulates in neurons over time in response to cocaine and other drugs of abuse,
and eventually becomes the predominant form of Fos. Targets of ΔFosB transcription include
dynorphin, the GluR2 AMPA glutamate receptor, Cdk5, NFκB, and c-Fos (Robison and Nestler,
2011). Changes in the function of such ΔFosB targets in the nucleus accumbens seem to enhance
the reinforcing properties of some drugs of abuse, and contribute to dendritic remodeling and
other neuroplastic processes (Robison et al., 2013). Thus ΔFosB appears to play the role of a
molecular switch involved in the initiation and maintenance of motivated behavior for drugs of
abuse, as well as for food and natural reward (Pitchers et al., 2013).
In an early IAA publication Li and colleagues showed that Sprague-Dawley rats exposed to
alcohol 15 times over 35 days on a 3-day-per-week IAA schedule significantly elevated their
consumption over 2 to 3 sessions, and increased alcohol consumption due to IAA was associated
with significantly increased ΔFosB levels in the nucleus accumbens core and the dorsolateral
striatum, but not in the nucleus accumbens shell or the dorsomedial striatum. Similar effects
were observed in the prefrontal cortex, where ΔFosB immunoreactivity was increased in the
ventral orbitofrontal cortex, but not in the medial prefrontal cortex. Acute naltrexone (2 mg/kg
I.P.) treatment attenuated the effects of IAA on drinking behavior, and reduced ΔFosB levels in
nucleus accumbens core, dorsolateral striatum, and orbitofrontal cortex compared to IAA rats
given saline (Li et al., 2010a). The mechanism by which naltrexone interferes with ΔFosB
accumulation seems to be downstream of opioid receptors, because treatment with Cytisine, a
nAChR antagonist, reduced alcohol intake of C57BL/6J mice in constant access and IAA
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drinking, and attenuated ΔFosB accumulation in the dorsal and ventral striatum following
drinking (Sajja and Rahman, 2013)
Interestingly, further studies examined the effects of electroacupuncture on drinking behavior
produced by IAA and regional ΔFosB accumulation, and found that electroacupuncture at a
particular point in rats at 100Hz, but not 2Hz, decreased consumption and preference induced by
IAA. This decrease was maintained for 72 hours following treatment, and intake of sucrose was
unchanged. ΔFosB levels in the prefrontal cortex, striatum, and VTA were elevated after bingelike ethanol consumption due to IAA, but these effects were abolished by 6 days of
electroacupuncture treatment. (Li et al., 2012b). These studies demonstrate that regional ΔFosB
accumulation is an important mediator of behavioral changes produced by IAA, and that diverse
methods of therapeutic intervention are effective at reducing ΔFosB levels and maladaptive
drinking behavior.
Naltrexone has been shown to be effective at reducing IAA-induced drinking, but it is a
nonselective opioid ligand, and the relative contribution of each opioid receptor subtype to its
effects has not been determined. While the contribution of kappa and mu type opioid receptor
subtypes to IAA behavior remains unclear, the delta opioid receptor seems to be involved. In
Long-Evans rats, intermittent alcohol access increased δ-opioid receptor (DOR) function in the
dorsal striatum compared to CA and water-drinking rats. This upregulation led to persistent
DOR-mediated analgesia in adulthood, when this effect is normally seen in young animals only.
Administration of the DOR antagonist naltrindole, both systemic and into the dorsal striatum,
decreases ethanol consumption and DOR activity in the dorsal striatum (Nielsen et al., 2012).
Thus DOR activity in the dorsal striatum seems to play a role in binge-like drinking induced by
IAA.
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Unlike other drugs of abuse, alcohol has caloric value, and thus drinking behavior is connected
to hunger and satiety more directly than is self-administration behavior for other drugs of abuse.
In the brain, satiety is partially mediated by the action of glucagon-like-peptide-1 (GLP-1),
which has receptors in the VTA and NAc, and modulates food intake through the mesolimbic
dopaminergic system (Dickson et al., 2012; Dossat et al., 2011). Administration of Glucagonlike-peptide and analogs reduced intake in the IAA model, and blockade of the GLP-1 receptor
exacerbated the effects of IAA. Microinjection studies indicated that this effect was produced by
action in the VTA, although other regions were not studied (Shirazi et al., 2013). Furthermore,
GLP-1 agonist Exendin-4 reduced ethanol-induced dopamine release in the nucleus accumbens
of mice, and altered several ethanol-related behaviors. Exendin-4 abolished conditioned place
preference for alcohol, reduced alcohol-induced locomotor activity, and reduced consumption of
20% ethanol in the IAA model (Egecioglu et al., 2013). Mesolimbic signaling through GLP1receptors thus represents an important mediator of the acute behavior effects of alcohol and of
escalation of drinking behavior due to IAA, and a promising therapeutic candidate.
Some further evidence for a role of processes involved in food reward in IAA binge-like
drinking was provided by the studies of Moorman and Aston-Jones (2009). Rats exposed to IAA
showed significantly greater preference for ethanol than sucrose-faded rats, and in both groups
the orexin-1 receptor antagonist SB-334867 reduced preference selectively in rats with high
ethanol preference (Moorman and Aston-Jones, 2009b). Orexin is produced only by a subset of
several thousand hypothalamic neurons, although their axons extend throughout the CNS, where
they exert a primarily excitatory influence. This result suggests that the orexin system, which is
associated with appetite and arousal, is causally related to ethanol preference.
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Alcoholism is associated with inhibited inhibitory signaling in the brain, which, with elevated
glutamatergic signaling, contribute to hyperexcitability and seizures associated with withdrawal
(Caputo and Bernardi, 2010; Hughes, 2009). Therefore the role of inhibitory signaling has been
investigated in IAA drinking behavior. Intake of ethanol, but not sucrose or water, was reduced
by infusion of glycine into the VTA of rats under IA and CA schedules. Glycine also reduced
responding for ethanol under operant self-administration conditions, and these effects were
mediated by strychnine-sensitive glycine receptors (Li et al., 2012a). In Long-Evans rats, IAA
upregulates GABAA receptor signaling in the hypothalamus, which is associated with lowered
HPA axis function and blood corticosterone levels. Administration of GABAA antagonist
picrotoxin into the paraventricular nucleus of IAA rats reduced alcohol intake and increased
blood corticosterone levels. This effect was specific to alcohol over sucrose, and blocked by
GABAA antagonist muscimol (Li et al., 2011a). Therefore it is clear that IAA alters inhibitory
signaling through receptors for GABA and glycine, and the IAA model is a useful test for
effectiveness of drugs for alcoholism that act on these systems.
Further evidence for changes in excitability due to IAA was provided by studies on potassium
channels involved in action potential regulation. Alcohol is known to alter function of SK-type
potassium channels in limbic areas, and Chlorzoxazone, an activator of these channels,
selectively and dose-dependently reduced alcohol consumption in rats exposed to intermittent,
but not continuous, alcohol access (Hopf et al., 2011). This effect was partially explained by
changes in excitability of nucleus accumbens core medium spiny neurons. These core neurons
showed increased firing, reduced control of SK-channels over firing, and more potent
Chlorzoxazone-induced inhibition of firing, compared to neurons from rats with continuous
alcohol access. Chlorzoxazone is an FDA-approved muscle relaxant and represents a high
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priority target for further preclinical and clinical study as a treatment for AUDs. These results
implicate changes in NAc excitability in the control of binge-like drinking behavior.
In a surprising result that further implicated changes in excitability and neurotransmission, the
antiparasitic agent Ivermectin was shown to interfere with alcohol-related behavior in a dosedependent manner (Yardley et al., 2012). In arthropods, Ivermectin acts at glutamate-gated
chloride channels, but in mammalian cell culture the drug blocked ethanol-induced inhibition of
P2RX4 (Purinergic receptor P2X, ligand-gated ion channel, 4) function. P2RX4 is a ligand-gated
cation channel with high calcium permeability that is activated by ATP and involved in
depolarization (Koshimizu et al., 2000; Shigetomi and Kato, 2004). Interestingly, P2X4R
activation has been linked to BDNF release from microglia, and increased BDNF is known to
reduce alcohol drinking and alter the rewarding properties of alcohol (Bahi and Dreyer, 2013;
Ulmann et al., 2008). Systemic Ivermectin reduced alcohol consumption in a 2-bottle-choice
voluntary drinking model and a 4-hour limited access model. The drug also reduced operant
alcohol self-administration, and the authors showed that significant reductions in intake
corresponded to peak Ivermectin levels in the brain. Ivermectin is therefore an intriguing
therapeutic candidate, with a mechanism of action supported by the literature that has not been
pharmacologically exploited.
Despite the established role of transcriptional regulation mediated through cyclic AMPresponsive element binding protein (CREB) in alcohol drinking and addiction to other drugs of
abuse, the role of cyclic AMP (cAMP) signaling and CREB in IAA drinking behavior has not
been well established (Green et al., 2006; McClung and Nestler, 2003; Misra and Pandey, 2006;
Misra et al., 2001; Pandey, 2004b; Robison and Nestler, 2011; Uddin and Singh, 2007).
Interference with cAMP signaling using the phosphodiesterase-4 inhibitor Rolipram reduced
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operant responding for ethanol, as well as continuous access and intermittent access drinking.
Interference with phosphodiesterase-4 function raises cellular cAMP levels and thus may
activate CREB signaling and alter transcription of genes involved in drug-related behavior, such
as BK-type calcium-activated potassium channels and BDNF (Wen et al., 2012). Further study of
the role of cAMP signaling and CREB-mediated gene expression in IAA will illuminate the
transcriptional mechanisms that mediate changes in behavior, and establish the similarities and
differences of IAA and other preclinical models of addictive behavior.
Other than those examining ΔFosB, relatively few studies have examined the role of regulation
of particular mRNA transcripts in IAA behavior. Transcript abundance of Prkcz, which in the
brain encodes primarily for protein kinase M zeta (PKMζ), is increased by ethanol exposure, and
is correlated with ethanol consumption in mice (Mulligan, 2006; Mulligan et al., 2011).
Furthermore, PKMζ has been shown to be involved in maintenance of long-term memories,
including memories of cocaine and morphine reward that cue reinstatement of drug-taking
behavior (Li et al., 2011c; Shabashov et al., 2012), Knockout of the Prkcz gene in mice reduced
intermittent access drinking, but not constant access drinking or drinking-in-the-dark. IAA
drinking increased PKMζ protein in the ventral striatum of wild-type littermates, and ethanol upregulated Prkcz transcript in cultured PC12 cells (Lee et al., 2013). These results are important
because they highlight differences in neurobiology associated with drinking behavior in models
that produce binge-like drinking. Specifically, the IAA model appears to produce binge-drinking
through mechanisms that are more similar to those involved in relapse behavior for other drugs
of abuse than does the drinking-in-the-dark model. The IAA model may therefore be considered
as one of repeated abstinence and relapse, supporting validity for representing behavior in
alcohol humans.
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Several recent studies have focused on the role of glial cell line-derived neurotrophic factor
(GDNF) as an ethanol-responsive gene and negative regulator of IAA drinking behavior, as well
as the role of dopaminergic signaling in the NAc and VTA. GDNF is a growth factor that is
required for the development and function of midbrain dopaminergic neurons (Airaksinen and
Saarma, 2002). Following GDNF binding to GDNF family receptor alpha-1 (GFRA1), Ret
tyrosine kinase is activated, which leads to transcriptional regulation and increased activity of
dopaminergic neurons (Yang et al., 2001). The primary site of GDNF production is the nucleus
accumbens, from which it is retrogradely transported to the VTA, where it alters gene expression
and excitability of dopaminergic neurons of the mesolimbic reward system(Wang et al., 2010).
Immediately following an IA consumption period dopamine levels in NAc begin to fall, and
differ significantly from levels in water drinkers after 1 hour of withdrawal. Decreased NAc
dopamine is maintained for at least 24 hours in abstinent rats, and intra-VTA GDNF increased
NAc dopamine to normal levels (Barak et al., 2011). Furthermore, intra-VTA GDNF reduced
ethanol intake in the IAA model, operant responding for ethanol, and relapse (Carnicella et al.,
2009b). One week of IA elevated GDNF levels in VTA, but after 7 weeks of IA this effect was
no longer present. Following 7 weeks of IAA, an abstinence period of 24 hours reduced GDNF
levels, which were in turn elevated by a subsequent period of alcohol exposure and binge-like
drinking. Rats that drank low amounts of alcohol during this post-deprivation binge showed
greater GDNF elevation than did rats that drank greater amounts of alcohol (Ahmadiantehrani et
al., 2013). These findings suggest that GDNF represents a potential treatment for alcoholism, and
that GDNF tone and responsiveness to alcohol contribute to individual variation in binge-like
drinking.
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Other studies have examined the effects of IAA on neuronal signaling, connectivity, and
excitability. Intermittent access to 20% alcohol in rats enhanced postsynaptic AMPA glutamate
receptor function and spontaneous tonic glutamate release, but did not alter evoked presynaptic
glutamate release (Stuber et al., 2008). In Wistar rats 7 weeks of IAA altered endocannabinoid
and GABAergic signaling in the dorsolateral striatum (Adermark et al., 2011). Endocannabinoid
signaling was inhibited at a level downstream from the CB1 receptor, and was accompanied by
reduced inhibitory control of striatal output mediated through GABAA receptors. Interestingly,
similar effects were seen in age-matched control animals that had received no experimental
manipulation other than being housed one rat per cage. This effect suggests that social isolation
may contribute to some of the changes in signaling that occur during IAA, and demonstrates the
need for more sophisticated experimental techniques that do not require single housing.
Examining Fos expression in medial prefrontal cortex (mPFC), central amygdala (CeA),
hippocampus, and NAc, indicated that IAA impairs inhibitory control of the mPFC on the CeA
to produce changes in drinking behavior and cognitive impairment (George et al., 2012).
Abstinence during IAA activated mPFC, and the number of Fos-positive neurons was
significantly correlated with impairment of working memory in the Y-maze and binge-like
drinking behavior. Interestingly, 2 hours of alcohol access normalized numbers of Fos-positive
neurons to control levels, suggesting that craving induced by IA is at least partially due to altered
mPFC function. Differences in regional connectivity between prefrontal cortex, nucleus
accumbens, and amygdala were induced by intermittent alcohol access as compared to constant
access. In mPFC the authors showed that abstinence from IA increased numbers of CRF-positive
neurons, and activated GABAergic interneurons. As a correlate to altered PFC functioning, IA
rats displayed impaired working memory after 24h of withdrawal, but not immediately following
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alcohol access. CA rats showed no deficits in working memory during immediate withdrawal,
and no group differences were observed after 50 days of withdrawal. Taken together these data
suggest that IAA activates CRF and GABA neurons in the mPFC during withdrawal, and that
changes in PFC/CeA connectivity impair executive control over drinking behavior and working
memory. Furthermore, activation of mPFC and CeA during abstinence seems to be predictive of
subsequent binge-like drinking behavior, and may represent an early test for the propensity to
develop AUDs.
Despite extensive data supporting IAA as a model for the transition to alcoholism, little effort
has been aimed at elucidating transcriptional regulation occurring over time that is associated
with the development of binge-drinking. Changes in mRNA abundance can provide insight into
the mediators of neuroplasticity associated with changing behavior, and thus potential
therapeutic targets for future study. Genomic study using DNA microarray technology allows for
the unbiased examination of thousands of mRNA transcript species at once. Patterns of gene
expression can then be associated with phenotypic data and experimental manipulation, such as a
disease state or drug response. Because differences in gene expression mediate the effects of
genotype on behavior, studies of this type can provide novel mechanistic information and inform
hypothesis generation for future experimentation (Abiola et al., 2003; Kerns et al., 2005; Miles
and Williams, 2007b; Mulligan et al., 2008a; Trabzuni et al., 2013; Wolen and Miles, 2012).
Alcoholism and the response to alcohol in the CNS have been extensively studied using genomic
methods, because alterations in transcription caused by alcohol and other drugs of abuse are
thought to underlie neuroplasticity that leads to addiction (Mulligan, 2006; Mulligan et al.,
2008b; Mulligan et al., 2011; Nestler and Aghajanian, 1997). Experimental approaches used to
study the relationship of alcohol and gene expression in animal models have tended to use two
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approaches, which are sometimes combined: study of alcohol-induced changes in gene
expression, and study of differences in basal gene expression across strains of mice with
divergent alcohol-related behavior (Kerns and Miles, 2008; Singh et al., 2007; Xu et al., 2001).
Studies have generally produced results consistent with knowledge of the neurobiological
underpinnings of alcohol-related behavior, such as alterations in glutamatergic signaling, but
have also been used identified novel players in those processes (Bowers et al., 2006).
Alcohol causes persistent changes in gene expression that are apparent within 4 hours of
exposure (Miles et al., 1991), and differences in the transcriptional response to ethanol seem to
contribute to the genetic heritability of alcoholism (Chesler et al., 2005; Schadt et al., 2003).
Expression profiling in whole brain of C57BL/6J and DBA/2J mice given a high dose of ethanol
identified ethanol-responsive genes gene expression, cell signaling, and response to stress
(Treadwell and Singh, 2004). Interestingly, although these strains show divergent ethanol-related
behavior, only a small subset of 16 transcripts were differentially regulated in the two strains by
alcohol, which was attributed to the use of whole brain tissue, rather than a particular region
(Crabbe and Belknap, 1993; Crabbe et al., 1998; Goldstein, 1973; Phillips et al., 1994) In recent
years most studies have opted for a regional approach for the study of ethanol-induced gene
expression and the contribution of basal transcript abundance to ethanol-related behaviors.
Regional approaches allow for more refined hypothesis generation through association of
expression and behavioral data in the context of regional roles in behavior.
Recent studies have shown that ethanol-responsive gene expression varies with brain region and
cell type (Kerns, 2005; Mulligan et al., 2011; Ozburn et al., 2012; Ponomarev et al., 2012). In
regions of the mesolimbic dopaminergic reward pathway, ethanol has been found to alter
transcription of genes associated with distinct functional areas: BDNF signaling in the NAc,
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myelination in the PFC, and retinoic acid signaling in the VTA (Kerns, 2005). Other studies have
found region-specific differences in alcohol-responsive gene expression in the NAc shell and
core, subregions of the amygdala, striatum, hippocampus, cerebellum, and other regions
(McBride et al., 2010; Vanderlinden et al., 2013). Regional gene expression has been shown to
be significantly correlated with alcohol drinking across strains and individuals (Mulligan et al.,
2011; Wolstenholme et al., 2011). Interestingly, distinct changes in gene expression have been
associated with drinking behavior, operant self-administration, and experimenter-administered
alcohol, suggesting that the method of alcohol administration strongly influences its effects on
gene expression (McBride et al., 2010; Rodd et al., 2008). Studies such as these, which examine
the acute transcriptional response to alcohol, are especially useful for determining the
mechanisms through which alcohol exerts its initial effects on neurons, and the immediate
consequences of this action.
However, the primary purpose of preclinical study of alcohol in animal models is to better
understand alcoholism in humans, which is characterized by binge-drinking, dependence and
withdrawal, and in recent years some progress has been made toward understanding the
contribution of transcriptome alteration to the development of dependence over time. The
chronic intermittent ethanol (CIE) vapor model induces cycles of dependence of withdrawal, and
leads to progressive increases in ethanol consumption similar to that seen in human alcoholics
(Lopez and Becker, 2005; O'Dell et al., 2004). In the CIE model changes in drinking behavior
are associated with changes in gene expression in cortex and amygdala for genes involved in
synaptic plasticity and glutamatergic neurotransmission, which are processes involved in
neuroplasticity leading to alcoholism (Rimondini et al., 2002). The utility of this type of study
was further illustrated by the confirmation of the role of metabotropic glutamate receptor
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signaling in nucleus accumbens in drinking produced by intermittent alcohol access (IAA)
(Meinhardt et al., 2013; Obara et al., 2009a).
No preclinical model can serve as a fully valid representation of the human disease of
alcoholism, and even models that appear to involve similar behavior can produce significantly
different regional changes in gene expression. For example, the DID model and the IAA model
produce binge-like drinking, but transcription in PFC induced by IAA was more closely
correlated with changes induced by lipopolysaccharide treatment than with those induced by
DID (Osterndorff-Kahanek et al., 2013). It is therefore important to apply genomic study of the
ethanol transcriptome across preclinical models of alcohol drinking and other alcohol-related
behaviors, to achieve the most complete understanding of alcoholism and progress toward its
successful treatment.
Therefore, herein are reported the results of studies performed with the goal of better
understanding genetic and environmental factors that contribute to binge-like drinking behavior
produced by scheduled abstinence in the EDE and IAA models, and the transcriptional
mechanisms operating in the nucleus accumbens that lead to the development of this behavior
over time. These results should contribute to basic understanding of addictive behavior and of
alcoholism, and provide novel targets for the study of therapeutic intervention in alcohol use
disorders. The guiding hypothesis for these studies was that scheduled abstinence in mice
produces regional changes in gene expression in the brain, which mediate changes in alcohol
drinking behavior over time.
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Chapter 3. Genomic analysis of the alcohol deprivation effect identifies
alterations in mesocorticolimbic gene expression functioning in
neuroplasticity

Introduction
Alcoholism is a strongly heritable disorder characterized by recurrent relapse despite severe
social and biomedical consequences, and availability of several pharmacological and psychiatric
treatment strategies (Garbutt, 2009). Even the most effective treatments rarely produce long-term
abstinence (Krampe et al., 2006; McKay, 2006). Chronic ethanol exposure produces behavioral
changes that are thought to be mediated in part by gene expression alterations in discrete
neuronal populations (Vengeliene et al., 2009; Vilpoux et al., 2009). These changes gradually
produce a state of dependence, during which ethanol withdrawal is associated with severe
dysphoria that is thought to contribute to relapse and progressive consumption (Breese et al.,
2011; Powell, 1999; Valdez et al., 2002). Moreover, alcoholics are prone to relapse long after
halting abusive ethanol intake, due perhaps to neuroplasticity evoked by chronic ethanol
exposure (Heinz et al., 2009; Heinz et al., 2005; Vollstadt-Klein et al., 2011).
Several prior studies have identified changes in gene expression in response to ethanol
administration or basal gene expression correlated with ethanol consumption. Such transcripts
regulated in brains of humans and animals provide insight into the nature of neuroplasticity
occurring with repeated exposure (Goldowitz et al., 2006; Kerns, 2005; Mulligan, 2006; Uddin
and Singh, 2007; Wolstenholme et al., 2011). However, these studies have not addressed
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molecular events that might be specifically associated with escalation of ethanol consumption
following a period of abstinence, or mechanisms underlying relapse drinking behavior.
The alcohol deprivation effect (ADE) is an increase in ethanol consumption and preference
following abstinence in animal models of voluntary self-administration, and has been
demonstrated using two-bottle-choice and operant self-administration procedures (Sparta et al.,
2009; Wise, 1973). Although the ADE is not a model of alcohol dependence, it is considered to
model increased craving for ethanol following abstinence in human alcoholics, because it is
attenuated by naltrexone and acamprosate (Heyser et al., 2003). The ADE has been demonstrated
in rodents and primates under various experimental parameters, including varied ethanol
concentrations and lengths of deprivations, and has been shown to be specific for ethanol over
sucrose and water (Bell et al., 2004a; Khisti et al., 2006b; McBride et al., 2002; Vengeliene et
al., 2006). Repeated deprivations of 1 to 6 days on various schedules produce gradual, but
significant, increases in ethanol consumption and preference over a period of several weeks in
ethanol-preferring animals. The ADE may thus model events related to recidivism following
abstinence and the transition from casual use to abuse, addiction and dependence (Hopf et al.,
2010; Melendez et al., 2006a).
The current study performs a detailed genomic analysis of changes in the brain transcriptome of
C57Bl/6NCrl mice after 4 days of deprivation from ad libitum ethanol access in a two-bottle
choice model, a time point at which reinstatement of alcohol access produces significant
increases in ethanol consumption and preference compared to baseline, and to non-deprived
animals. Microarrays and bioinformatics analysis were used to assess changes in gene expression
associated with ethanol deprivation in nucleus accumbens (NAC), prefrontal cortex (PFC) and
ventral midbrain (VMB), regions of the mesocorticolimbic dopaminergic pathways that have
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been shown to be important in reward and motivated behavior (George and Koob, 2010). Our
results showed significant gene regulation by the ADE, particularly in NAC, as compared to PFC
and VMB. Bioinformatics analysis revealed a striking enrichment for genes involved in neuronal
plasticity and ion channel function in NAC, particularly regarding calcium signaling. Our results
provide novel insight into molecular adaptations occurring with the ADE and identify novel
targets for preclinical study of alcohol-related behavior and pharmacotherapy.

Materials and Methods
Animals
39 male C57BL/6NCrl mice were obtained from Charles River Laboratories (Wilmington, MA)
at 60 – 80 days of age. This substrain of C57BL/6 mouse was used since we had previously
demonstrated that they show a robust ADE (Khisti et al., 2006b). Mice were given ad libitum
access to standard chow (Harlan TekLad#7912, Madison, WI) and water throughout the
experiment and were housed individually in an AAALAC-approved colony room under a
12hr/12hr light/dark cycle with weekly cage and bedding (Harlan Sani-chips, #7090A, Harlan
TekLad, Madison, WI) changes. All procedures were approved by the Institutional Animal Care
and Use Committee at Virginia Commonwealth University Medical Center and conformed to the
NIH Guide for the Care and Use of Laboratory Animals. Mice were acclimated to the colony for
one week before experimentation. Mice were separated into 3 groups: ethanol
deprivation/sacrifice (N = 12), ethanol deprivation/reinstatement (N = 18), and water only (N =
9).
Two-bottle choice drinking

41

Mice in the ethanol deprivation group (N = 30) were allowed access to tap water and 10% w/v
ethanol in tap water for 18 hours/day, and to water only for the remaining 6 hours as described
previously (Khisti et al., 2006b). Bottle positions were alternated every 2 days to control for bias.
Mice were given access to ethanol for 13 consecutive days prior to a single 4-day deprivation
period, and 12 mice were sacrificed on the final day of deprivation for microarray studies. The
remainder of the ethanol deprived mice (N = 18) were allowed continuous access to alcohol after
the 4-day deprivation period to confirm the EDE and measure the transience of increased
drinking behavior. The water control group (N = 9) was treated identically but with access only
to water for the length of the experiment. Water group mice were sacrificed concurrently with
mice used for microarray studies. Statistical analyses of behavioral data were performed with
GraphPad Prism 5 software using one-way ANOVA with repeated measures and Dunnett’s
Multiple Comparison Test to compare days of ethanol exposure post hoc. The dependent
variables were ethanol intake (in g/kg/18 hours) and ethanol preference (the ratio of ethanol
intake to total fluid intake).
Tissue collection and RNA isolation
Mice were sacrificed by cervical dislocation and tissue from nucleus accumbens, prefrontal
cortex, and ventral midbrain was collected according to published procedures (Kerns, 2005).
Tissue for each brain region was randomized to produce 5 groups of 3 mice each for both
treatment groups (water vs. ethanol deprivation), which was pooled and homogenized in RNA
STAT-60 reagent (Tel-Test, Friendswood, TX) using a Tekmar homogenizer. RNA isolation and
quality control was performed as described previously (Kerns, 2005). RNA from each pooled
sample (7 μg) was processed to cRNA for array hybridization as per standard protocols from the
array manufacturer (Affymetrix).
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Microarray hybridization and scanning analysis
RNA samples were hybridized to individual Affymetrix murine 430A 2.0 arrays for each of the
three brain regions (10 arrays per region) and analyzed on an Affymetrix GeneChip Scanner
3000. Hybridization quality was assessed via standard RNA degradation functions, scatter plot
and histogram analyses for each array. One sample (VMB EDE 2) had an excessively large
scaling factor and was removed from further analysis. Inter-array correlations for remaining
chips all exceeded 0.98.
Probesets were subjected to absent-present-call quality control procedures using open-source R
software, and analyzed using the S-score algorithm as described previously (Kerns, 2005), but
using the R implementation of the S-score algorithm (Kennedy et al., 2006a; Kennedy et al.,
2006b). Following global normalization, probe level values for control animals for each probeset
in each brain region were averaged, and each ethanol deprivation sample array was subjected to
pair-wise S-score analysis versus this averaged control file. S-scores are normally distributed
with a mean=0, have a standard of deviation of 1, and are proportional to fold change (Kerns et
al., 2003). Probesets consistently called “absent” across all samples in a brain region were
removed from the analysis. This absent-present filtering left 10,417 probesets in NAC, 15,321
probesets in PFC, and 13,784 probesets in VMB for significance analysis, which was performed
separately for each region. S-scores across biological replicate arrays were analyzed using Oneclass Significance Analysis of Microarrays (SAM) for each brain region (Tusher et al., 2001)
with a false discovery rate <0.05 for PFC and NAC and <0.1 for VMB considered significant. A
higher FDR was used for VMB due to having fewer control samples (n=3) for statistical analysis
of that region. Gene lists were finally filtered to remove probesets with S-score values between 1.5 and 1.5, to eliminate very low magnitude expression changes.
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Bioinformatic analysis of microarray data
Toppgene (http://toppgene.cchmc.org/), an open-source online gene ontology analysis tool, was
used for gene set enrichment analysis with a FDR correction of p-values. Results were filtered
for FDR < 0.05 in NAc and FDR < 0.1 in VMB. No significant over-represented gene groups
were obtained from PFC at this statistical threshold. Results were further filtered to remove
terms containing fewer than 2 genes or greater than 350 genes, and terms with similar definitions
and gene lists were trimmed for clarity. Toppgene was also used to rank candidate genes within
and across each region using the ToppNet analysis tool. ToppNet uses a user-defined “training
set” of genes (see Results), which are mapped onto a protein-protein interactions network (PPIN)
along with the “test set”, which are the genes to be prioritized. The test set is ranked according to
topological distance and interactions with the training set (Chen et al., 2009a; Chen et al.,
2009b).
Ingenuity Pathways Analysis (Ingenuity Systems Inc., Redwood City, CA, USA) was used to
analyze gene sets for overrepresentation of genes in canonical pathways and specific gene
networks highly regulated by ethanol deprivation. Networks were limited to 35 molecules, and
scored by IPA based on the hypergeometric distribution, calculated using the right-tailed Fisher’s
Exact test. Results were reported as the –log of this value, such that a score of 20 indicates that
there is a 1 in 1020 chance of producing a network containing at least the same number of genes
of interest from 35 randomly chosen genes.
Gene sets regulated in each brain region were also analyzed for overrepresentation of
transcription factor binding sites in promoter regions ±2000 bp from the transcription start site
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using the oPossum Single Site Analysis (http://burgundy.cmmt.ubc.ca/oPOSSUM/) algorithm
with a matrix match threshold of 80% (Ho Sui et al., 2005).
Filtered gene sets were further analyzed for overlap with published gene sets relevant to ethanolrelated behaviors using Gene Weaver, an open-source tool for gene set analysis
(http://geneweaver.org). Significance of these overlapping genes was determined based on the
likelihood of an equal sized overlap in two random gene sets of the same size, chosen from a
total gene population of 14,000, the number of genes represented by probesets on the Affymetrix
M430A 2.0 chip.
Quantitative Real-Time Polymerase Chain Reaction (Q-rtPCR)
Q-rtPCR was used to confirm microarray results for select genes as described in Results. cDNA
(Superscript First Strand Synthesis, Invitrogen, Carlsbad, CA) was generated from DNAsetreated (DNA-Free, Ambion, Austin, TX) total RNA (1 µg) isolated as above. Q-rtPCR was
performed with SYBR Green I-based detection according to the manufacturer’s instructions (iQ
SYBR Green, Bio-Rad, Hercules CA) using the iCycler iQTM system (BioRad, Hercules, CA).

Results
Alcohol Deprivation Effect (ADE) in C57Bl/6NCrl Mice
C57Bl/6NCrl mice consumed 2.6 g/kg/18h of 10% w/v ethanol during the 13 day baseline access
period, during which their ethanol preference (ethanol/total) was 0.19. The 4-day ethanol
deprivation period significantly increased ethanol consumption (4.9 g/kg/18h; F4,17 = 21.18, p <
0.0001) and preference for ethanol over water (0.29; F3,17 = 10.43; p < 0.0001) upon
reinstatement (see Figure 3.1), similar to previously published results (Khisti et al., 2006b).
Elevated ethanol consumption and preference in 18 mice not sacrificed for microarrays gradually
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extinguished over the following 6 days. On the seventh day of access following deprivation
ethanol consumption and preference were not significantly different from baseline, but showed a
slight trend towards decreased preference.

Figure 3.1. Alcohol deprivation effect in C57BL/6NCrl mice. A 4-day abstinence period
following 13 days of ethanol access produced significant and transient increases in (A,B) ethanol
consumption and (C) preference for ethanol as a proportion of total fluid intake compared to
baseline. Total fluid intake (D) did not change significantly. Data are expressed as group average
+ SEM. Analysis was one-way ANOVA with repeated measures and Dunnett’s post-hoc test,
with a value of p < .05 (*) indicating statistical significance.
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Microarray Analysis
To identify genes regulated by ADE vs. water, we used the S-score algorithm to directly
compare arrays at the probeset level as described previously (Kerns, 2005; Wolen et al., 2012).
This analysis yielded groups of probesets in each brain region significantly regulated by ethanol
drinking and deprivation as compared to water drinking animals, but with a striking
predominance in NAC. We observed 525 significantly different probesets in NAC, 189 in PFC,
and 93 in VMB (see Figure 2, Supplementary Tables 1, 2, 3). These probesets represented 498
genes in NAC, 186 genes in PFC, and 87 genes in VMB. More transcripts were down-regulated
by ethanol deprivation than up-regulated in NAC (341 vs 184) and PFC (111 vs 78), but in VMB
all identified probesets were up-regulated.
Q- rtPCR Verification of Select Genes
Nine transcripts identified by microarray analysis were selected from the NAC gene set for
confirmation by Q-rtPCR. Six genes were found to be significantly regulated in the same
direction indicated by the microarray analysis: Cacna1d, Cacna1g, Eif2c2, Gria1, Kif5c, and
Smarca4 (see Figure 3.2). Three genes tested did not show significant differences on Q-rtPCR
(Cacna1h, Aprl1, and Clns1a).
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Figure 3.2. Regional changes in gene expression associated with ethanol deprivation. In (A) the
regional magnitude of changes in transcript abundance are indicated for NAC, VMB, and PFC,
with overlap between regions. The directionality of these changes is indicated in (B), and in (C)
the fold-change for selected transcripts confirmed by quantitative PCR is shown next to the foldchange indicated by microarray analysis.
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Bioinformatics Analysis
Toppgene analysis identified overrepresented gene ontology (GO) terms among sets of regulated
genes for biological processes (BP), molecular functions (MF) and cellular component (CC).
Significant results were obtained from NAC with a FDR ≤0.01 but we elected to relax the
statistical significance to an FDR of ≤0.05 to increase our ability to identify potentially important
functional gene networks (see Supplementary Table 4). Significant results were obtained for
VMB at FDR<0.1 (see Supplementary Table 5). No significantly over-represented GO categories
were observed in PFC at any FDR < 0.2, so analysis was focused on NAC and VMB.
Analysis with a FDR of 0.05 identified 19 MF terms and 75 BP terms as over-represented in
genes regulated by ADE in NAC. These GO terms largely converged on a few related areas:
myelination, ion channel activity, RNA splicing/translation, peptide and steroid hormone
function, neurogenesis and synaptic function. Of particular interest, there was a striking number
of calcium-signaling and potassium channel related genes and terms within the ToppGene
results.
The most significant over-represented MF term was “structural constituents of the myelin
sheath”, with 4 out of 5 transcripts down-regulated by ethanol deprivation. Both genes in the
related term “ceramide glucosyltransferase activity” (Ugcg, Ugt8), which are involved in
synthesis of myelin sphingolipids, were also down-regulated (Bosio et al., 1996; Watanabe et al.,
2010). Regulation of 4 genes involved in “RNA cap binding” suggested inhibition of mRNA
translation via enhancement of RNAi (Eif2c2) and inhibition of translation initiation. The MF
term “purine nucleoside binding” was identified in connection with 23 genes involved in diverse
processes: cell signaling, transport, and mRNA transcription and translation. Potential
enhancement of protein degradation processes was indicated by the down-regulation of several
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genes in the “small conjugating protein-specific protease activity” term involved in ubiquitin
removal.
Many of the remaining MF terms identified in NAC related to ion channel and ion channel
regulator activity. Genes identified in the “gated channel activity” term primarily affected cation
currents, but 4 genes were involved in chloride transport: gamma-aminobutyric acid (GABA)
receptor subunits α1 (Gabra1) and γ2 (Gabrg2), as well as chloride transporters coupled to
transport of protons (Clcn5) and potassium (Slc12a5). Several transcripts modulating potassium
transport were regulated by deprivation and tended to be down-regulated. Two regulators of
sodium channel activity were down-regulated (Commd1, Nedd4), while two regulators
(Slc9a3r1, Slc9a3r2) of solute carrier family 9, member 3 (Slc9a3), a sodium/hydrogen
exchanger, were up-regulated. The transcript coding for the pore-forming α subunit (Scn8a) of
the type VIII voltage-gated sodium channel, which is involved in formation of the action
potential in excitable neurons, was down-regulated (Chatelier et al., 2010).
MF results in NAC featured several significantly over-represented calcium-related terms, due to
the presence of several genes coding for subunits of calcium-permeable ion channels, including 6
voltage-gated calcium channel subunits, 2 transient receptor potential (TRP) channels (Trpc1,
Trpc7), 2 glutamate receptors (Grin1, Gria1), and the inositol 1,4,5-triphosphate receptor 1
(Itpr1). In addition, several genes in the term “calmodulin binding” were identified, suggesting
coordinated regulation of calcium-related signaling at the transcriptional level during ethanol
deprivation.
Over-represented BP terms in NAC indicated potential regulation of diverse cellular processes in
neurons in this region. Several subsets of related terms with similar transcript membership were
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identified. First, a set of 14 similar terms containing genes involved in ion transport and
homeostasis, primarily of calcium, were identified. A related set of 13 terms was identified that
contained transcripts involved in neurotransmission. These genes were involved in calcium-ion
dependent exocytosis, membrane fusion, signal release, and transport and secretion of
acetylcholine, glutamate, and GABA. Steroid hormone receptor signaling and cellular response
to peptide hormone stimulus were represented by 7 BP terms that contained diverse transcripts
involved in cell signaling and gene expression. Two deprivation-regulated transcripts were
contained in 6 of 7 hormone-related terms: growth hormone 1 (Gh1) and v-src sarcoma
(Schmidt-Ruppin A-2) viral oncogene homolog (Src). Interestingly, more genes were upregulated than down-regulated by deprivation in the terms related to peptide hormone response,
which was a reversal of the trend of the gene set as a whole. Four terms loosely related to kinase
activity were identified, which contain a wide variety of genes involved in cell signaling.
A set of 11 BP terms involved in transcription, RNA processing, and translation were identified
that contained diverse transcripts involved in regulation of DNA binding, transcription initiation
from RNA polymerase II promoter, spliceosome assembly and RNA splicing, and
ribonucleoprotein complex biogenesis and assembly. Four terms contained genes that were
related to protein modification and metabolism, primarily by ubiquitination. A set of 14 BP terms
was produced that contained deprivation-regulated transcripts involved in regulation of
neurogenesis, cell differentiation, development, and apoptosis.
Three significantly over-represented BP terms did not clearly form a biologically cohesive set
with any other terms: positive regulation of glucose metabolic process, negative regulation of
molecular function, and peptidyl-amino acid modification. Transcripts in these terms were
primarily involved in cell signaling, but 3 transcripts had known or suspected histone
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acetyltransferase or methyltransferase activity (Mll3, Naa15, Prmt7), and thus the ability to
induce and maintain changes in gene expression that could influence behavior (Maze and
Nestler, 2011; Pandey et al., 2008). Three identified terms pertained to higher level sensory and
behavioral processes: adult behavior, feeding behavior, and regulation of sensory perception of
pain. All identified transcripts in the latter two terms were found to be down-regulated by
ethanol deprivation, and represented 9% and 17%, respectively, of the genes in these terms.
In VMB gene ontology analysis identified 8 over-represented MF terms and 18 over-represented
BP terms, which converged on a few key areas: cell adhesion and cell skeleton regulation,
neuron apoptosis, mRNA processing/modification, and cell signaling via phosphoinositide 3kinase cascade, steroid hormone signaling, and vascular endothelial growth factor (VEGF)
signaling (see supplementary table 5).
Ingenuity Pathways Analysis
Ingenuity Pathways Analysis (IPA) was used to identify gene networks and over-represented
canonical signaling pathways among genes identified as significantly regulated by ethanol
deprivation (-log(p-value) ≥ 1.30). In NAC 62 canonical signaling pathways were identified as
significantly over-represented, 16 pathways were identified in PFC, and in VMB 2 pathways
were identified (see Figure 3.3, Supplementary table 6).
The most significantly (-log(p-value) > 3) over-represented canonical signaling pathways were
cAMP-mediated signaling, G-protein coupled receptor signaling, insulin-like growth factor 1
(IGF-1) signaling, corticotropin releasing hormone (CRH) signaling, androgen signaling, and
CXCR4 signaling. The majority of identified pathways had –log(p-value) between 2 and 3, and
included calcium signaling, synaptic long term potentiation, glucocorticoid receptor signaling,
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CREB signaling in neurons, and PI3K/AKT signaling, among others. Less significantly overrepresented pathways included ephrin receptor signaling, insulin receptor signaling, and axonal
guidance signaling, among others.
Several genes were represented in several identified pathways: adenylate cyclase 6 (Adcy6), vakt murine thymoma viral oncogene homolog 1 (Akt1), calmodulin 3 (Calm3), guanine
nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 (Gnai2), guanine
nucleotide binding protein (G protein), gamma 4 (Gng4), inositol 1,4,5-triphosphate receptor,
type 1 (Itpr1), mitogen-activated protein kinase kinase 2 (Map2k2), 3-phosphoinositide
dependent protein kinase-1 (Pdpk1), catalytic (Prkacb) and regulatory (Prkar1a) subunits of
cAMP-dependent protein kinase (PKA), protein kinase C, eta (Prkch), and v-src sarcoma
(Schmidt-Ruppin A-2) viral oncogene homolog (avian) (Src).
All significantly over-represented canonical pathways in PFC had –log(p-value) between 1.30
and 1.96, and included LPS-stimulated MAPK signaling, insulin receptor signaling, VDR/RXR
activation, VEGF signaling, and MIF-mediated glucocorticoid regulation. Transcripts common
to several pathways included dual specificity mitogen-activated protein kinase kinase 2
(Map2k2), phosphatidylinositol 3-kinase regulatory subunit alpha (Pik3r1), and NF-kappa-B
inhibitor beta (Nfkbib).
Only 2 canonical signaling pathways were significantly over-represented in VMB: thyroid
cancer signaling and EGF signaling.
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Figure 3.3. Over-represented canonical signaling pathways identified by Ingenuity Pathways
Analysis. (A) nucleus accumbens, (B) prefrontal cortex, and (C) ventral midbrain. Pathways in
NAC have been filtered to remove those specific to non-neuronal cell types. A –log(p-value) >
1.30 indicates statistical significance.
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More than 25 gene networks were identified in NAC, while in PFC and VMB only 10 and 6
networks that contained more than 2 molecules were identified, respectively. Top functions for
each network were identified based on the IPA literature database. In NAC it was found that the
2 top-scoring networks contained a gene in common, smarca4, and were merged to create a gene
network with RNA post-transcriptional modification, gene expression, and protein trafficking as
top functions (see Figure 3.4). For PFC networks 1 and 3 were merged to create a network with
gene expression, cancer, and carbohydrate metabolism as top functions (see Figure 3.5).
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Figure 3.4. Coordinately regulated gene network identified by Ingenuity Pathways Analysis in
nucleus accumbens. Top functions for this network are RNA post-transcriptional modification,
gene expression, and protein trafficking. Network hubs (clockwise from top-left) are POLR2A,
SMARCA4, MBP, Histone H4, YWHAZ, YWHAG, and Histone H3. Red shading indicates upregulation, while green shading indicates down-regulation. Color saturation indicates relative
significance of regulation, such that greater saturation indicates more significant regulation in the
direction indicated.
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Figure 3.5. Coordinately regulated gene network identified by Ingenuity Pathways Analysis in
prefrontal cortex. Top functions for this network are gene expression, cancer, and carbohydrate
metabolism. Network hubs (clock-wise from top-left) are RNA polymerase II, CREB, ERK1/2,
PKC, VEGF, TGFB1, HDAC1, Histone H4, Histone H3, and SPP1. from Red shading indicates
up-regulation, while green shading indicates down-regulation. Color saturation indicates relative
significance of regulation, such that greater saturation indicates more significant regulation in the
direction indicated.
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Transcription factor binding site analysis
A total of 66 significantly over-represented consensus sequences were identified in promoter
regions of genes regulated in NAC, 25 sequences were identified in VMB, and 9 sequences were
identified in PFC (p < 0.05, see Table 3.1). All sequences identified in VMB and PFC were also
identified in NAC, and binding sites for 3 transcription factors were found to be significantly
over-represented in all 3 regions: SRY (sex determining region Y)-box 5 (SOX17), E74-like
factor 5 (ets domain transcription factor) (ELF5), and myeloid zinc finger 1 (MZF1).
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Table 3.1. Top 25 results in NAc from transcription factor binding site analysis performed with
oPossum (http://burgundy.cmmt.ubc.ca/oPOSSUM/) in promoter regions +/- 2000 base-pairs
from transcription start site for genes regulated by ethanol deprivation in nucleus accumbens,
prefrontal cortex, and ventral midbrain of C57BL/6J mice. A total of 66 consensus binding
sequences were significantly over-represented in NAC. Three sequences were over-represented
in genes from all regions: ELF5, MZF_1-4, and SOX17.

Consensus Sequence
GABPA
E2F1
ELK4
Arnt-Ahr
MAX
USF1
Ddit3-Cebpa
MZF1_5-13
RORA_1
Cebpa
FOXD1
CREB1
Mycn
Arnt
ELK1
PBX1
SP1
SRY
HNF4A
Bapx1
Sox5
Myb
Lhx3
HLF

Transcription Factor
NAC Z-score NAC P-value
Class
ETS
5.42
6.14E-07
E2F_TDP
2.06
8.63E-07
ETS
6.14
2.19E-06
bHLH
7.14
3.98E-06
bHLH-ZIP
5.07
8.37E-06
bHLH-ZIP
4.38
1.34E-05
bZIP
10.14
1.62E-05
ZN-FINGER, C2H2
-1.19
2.19E-05
NUCLEAR RECEPTOR
-1.7
2.76E-05
bZIP
11.05
2.86E-05
FORKHEAD
12.45
3.23E-05
bZIP
3.76
3.55E-05
bHLH-ZIP
3.74
3.89E-05
bHLH
3.79
3.95E-05
ETS
-3.44
6.85E-05
HOMEO
8.37
1.30E-04
ZN-FINGER, C2H2
-5.28
1.36E-04
HMG
22.93
1.51E-04
NUCLEAR RECEPTOR
2.09
1.94E-04
HOMEO
7.65
2.07E-04
HMG
19.2
2.14E-04
TRP-CLUSTER
0.75
2.17E-04
HOMEO
12.99
2.49E-04
bZIP
7.36
2.59E-04
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The majority of over-represented transcription factor binding sites were only identified in NAC.
The cAMP response element (CRE), which is bound by the transcription factor cAMP
responsive element binding protein 1 (CREB1) was identified in the promoter regions of 142
genes. Many of these genes were involved in ion transport (Cacna1g, Gabra1, Kcnb1, Trpc7)
and GPCR-mediated cell signaling (Adcy6, Htr2c, S1pr5). Several genes were identified with
functions related to nervous system development and plasticity: Bdnf, Dlx2, Fgf11, Foxp2,
Map1b, Mef2c, Naa15, Nr2c2, Tcf12, And Tnfrsf21. The CRE site showed a trent for overrepresentation in genes from PFC and VMB, with p-values of 0.09 and 0.06, respectively.
Consensus binding sequences for 4 transcription factors or protein complexes with known
chromatin remodeling functions were significantly over-represented in NAC: FOXA2, REST,
the MYC-MAX complex, and the STAGA complex. The FOXA2 and the MYC-MAX
complexes tend to act as transcriptional activators (Duncan et al., 1998), while REST represses
gene expression by binding to the neuron-restrictive silencer element (NRSE) and to
corepressors MSIN3 AND COREST, followed by recruitment of histone deacetylases (Andres et
al., 1999). In PFC the Rcor1 transcript was reduced by 18% following ethanol deprivation, and it
showed a non-significant increase of 20% in NAC. The multi-protein STAGA complex is a
chromatin remodeling complex with acetyltransferase activity (Martinez et al., 2001). Sites for
binding of PAX6 and ROAZ, which function in neurogenesis and development, were overrepresented in NAC (Cocas et al., 2011; Hata et al., 2000). It has recently been shown that
prenatal ethanol exposure in rats impairs PAX6 function and cerebral cortex development
(Aronne et al., 2011). Binding sequences for 2 transcription factors with functions related to
neuronal differentiation and maintenance were also identified: MEF2A and FOXD3 (Guo et al.,
2002; Shalizi et al., 2006).
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Consensus binding sites for 4 transcription factors involved in epigenetic regulation of gene
expression by histone modification and chromatin remodeling were over-represented in NAC
and VMB: Sp1 transcription factor (SP1), MYC associated factor X (MAX), YY1 transcription
factor (YY1), and growth factor independent 1 transcription repressor (GFI). SP1 regulated gene
expression is involved in diverse cellular processes, and has been implicated in mu opioid
receptor regulation via recruitment of SWI/SNF related, matrix associated, actin dependent
regulator of chromatin, subfamily a, member 4 (smarca4, also known as BRG1), which is upregulated nearly 2-fold by ethanol deprivation (Hwang et al., 2010). MAX is a transcriptional
regulator that binds to MYC or MAD proteins to activate or repress transcription, respectively
(Hurlin and Huang, 2006). YY1 is involved in targeting of histone acetyltransferase (HAT) and
histone deacetylase (HDAC) proteins to gene promoter regions (Ren et al., 2009), and GFI
associates with HDAC1, HDAC2, and HDAC3 to direct histone deacetylation processes
(McGhee et al., 2003).
Overlap with published ethanol-related gene sets
GeneWeaver, an online gene set analysis tool, was used to study similarity in gene sets identified
by SAM analysis to gene sets with relevance to alcohol drinking behavior. For NAC the set of
significantly regulated genes was compared to 2 other gene sets: 854 genes influencing
individual variation in consumption within the C57BL/6NCrl strain (INV) (Wolstenholme et al.,
2011) and 305 genes found to be important for basal ethanol consumption by meta-analysis
across several experiments and strains of mice (MMT) (Mulligan, 2006). The INV set was
specific to the NAC, while the MMT set was derived from whole brain. The overlaps between
the gene set regulated by ethanol deprivation in NAC and the INV (p < 1.828e-11) and MMT (p
< 2.262e-04) strains were highly significant (see Figure 3.6).
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Figure 3.6. Overlap of two gene sets associated with ethanol-related behavior and the gene set
identified as regulated by ethanol deprivation in nucleus accumbens.
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ToppNet Candidate Gene Prioritization
The open-source ToppNet tool was used to rank transcripts identified in each brain region based
on a protein-protein interaction network (PPIN). The test set (deprivation-regulated transcripts in
a particular brain region) and a training set (1 of 4 sets of genes with relevance for ethanol
consumption behavior) were mapped to the PPIN and genes in the test set were ranked based on
relative location to the training set genes using global network-distance measures. The training
sets used for each region were the full (MMF) and top (MMT) results from the meta-analysis
performed by Mulligan et al. (2006), genes associated with individual variation in ethanol
consumption in C57BL/6NCrl derived from whole brain (INV), and the subset of INV genes from
the region from which the test set is derived (Wolstenholme et al., 2011). The scores derived
from ranking with these 4 gene sets were averaged to obtain a regional score and ranked gene list
for each brain region prioritized for likely biological and behavioral relevance for ethanol
drinking behavior. Genes were then ranked by regional scores across brain regions to produce an
overall ranking (see Table 3.2). The top 6 genes in NAC were the top 6 genes overall, and the
majority of the top 35 ranked genes (27 of 35) were from the NAC gene set.

64

Table 3.2. Top 20 candidate genes for deprivation-induced elevated ethanol consumption within
and across brain regions based on ranking with ToppNet (http://toppgene.cchmc.org/) using 5
gene lists related to ethanol consumption as training sets. Gene lists were scored and ranked
separately using each training set, and these scores were averaged to produce a regional score,
which was used to rank genes within each region. Regional scores were averaged across all brain
regions to produce an overall average score, which was used to rank candidate genes across brain
regions.

Rank

Top 20
Crossregion
Genes

Crossregion
Average
Score

Top 20
NAC
Genes

NAC
Score

Top 20 PFC
Genes

1

Ywhag

3.47E-03

Ywhag

3.47E-03

Pik3r1

9.74E-04

Fn1

6.53E-04

2

Src

1.64E-03

Src

1.64E-03

Ndrg1

5.33E-04

Cdh1

5.17E-04

3

Eif4e

1.64E-03

Eif4e

1.64E-03

Sfrs12

5.10E-04

Cbx5

4.31E-04

4

Ywhaz

1.58E-03

Ywhaz

1.58E-03

Ncoa2

3.61E-04

Nedd4

4.24E-04

5

Akt1

1.10E-03

Akt1

1.10E-03

Fhl2

3.46E-04

Khdrbs2

3.75E-04

6

Usp7

1.09E-03

Usp7

1.09E-03

Strn4

2.83E-04

Bcr

3.37E-04

7

Pik3r1

9.74E-04

Polr2a

9.36E-04

Rpap1

2.68E-04

Apc

2.94E-04

8

Polr2a

9.36E-04

Hsp90aa1

7.85E-04

Trim27

2.51E-04

Atg12

2.51E-04

9

Hsp90aa1

7.85E-04

Rhoa

7.84E-04

Ccne1

2.38E-04

Nrip1

2.47E-04

10

Rhoa

7.84E-04

Mdm2

5.87E-04

Rfc1

2.16E-04

Hnrnpu

2.05E-04

11

Fn1

6.53E-04

Jak2

5.59E-04

Nfkbib

1.97E-04

Map2k7

2.03E-04

12

Mdm2

5.87E-04

Crk

5.20E-04

Tmpo

1.90E-04

Itgb5

1.89E-04

13

Jak2

5.59E-04

Acvr1

5.13E-04

Rhog

1.77E-04

Itsn1

1.88E-04

14

Ndrg1

5.33E-04

Usp39

4.71E-04

Cyth3

1.68E-04

Braf

1.74E-04

15

Crk

5.20E-04

Smarca4

4.69E-04

Smarcc1

1.68E-04

Safb

1.64E-04

16

Cdh1

5.17E-04

Efemp2

4.45E-04

Spp1

1.68E-04

Kcna2

1.57E-04

17

Acvr1

5.13E-04

Rasa1

4.27E-04

Grb10

1.62E-04

Gm3579

1.34E-04

18

Sfrs12

5.10E-04

Fos

4.24E-04

Trip10

1.54E-04

Racgap1

1.33E-04
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PFC
Score

Top 20
VMB
Genes

VMB Score

19

Usp39

4.71E-04

Mbp

4.19E-04

Gtf2a1

1.41E-04

Cux1

1.25E-04

20

Smarca4

4.69E-04

Gnai2

4.12E-04

Fubp1

1.40E-04

Gstm2

1.19E-04
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Discussion
It has been reported by our laboratory and others that ethanol and other drugs of abuse produce
regional changes in neuronal gene expression (Costin et al., 2013b; Iancu et al., 2013; Kerns,
2005; Lewohl et al., 2000; Nunez and Mayfield, 2012; Osterndorff-Kahanek et al., 2013;
Robison et al., 2013; Serrano et al., 2012; Tapocik et al., 2013; Wolen et al., 2012;
Wolstenholme et al., 2011). However, rodents allowed constant access to ethanol maintain
steady intake over time, demonstrating that changes in gene expression produced by ethanol
consumption are not sufficient to produce elevated voluntary intake. Short periods of abstinence
or ethanol deprivation produce striking increases in ethanol consumption and preference without
induction of dependence or withdrawal (Heyser et al., 2003; Khisti et al., 2006b; Lopez-Moreno,
2004; Serra et al., 2003a; Spanagel and Holter, 2000). Repeated deprivations produce
progressive increases in binge-like drinking that lead to inflexible drinking behavior and altered
glutamatergic signaling (Hopf et al., 2010; Loi et al., 2010; Obara et al., 2009a). Thus such
models have become increasingly used to study brain adaptations that may be similar to those
involved in the transition to alcohol use disorders in humans. Our laboratory and others have
documented that exposure to ethanol and other drugs of abuse can alter gene expression within
brain regions comprising the mesolimbocortical dopamine pathway. Within this pathway the
most studied regions have been the ventral midbrain or ventral tegmental area, the nucleus
accumbens, and the prefrontal cortex; interconnected regions involved in reward processes,
motivated behavior, and decision making (Bardo, 1998; George and Koob, 2010). We have thus
proposed that neuroplasticity during abstinence, mediated in part by changes in gene expression
within the mesolimbocortical dopamine pathway, is a potential important contributor to elevated
consumption upon reinstatement. However, genome-wide studies on gene expression after
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multiple days of deprivation following voluntary continuous access drinking—the period directly
preceding elevated consumption—have not been previously reported. Here we confirmed the
production of an alcohol deprivation effect (ADE) in C57BL/6NCrl mice, as reported by (Khisti
et al., 2006b), further demonstrating the potential of this model to produce significantly elevated
ethanol consumption and preference. We further show using this model that striking changes in
gene expression occur following 2 weeks of alcohol drinking and a four day abstinence period,
particularly within the nucleus accumbens.
Novel gene networks and canonical signaling pathways composed of functionally-related
transcripts regulated by ethanol deprivation were identified, and these tended to be regionspecific, although there were some biological themes common to one or more regions: PI3K
signaling, regulation of cell fate and neuronal connectivity, hormone signaling, and regulation of
mRNA expression and processing. These networks and pathways together form a molecular
picture of the initial program of neuroplasticity associated with elevated ethanol consumption in
mice due to deprivation. Regulated genes in NAC were found to significantly overlap with gene
sets associated with differences in voluntary ethanol consumption between mouse strains and
among individuals of the C57BL/6NCrl strain, supporting the role of these genes in ethanolrelated behavior.
Promoter regions of transcripts found to be regulated in each brain region were subjected to
transcription factor consensus binding site analysis and several over-represented sequences were
identified. Three sites were found to be significantly over-represented across the brain regions
examined and may represent common mediators of the transcriptional effects of ethanol
deprivation. Finally, genes in each region were ranked based on protein-protein interaction and
similarity to ethanol-related gene sets to identify potential therapeutic targets for which
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manipulation will likely produce the greatest effect on cell signaling related to ethanol
consumption.
The magnitude of transcript regulation was greatest in NAC, and the 341 down-regulated genes
in NAC represented approximately 42% of all significant results. Interestingly, in VMB only 93
probesets were identified, all of which were up-regulated. Thus, the transcriptional effects of
alcohol deprivation are most pronounced in nucleus accumbens, and this may be a primary site
of plasticity associated with changing behavior. The lack of down-regulated transcripts in VMB
may be an artifact caused by exclusion of 1 control microarray. However, it seems likely that this
result does provide an accurate indication of the most robust changes in gene expression in VMB
associated with ethanol deprivation, because use of a far less stringent FDR (> 0.20) for SAM is
required to identify downregulated genes in this region.
Several primary targets of ethanol and genes related to these targets were identified as regulated
in NAC: NMDA receptors, GABAA receptors, and L-type calcium channels. These genes
represent potential primary mediators of neuroplasticity associated with deprivation following
ethanol consumption (Spanagel, 2009; Vengeliene et al., 2009). Ethanol inhibits glutamatergic
signaling and enhances GABAergic signaling, and compensatory regulation of receptors for
these ligands may represent an early mediator of neuroplasticity during ethanol access and
subsequent deprivation. It has been shown that L-type calcium channels are up-regulated in
cerebral cortex of mice physically dependent on ethanol (Katsura et al., 2006). Although mice in
this experiment were not ethanol-dependent, inhibition of L-type calcium channels by ethanol
may result in the compensatory up-regulation of these and other calcium channels seen in NAC,
which during abstinence may produce abnormal neuronal function and behavior, driving the
animal to seek ethanol to restore calcium homeostasis and normal functioning.
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Gene ontology (GO) analysis identified over-represented molecular functions among the protein
products of regulated transcripts and the biological processes to which these functions contribute.
The NAC—with the most regulated transcripts—yielded the most robust GO results, while the
VMB also produced several significantly over-represented terms related to biological processes
and molecular functions. Interestingly, the PFC gene set—with more than twice as many
significantly regulated transcripts as VMB—did not produce meaningful GO results. Thus it is
seems that regulation of gene expression associated with ethanol deprivation is more likely to
produce relevant changes in biological processes and molecular functions in NAC and VTA than
in PFC, despite the fact that differences in overall magnitude of regulation might indicate
otherwise.
Although experimental verification—including immunoblotting and electrophysiology—will be
required to draw conclusions regarding the effects of ethanol deprivation on neuronal function,
GO results indicated several areas that may be fruitful for future study, based on the ratio of
regulated to unregulated genes in the significant terms, and the direction of regulation for each
gene(Watanabe et al., 2010).
Most striking is the downregulation in NAC of transcripts coding for 4 of 5 structural
constituents of the myelin sheath and 2 of 2 ceramide glucosyltransferase enzymes involved in
synthesis of myelin sphingolipids, indicating potential inhibition of myelin maintenance
processes and neurotransmission (Bosio et al., 1996). Alterations in neurotransmission through
the NAC would be expected to affect behavior towards rewarding stimuli (Bardo, 1998;
Kapasova and Szumlinski, 2008; Middaugh et al., 2003; Thielen et al., 2004). For example,
axonal segments of projections from the VTA were likely represented in our NAC sample, and
demyelination of these neurons would attenuate or cease dopamine release in the NAC in
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response to reward, and lead to compensatory increased alcohol consumption. Similarly, altered
transmission within NAC and to other connected regions, such as PFC or amygdala, could lead
to maladaptive processing of internal and external stimuli, and so to increased drinking (Bardo,
1998; George and Koob, 2010; Hwang et al., 2004; Koob, 2009; Orozco-Cabal et al., 2008;
Smith and Aston-Jones, 2008).
Nearly half of the GO terms over-represented in the NAC gene set were related to voltage-gated
and ligand-gated channels (11/19 MF terms; 29/75 BP terms). These terms were represented by
genes involved in transport of and response to: calcium, sodium, potassium, chloride, and
hydrogen.
Calcium is tightly regulated in the cell, and changes in neuronal calcium levels and calciumrelated signaling may have diverse consequences for biological processes related to excitability,
neurotransmitter release, gene expression, and cell fate (Catterall et al., 2005). Indeed, several of
these processes were identified GO terms in the NAC gene set: membrane fusion and calcium
ion-dependent exocytosis; neurogenesis, neuron differentiation, and apoptosis; and alterations in
glutamatergic, GABAergic, and cholinergic signaling.
Several transcripts coding for subunits of voltage-gated calcium channels (VGCCs) were found
to be up-regulated in NAC, with abundance of 3 α subunit mRNAs (Cacna1a, Cacna1d,
Cacna1g) increased by about 25%. These subunits are most responsible for determining the
nature of the channel, and they correspond to the CaV2.1 (P/Q-type), CaV1.3 (L-type), and
CaV3.1 (T-type) channels, respectively. Ethanol is known to alter function of VGCCs at
concentrations at concentrations achieved by human drinkers (Walter and Messing, 1999). Ttype VGCCs are potentiated by ethanol in vitro at low concentrations and inhibited at high
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concentrations (Mu et al., 2003). In addition, acute ethanol inhibits CaV2.2 (N-type) channels,
while chronic ethanol increases function and density of these channels, and CaV2.2 (-/-) mice
show decreased voluntary ethanol consumption and reduced duration of the loss of righting
reflex caused by a high dose of ethanol (McMahon et al., 2000; Newton et al., 2004; Solem et al.,
1997). Administration of NP078585, an antagonist of T-type and N-type channels with
concentration-dependent selectivity, reduced conditioned place preference associated with
ethanol in mice and operant self-administration of ethanol in rats (Newton et al., 2008). Other
subunits of these channels can modify channel function, and 3 were found to regulated by
ethanol deprivation in NAC: Cacna2d1, Cacnb2, and Cacnb4.
Several other calcium-permeable channels were also found to be regulated by ethanol
deprivation. The GRIN1 (aka NR1, NMDA1) subunit of the NMDA-type glutamate receptor was
down-regulated (27%) and the GRIA1 (aka GLUR1, AMPA1) subunit of the AMPA-type
glutamate receptor was up-regulated (42%). The decrease in Grin1 transcript likely represents a
decrease in NMDA receptor density, because each receptor consists of 1 of these subunits
combined with 1 or more NR2 or NR3 subunits (Kumar and Mayer, 2013). In contrast, the
increase in Gria1 mRNA may represent an alteration in receptor function, because AMPA-type
glutamate receptors containing only the GRIA1 subunit are highly permeable to calcium, while
those also containing the GRIA2 subunit have low calcium permeability (Chen et al., 2001).
Alterations in density and function of glutamate receptors are thought to be necessary for
learning processes, and thus may mediate plasticity leading to changes in behavior following
ethanol deprivation, during which a subject learns that abstinence is less rewarding than
inebriation. On a more basic physiological level, changes in calcium homeostasis in the NAC
and connected regions could lead to hyper-excitability. In the amygdala, for example, this could
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trigger anxiety or fight-or-flight responses, driving the organism to seek alcohol to restore
normal activity and relieve these symptoms. When considered in light of identified
transcriptional regulation of genes involved in cellular calcium homeostasis (Atp2b2, Itpr1,
Trpc1, Trpc7) and calmodulin signaling (Iqgap2, Marcksl1, Ppp3r1) it appears likely that
changes in NAC calcium signaling occur with deprivation.
Transcripts coding for products related to other ion species were well-represented in results from
NAC. Two voltage-gated potassium channels (Kcnab1, Kcnb1) were regulated, as were 2
voltage-gated potassium channel-interacting proteins (Kcnip3, Kcnip4). These channelinteracting proteins were both down-regulated, and function as calcium sensors to alter both
potassium channel function and gene expression in response to changes in intracellular calcium,
thus providing a connecting mechanism from direct effects of ethanol on intracellular calcium to
modulation of excitability and transcription. The product of Kcnip3 is also known as calsenilin or
DREAM, and functions as a calcium-dependent transcriptional repressor that may be involved in
nociception (Carrion et al., 1999). The mRNA transcript Scn8a, which codes for a pore-forming
voltage-gated sodium channel involved in the action potential, was reduced by 33%. Chloride
channel expression also appeared to be regulated by ethanol deprivation, as transcript for the
proton-coupled chloride transporter CLCN5 was increased, while those for 2 GABA receptor
subunits, GABRA1 and GABRG2 were decreased. Extensive changes in transcript abundance
for ion channels indicates that ethanol deprivation is causing elevations in neuronal excitability
and neurotransmitter release in NAc, which are consistent with known effects of long-term
ethanol exposure and withdrawal (Kapasova and Szumlinski, 2008; Melendez et al., 2005;
Moghaddam and Bolinao, 1994; Obara et al., 2009a; Piepponen et al., 2002; Szumlinski et al.,
2008; Szumlinski et al., 2007).
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Although little overlap was found in GO terms for molecular functions between regions, the
biological processes affected by alterations in these functions revealed similarities in terms
related to neuroplasticity: RNA splicing, RNA modification, mRNA processing, neurotransmitter
release, and regulation of neurogenesis and apoptosis. The prevalence of these terms indicated
adaptation of protein composition, inter-neuron communication, and neuron population to the
condition of ethanol deprivation across regions.
In NAC terms related to signaling by peptide hormones and steroid hormones, in particular
androgen receptor signaling, represent genes that may play a role in regulation of gene
expression during ethanol deprivation. Ethanol drinking activates the HPA-axis, and this
activation has been shown to be necessary for some changes in gene expression induced by
alcohol in PFC (Costin et al., 2013b). This activation causes changes in levels of circulating
hormones, which cross the blood-brain-barrier and regulate transcription in the brain. Repeated
deprivation in rats during adolescence has been shown to reduce anxiety-like behavior in
adulthood, which may be caused by reduced HPA-axis function, as seen in alcohol dependence
(Gilpin et al., 2012; Richardson et al., 2008). Interestingly, IAA during adulthood did not alter
anxiety-like behavior, but induced working memory deficits (George et al., 2012).
Several terms related to mRNA processing and splicing were identified in NAC, which may be a
result of drastic changes in transcript abundance in this region. It should be noted that changes in
splicing could be responsible observed differences in abundance; microarray probeset
hybridization efficiency may be altered by splice-variants, causing apparent changes in
abundance of a particular transcript, when in fact only the balance of isoforms has been altered.
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Deprivation also appears to alter translation and degradation of proteins. Transcripts coding for
eukaryotic translation initiation complex proteins were regulated in NAC: Eif2s2, Eif4a1, Eif4e,
Eif4e2, Eif4ebp2, And Eif5. It has previously been shown that ethanol inhibits protein translation
in skeletal and cardiac muscle tissue, contributing to myopathy in humans (Lang et al., 2001). In
CNS ethanol exposure decreases protein synthesis in developing neuronal tissue, leading to
apoptosis (Chen et al., 2006). A group of terms related to small protein conjugation and removal,
primarily of ubiquitin, were significantly regulated, with several transcripts coding for proteins
involved in de-ubiquitination found to be decreased in abundance. This regulation may indicate
enhanced protein degradation via hyper-ubiquitination of target proteins. and indicates that the
ADE may be mediated in part by alterations in protein translation and degradation in the NAC.
In NAC and VMB the canonical pathways identified tended to be similar to the biological
processes identified by GO analysis. For NAC these pathways included several functioning in
neuroplasticity, gene expression, and addictive behavior: corticotropin releasing hormone
signaling, glucocorticoid receptor signaling, CREB signaling in neurons, calcium signaling,
synaptic long term potentiation, and axonal guidance signaling.
Transcription factor binding site analysis allowed further examination of the mechanisms of gene
regulation during deprivation. Consensus binding sequences for 3 transcription factors were
significantly (p < 0.05) over-represented in promoter regions (+/- 2000 bp from transcription
start site) of genes regulated by deprivation in all brain regions studied: ELF5, MZF1, and
SOX17. None of these factors were regulated at the transcriptional level by ethanol deprivation,
but represent potential targets for therapeutic interference to prevent maladaptive regulation of
entire groups of genes.
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Epigenetic mechanisms of gene regulation via histone modification have been posited to play a
role in the acute and chronic effects of ethanol, and on susceptibility to stress and drug addiction
(Bardaggorce et al., 2007; Liu et al., 2009; Meaney et al., 2007; Pandey et al., 2008; Renthal et
al., 2007; Wolstenholme et al., 2011). Several transcription factor binding sites in NAC and
VMB genes were associated with proteins or protein complexes with chromatin remodeling
functions, indicating that epigenetic mechanisms of gene regulation may mediate some
transcriptional regulation associated with ethanol deprivation. For example, transcription factor
SP1 regulates gene expression via the ATP-dependent SWI/SNF chromatin remodeling complex
(Murphy et al., 1999; Trotter, 2007). After ethanol deprivation the Smarca4 transcript, which
codes for the protein that acts as the ATPase and helicase for this and several other chromatin
remodeling complexes, showed a two-fold increase in NAC compared to control mice, and may
represent an important mediator of deprivation-induced changes in gene expression. This degree
of regulation placed it in the top 2% of regulated transcripts, as measured by magnitude of
change in transcript abundance compared to controls. Of particular interest would be alcohol
deprivation experiments in regional conditional knockout mice for Smarca4, and to inactivate the
gene at particular phases of the experiment, such as immediately after alcohol cessation, or prior
to reinstatement. These mice have not yet been developed, but the production of the appropriate
constructs is an ongoing research effort by the International Knockout Mouse Consortium, so the
generation of such mice should be possible in the near future.
The CRE consensus sequence was over-represented in promoter regions of genes from NAC, and
chromatin remodeling is implicated in transcription mediated by CREB through the action of two
closely related coactivator proteins with histone acetyltransferase activity: E1A binding protein
p300 (P300) and CREB-binding protein (CBP). CREB-mediated transcriptional activation has
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been implicated in addiction-related studies for alcohol (Hu et al., 2008; Zou and Crews, 2006)
and other drugs of abuse (Barrot et al., 2002; Green et al., 2006; McClung and Nestler, 2003).
CREB-mediated transcription acts as a gating mechanism for emotional stimuli in the NAC,
serving to blunt behavioral responses to emotional stimuli (Barrot et al., 2002). Ethanol has been
shown to decrease CREB activation and DNA binding in the nucleus accumbens (Misra and
Pandey, 2006; Misra et al., 2001; Zou and Crews, 2006). Furthermore, ethanol drinking behavior
is increased by partial deletion of CREB or inhibition of cAMP-dependent protein kinase A
(PKA) (Misra and Pandey, 2006; Pandey, 2004b). Over-representation of CREB binding sites in
deprivation-regulated genes is consistent with a previous report analyzing ethanol responsive
gene expression (Uddin and Singh, 2007). This evidence, when considered in the context of
previously reported involvement of CREB in the nucleus accumbens in addiction, suggests that
gene expression mediated by CREB may be integral to the ADE.
The mechanism by which modulation of CREB-mediated transcriptional regulation contributes
to the ADE is likely to be complex, due to the large number of transcripts regulated by CREB,
and the diverse molecular effects of ethanol, which include potentiation of GABAergic signaling.
In NAC, animals deprived of ethanol showed decreased expression of GABAA receptor subunits
α1 (GABRA1) and γ2 (GABRG2). In VMB, these animals showed increased expression of the
α6 (GABRA6) receptor subunits. GABAA receptor surface expression has been reported to be
controlled by CREB and the dominant-negative inhibitor inducible cAMP early repressor (ICER)
(Hu et al., 2008), which has also been implicated in addiction-related behavior in NAC (Green et
al., 2006). These proteins bind to the promoter of the GABRA1 gene and decrease expression of
its transcript and thus limit production of α1-containing receptors. In addition, it has been shown
that the γ2 subunit is phosphorylated by protein kinase C in response to ethanol exposure,
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serving to decrease sensitivity to ethanol (Qi et al., 2007). Altered GABAA receptor expression
in NAC of deprived animals could increase the activity of the mesolimbocortical dopaminergic
pathways and thus alter ethanol consumption behavior, and this mechanism could be dissected
through regional quantitative PCR to examine expression of CREB and related genes, in
combination with regional administration of GABAA antagonists, such as picrotoxin (Carpenter
et al., 2013; Li et al., 2011a).
Another mechanism responsible for gene regulation associated with ethanol deprivation may be
RNA-mediated gene silencing (RNAi), a process which is altered in brains of human alcoholics
and produces teratogenic effects (Lewohl et al., 2011; Nunez and Mayfield, 2012; Wang et al.,
2008a). The Eif2c2 transcript coding for the eukaryotic translation initiation factor 2C, 2, also
known as argonaute 2, is necessary for RNAi and was significantly up-regulated by ethanol
deprivation (Cenik and Zamore, 2011). Upregulation of Eif2c2 may be indicative of potentiation
of RNAi processes in NAC neurons, and account for the prevalence of downregulated transcripts
in this region. Future studies should use microarrays that measure miRNA abundance in addition
to mRNA, which will allow for the discovery of regulatory networks and involved biological
processes, and thus potential therapeutic vectors (Chavali et al., 2013; Lau et al., 2013; Zadran et
al., 2013).
The primary utility of genomic analysis of the type reported in this study is to identify genes not
previously examined in the context of ethanol- or drug-related behaviors, which may provide
insight into biological processes leading to addiction, and novel targets for therapeutic
intervention for drug abusers. However, due to the large number of genes identified, it is
necessary to apply a method of prioritization for further study. Toward this end genes in each
region were ranked based on the nature of their known protein-protein interactions—specifically
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the similarity of these interactions to those found in other gene sets related to ethanol
consumption, as well as compared to other microarray-derived gene sets relevant to ethanol
consumption. Genes thus identified may play central roles in plasticity due to ethanol deprivation
that leads to elevated ethanol consumption, possibly as hubs in gene networks regulated during
abstinence.
When interpreting these results caution must be taken with regard to the attribution of cause and
effect to regulation of specific genes. Because a single time point was examined, and this at the
end of the deprivation period, the sequence of changes in gene expression during the previous 4
days of ethanol deprivation remains unknown, as do the actual cell types containing the
expression changes identified in our studies. Future studies will address these concerns by
examining the time course of expression changes following cessation of ethanol access, and
studying candidate genes at the cellular level to identify neural/glial networks contributing to the
ADE. Perhaps the biggest caveat of the study is that only one strain was examined, and it is
unclear the degree to which results are generalizable to other strains. Future experimentation
should verify functional mechanisms and gene expression in other inbred strains. High priority
targets for verification of this type are strains known to differ in ethanol-related behavior, and
strains with diverse and well-characterized genotypes and phenotypes, for example the DBA/2J,
C57BL/6J, BXD panel, and the Hybrid Mouse Diversity Panel (Costin et al., 2013b; Ghazalpour
et al., 2012; Li et al., 2010c; Vanderlinden et al., 2013).
Persistent perturbation of the brain by ethanol induces neuroplasticity to maintain homeostasis
and organism function (Francesconi et al., 2009; George and Koob, 2010; George et al., 2012).
Although in the ADE model these changes do not reach the level of clinical dependence—in
which withdrawal symptoms occur with abstinence—upon cessation of ethanol use this plasticity
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seems to become maladaptive and causes the organism to seek the drug. In light of recent
studies—utilizing repeated deprivation cycles and intermittent ethanol access in rodents—these
behavioral and genomic results supports the idea that limited ethanol access schedules represent
a valid animal model for the development of alcoholism that does not rely on forced dependence
(Hopf et al., 2010; Melendez, 2011; Melendez et al., 2006a). In particular the transition after an
extended period of 3 days-per-week access to inflexible intake behavior, in which quinine
adulteration does not reduce voluntary ethanol consumption, may mark a second behavioral
indicator in the development of alcohol addiction—after the initial increase in consumption and
preference—that would not otherwise be apparent, and study of the molecular correlates of this
behavioral state change will further illuminate the transition to uncontrollable alcohol
consumption.
Alcoholism is a condition partially defined by relapse (DSM-IV-TR, APA, 2000; Haeny et al.,
2013; Kopak et al., 2013). Research into changes in gene expression resulting from acute ethanol
exposure provides a starting point for study of the cellular response to ethanol exposure, but
knowledge of gene expression changes after cessation of ethanol intake can provide important
insights into vulnerability to alcohol abuse and treatment of abusive behavior. Thus, alteration in
gene expression during abstinence following periods of use is vital to understanding of the
maintenance of alcoholism. The molecular and behavioral effects of acute ethanol exposure
following a period of abstention, which are predictive of relapse behavior, depend on the state of
gene and protein expression in the subject at the time of reinstatement. In reporting several
molecular pathways containing ethanol responsive proteins regulated at the mRNA level after 4
days of withdrawal from voluntary ethanol exposure, this study provides evidence that the level
of expression of particular genes relevant to the behavioral response to ethanol re-exposure is
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altered by cessation itself. This report identified genes, pathways, and networks regulated days
after cessation of ethanol intake which likely contribute to the magnitude of the ADE, and thus
potentially to relapse in alcoholics, providing direction for future studies on the molecular
determinants of relapse to alcoholism.
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Chapter 4. Intermittent alcohol access elevates ethanol intake in C57BL/6J
and C57BL/6NCrl mice

Introduction
The transition from social alcohol drinking to alcohol use disorders (AUDs) is often
characterized by binge drinking, which is defined by the National Institute on Alcohol Abuse and
Alcoholism as a pattern of consumption that leads to blood alcohol levels (BALs) of greater than
80 mg/dl . For a typical adult BALs representative of binge-like drinking are achieved by
consumption in a 2 hour period of 5 drinks for males, and 4 drinks for females (Fillmore and
Jude, 2011). Binge drinking is not rare; approximately 23% of the U.S. population engages in
binge drinking at least once per month. Frequent binge drinkers, who consume 5 or more drinks
on 5 or more occasions per month, make up 7% of the U.S. population, and drink 45% of the
alcohol consumed by American adults. Remarkably, in drinkers 18 to 20 years of age, binge
drinking accounts for 96% of alcohol consumed by the age group (NSDUH, 2003). Although
binge drinking does not always lead to alcohol dependence, it is associated with diverse negative
health effects, as well as negative social and economic outcomes (Standridge et al., 2004). Better
understanding of this behavior will contribute to understanding of the genetic and environmental
factors that contribute to binge drinking, and help identify patterns of binge drinking that may
lead to dependence. Effective preclinical models that produce high alcohol consumption in a
short period of time are crucial to this understanding, and in general may be classified by
whether or not they induce alcohol dependence (Crabbe et al., 2011).
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In rodents, binge-like drinking that leads to dependence is hypothesized to be motivated by
negative reinforcement, or the desire to mitigate the negative symptoms associated with alcohol
withdrawal. Preclinical models of binge-like drinking that do not lead to alcohol dependence are
hypothesized to be motivated by the positive reinforcing and rewarding effects of alcohol (Barak
et al., 2011; Becker, 2013; Lopez et al., 2012). Models of binge-like alcohol exposure that lead to
dependence manipulate animals to achieve extremely high BALs, which may exceed 200 mg/dl
(Criado and Ehlers, 2013). Following this exposure animals are allowed to drink under voluntary
conditions, and display elevated consumption with repeated exposures. Examples of this type of
model are those using ethanol vapor exposure, alcohol-containing liquid diets, and alcohol
offered as the only source of liquid (Cheaha et al., 2013; Lopez and Becker, 2005; Roberts et al.,
2000a; Wise, 1973). In contrast, drinking-in-the-dark (DID), saccharin-sweetened solutions
(“supersac”), schedule-induced polydipsia, and intermittent alcohol access (IAA) produce bingelike drinking without associated alcohol dependence (Broadwater et al., 2013; Crabbe et al.,
2009; Falk and Samson, 1975; Melendez, 2011; Simms et al., 2013). Non-dependent models
have several advantages in validity and feasibility compared to models that induce binge-like
drinking through dependence, and the IAA model in particular has received much research
attention in recent years.
The IAA model was developed in the early 1970s by Roy Wise and colleagues at Sir George
Williams University (now Concordia University) in Montreal, while studying intra-cranial selfstimulation in rats. In adult Wistar rats, scheduled abstinence punctuated by 24-hour access
periods produces consumption of nearly 5 g/kg/day, compared to approximately 3 g/kg/day in
continuous access (CA) subjects (Amit et al., 1970; Wise, 1973). The model has recently been
readopted by several laboratories because it requires minimal experimental manipulation and
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produces high levels of alcohol intake and blood ethanol concentration (BEC) in rodents (Hwa et
al., 2011; Melendez, 2011; Simms et al., 2013; Simms et al., 2008). In the typical IAA
procedure, alcohol is offered along with water for one or three nonconsecutive 24-hour
consumption periods per week. IAA gradually increases alcohol consumption and preference for
alcohol over water, although significant differences compared to CA subjects are often observed
by the second drinking session. IAA drinking behavior is influenced by environment and
genotype, and not all strains of rodent display increases in alcohol intake (Crabbe et al., 2012;
Palm et al., 2011; Rosenwasser et al., 2013). Concurrent access to multiple alcohol
concentrations and the temporary use of sweetened alcohol solutions significantly increase the
efficacy of IAA, as do early life stressors such as maternal separation and social isolation
(Chappell et al., 2013; Daoura et al., 2011; Hwa et al., 2011; Melendez et al., 2006a).
There is significant molecular and behavioral evidence that IAA is a useful model for the
transition to alcoholism. Binge-like drinking produced by IAA is dose-dependently attenuated by
naltrexone and acamprosate, which are approved by the FDA for use in patients with AUDs
(Sabino et al., 2013; Simms et al., 2008). Most studies have implied a role for the corticotropin
releasing hormone (CRH) system in IAA behavior, which may exert influence through
hypothalamic and extra-hypothalamic mechanisms (Gilpin et al., 2008b; Hwa et al., 2011;
Sabino et al., 2013; Simms et al., 2008). After several weeks or months of IAA a distinct set of
behavioral changes are observed: significantly decreased water intake, resistance to adulteration
of alcohol with the bitter substance quinine, impaired performance in the Rota-rod test, and
reduced preference for sweet solutions compared to alcoholic solutions (Hopf et al., 2010; Loi et
al., 2010; Obara et al., 2009a). Furthermore, withdrawal from extended IAA elevated levels of
several proteins involved in glutamatergic signaling in the nucleus accumbens and amygdala of
84

alcohol-preferring P-rats (Obara et al., 2009a). These brain regions are known to be involved in
motivated behavior and stress responses, and withdrawal from alcoholism in humans is
associated with upregulation of glutamatergic signaling that contributes to craving and relapse
(Bauer et al., 2013; Hermann et al., 2012; Nardone et al., 2012). It is therefore useful to study the
transcriptional response to intermittent access in conjunction with drinking behavior, to provide
insight into plasticity that alters neurotransmission and alcohol intake over time, because the
model produces behavior and neuromolecular states similar to those seen in alcoholics.
While the IAA procedure seems to show validity as a model for the transition to alcoholism, the
genetic and environmental influences on its effects are not well understood, and results have
varied significantly among laboratories, even within an inbred strain (Crabbe et al., 2012; Hwa et
al., 2013; Rosenwasser et al., 2013; Sabino et al., 2013). Therefore, studies are reported herein
that were conducted to better understand the effects of genetic background and choice of alcohol
concentration on binge-like alcohol drinking behavior, and to examine associated transcriptional
regulation in the nucleus accumbens produced by binge-like intake. It is hypothesized that IAA
will be more effective in the alcohol-preferring C57BL/6J mouse strain compared to the closelyrelated C57BL/6NCrl strain of mouse, which typically drinks less alcohol, and has not been
published on in the context of the IAA model. Furthermore it is hypothesized that offering
multiple concurrent alcohol concentrations to C57BL/6J mice will increase alcohol intake
relative to use of a single concentration, but that both procedures will significantly elevate
consumption and preference over time.
Three studies are reported that were conducted toward this end. Experiment 1 reports the effect
of 1-day-per-week IAA on C57BL/6NCrl mice from Charles River Laboratories. Experiment 2
reports the effect of 1-day-per-week IAA on C57BL/6J mice with access to either 15% alcohol
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or 7.5%, 15%, and 30% alcohol concurrently. Finally, quantitative real-time PCR was used to
examine differences between groups in nucleus accumbens gene expression of transcripts known
to be regulated by a single 4-day ethanol deprivation: Smarca4, Cacna1g, Cacna1d, Kif5c, and
Gria1, to examine commonalities in transcriptional regulation across deprivation models
(Warner, unpublished data, thesis chapter 2).

Materials and Methods
Animals
For experiment 1, 50 male C57BL/6NCrl mice were obtained from Charles River Laboratories
(Wilmington, Massachusetts) at 8 to 9 weeks of age. For experiment 2, 56 male C57BL/6J mice
were obtained from The Jackson Laboratory (Bar Harbor, Maine). Upon arrival mice were
individually housed in standard clear plastic mouse cages on wood-chip based bedding (Harlan
Sani-chips, #7090A, Harlan, Teklad, Madison, WI). Mice were offered food and water at all
times during all experiments. All experimental procedures adhered to the guidelines of the
National Institutes of Health Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth
University.
Two-bottle choice drinking
Animals were offered water and alcohol solutions in drinking tubes fashioned from 10 mL
disposable polystyrene pipets, into which were inserted 1.5” steel ball-bearing sipper tubes
(Ancare Corporation, Bellmore, NY). After filling, the tubes were sealed with standard size 0
rubber stoppers, and offered to animals by inserting the sipper tube through the metal bars of the
cage tops. Solutions were changed daily, and the side on which alcohol and water solutions were
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offered was alternated every other day to avoid the development of position preference. Fluid
measurements were taken by the distance from meniscus to a mark made at the meniscus the
previous day. Solutions were measured to the nearest 0.1 mL and changed at 5:00pm every day,
and lights were off from 6:00pm to 6:00am. During IAA, alcohol was offered on Fridays, and
animal weight was measured every other Wednesday to avoid stress from handling. For all
experiments alcohol consumption was calculated as g/kg/day, and alcohol preference was
calculated as total alcohol consumed in mL divided by total fluid consumed in mL.
For experiment 1, mice were separated into three groups: intermittent access (IAA, N = 25),
continuous access (CA, N = 12), and water only (WON, N = 12). All alcohol solutions offered
were 15% alcohol by volume. The IAA group was allowed a 30-day baseline period of
continuous access to alcohol as a point of comparison, followed by 8 weekly cycles of 6 days of
abstinence and 1 day of drinking (86 days total). The CA group was allowed continuous access
to alcohol for 86 days, and the H group was allowed access to water only for the entire study
period. After the 8th cycle of IAA mice were abstinent for 6 days, and then sacrificed for brain
collection. Nucleus accumbens tissue was obtained and frozen immediately at -80 degrees C.
For experiment 2, mice were separated into five groups: intermittent access with multiple alcohol
concentrations (IAMC, N = 12), intermittent access with 15% alcohol only (IASC, N = 12),
continuous access with multiple alcohol concentrations (CAMC, N = 12), continuous access with
15% alcohol only (CASC, N = 12), and water only (WOJ, N = 12). When multiple alcohol
concentrations were offered, they were 7.5%, 15%, and 30% ethanol by volume. The IAA group
was allowed a 17-day baseline period of continuous access to alcohol as a point of comparison,
followed by 7 weekly cycles of 6 days of abstinence and 1 day of drinking (86 days total). The
CA group was allowed continuous access to alcohol for 56 days after a delayed start, to give an
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equal number of days of access as the IA group. The H group was allowed access to water only
for the entire study period. After the 7th cycle of IAA mice were abstinent for 6 days, and then
sacrificed for brain collection. Nucleus accumbens tissue was obtained and frozen immediately
at -80 degrees C.
For experiment 1 (IAA in C57BL/6NCrl mice) 2-way ANOVA and Fisher’s LSD test were used
to determine statistical significance for changes in drinking behavior over time and between
groups. Repeated measures could not be used for experiment 1 due to missing data caused by
leaking drinking tubes. For experiment 2 (IAA in C57BL/6J mice) 2-way ANOVA with repeated
measures and Fisher’s LSD test were used to determine statistical significance for changes in
drinking behavior over time and between groups.
RNA isolation and quantitative real-time PCR
Total RNA was extracted from NAc from individual mice in STAT 60 reagent (Tel-Test,
Friendswood, TX) according to the manufacturer’s protocol. RNA concentration and quality was
assessed by Experion automated electrophoresis and UV spectrophotometer (BioRad, Hercules,
CA). All samples met quality control standards and no samples were excluded from analysis.
cDNA was generated from 1 μg total RNA by reverse transcription with the iScript CDNA kit
(Bio-Rad, Hercules, CA) following the manufacturer's instructions. Quantitative real-time
polymerase chain reaction (Q-rtRCR) was performed using the iCycler iQ system (Bio-Rad)
according to the manufacturer's instructions for SYBR Green-based detection.
Quantification of gene expression levels was determined based on the threshold cycle for each
well using the provided software, and all results were normalized to multiple stable reference
genes using Genorm (Vandesompele et al., 2002). One-way ANOVA was used to determine
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statistically significant differences across groups in transcript abundance, followed by Tukey
post-tests for pair-wise group differences. Significance was taken as p < .05 for all comparisons.
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Results
Experiment 1: 2-bottle choice intermittent access drinking in C57BL/6NCrl mice
IAA caused an immediate and significant increase in ethanol consumption in C57BL/6NCrl
mice, which remained significant over 8 test sessions (see Figure 4.1). Mice in the CA group did
not alter consumption over the course of the experiment. Two-way ANOVA identified a
significant effect of group [F(1, 314) = 19.12, p < .0001], but not of time [F(8, 314) = 1.316, p =
0.2345], and there was no interaction [F(8, 314) = 0.6695, p = 0.7184]. In IAA mice Fisher’s
LSD test identified significant differences in consumption compared to baseline at p < .05 or
lower (p < .01 for test days 4 and 6, p < .001 for test days 3 and 7) for all test days. In CA mice
Fisher’s LSD test identified no significant differences compared to baseline on any test day. For
between groups comparison Fisher’s LSD identified significant differences between IAA and
CA groups on test days 3, 7, and 8 (p < .05).
IAA also caused an immediate and significant increase in ethanol preference in C57BL/6NCrl
mice, which remained significant for all but the final test session (see Figure 4.2). Mice in the
CA group did not alter preference over the course of the experiment. Two-way ANOVA
identified a significant effect of group [F(1, 314) = 9.140, p = .0027], but not of time [F(8, 314)
= .9818, p = 0.4501], and there was no interaction [F(8, 314) = 0.6251, p = 0.7567]. In IAA mice
Fisher’s LSD test identified significant differences in preference compared to baseline at p < .05
or lower (p < .01 for test days 3 and 7) for all test days. In CA mice Fisher’s LSD test identified
no significant differences compared to baseline on any test day. For between groups comparison
Fisher’s LSD identified no significant differences between IAA and CA groups at p < .05.
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Figure 4.1. Ethanol consumption over time in mice offered intermittent access (IAA) or
continuous access (CA) to 15% ethanol and water in a 2-bottle choice model. One-way
ANOVA with repeated measures within each group. * : p < .05 in Fisher’s LSD test compared
to baseline.
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Figure 4.2. Ethanol preference over time in mice offered intermittent access (IAA) or
continuous access (CA) to 15% ethanol and water in a 2-bottle choice model. One-way
ANOVA with repeated measures within each group. * : p < .05 in Fisher’s LSD test compared
to baseline.
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Experiment 2: 2-bottle choice and 4-bottle choice intermittent access drinking in C57BL/6J mice
Continuous alcohol access: single concentration vs. multiple concentrations
Two-way ANOVA with repeated measures revealed significant differences in ethanol
consumption between C57BL/6J mice allowed continuous access to a single ethanol 15%
concentration (CASC) and mice offered access to 7.%, 15%, and 30% ethanol (CAMC) (see
Figure 4.3). Comparisons were drawn for the 7 days running from day 11 to day 17 of the 25 day
continuous alcohol access period. There was a significant effect of group [F(1, 22) = 62.58, p <
0.0001], a trend toward a significant effect of time [F(6, 132) = 1.978, p = 0.0732], and no
interaction [F(6, 132) = 0.7509, p = 0.6098]. Consumption was significantly different between
the CASC and CAMC mice on all drinking days (Fisher’s LSD test; p < .0001).
Two-way ANOVA with repeated measures also revealed significant differences in ethanol
preference between C57BL/6J mice allowed continuous access to a single ethanol 15%
concentration (CASC) and mice offered access to 7.%, 15%, and 30% ethanol (CAMC) (see
Figure 4.4). For CAMC mice ethanol preference was calculated as total intake of fluid containing
alcohol in mL divided by total fluid intake in mL, and for CASC mice ethanol preference was
calculated as intake of 15% alcohol in mL divided by total fluid intake in mL. Comparisons were
drawn for the 7 days running from day 11 to day 17 of the 25 day continuous alcohol access
period. There was a significant effect of group [F(1, 22) = 8.009, p = 0.0097], no significant
effect of time [F(6, 132) = .6545, p = 0.6864], and no interaction [F(6, 132) = 0.7872, p =
0.5814]. Preference was significantly different between the CASC and CAMC mice on days 2
through 6 of the 7 day drinking period (Fisher’s LSD test; p < .05).
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Figure 4.3. Total ethanol consumption in mice offered continuous access to water, and to either a
single concentration (15%) or multiple concentrations (7.5, 15, and 30%) of ethanol. * : p < .05;
two-way ANOVA with repeated measures, Fisher’s LSD test for daily mean between groups.
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Figure 4.4. Total ethanol preference in mice offered continuous access to water, and to either a
single concentration (15%) or multiple concentrations (7.5, 15, and 30%) of ethanol. * : p <
.05; two-way ANOVA with repeated measures, Fisher’s LSD test for daily mean between
groups.
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Intermittent alcohol access: single concentration vs. multiple concentrations
Total alcohol consumption and preference
In C57BL/6J mice IAA produced significantly increased total ethanol consumption when a
single concentration (15%) or multiple concentrations (7.5%, 15%, and 30%) were offered (see
Figure 4.5). Comparison of single-concentration (IASC) and multiple concentration (IAMC)
mice using two-way ANOVA with repeated measures revealed significant effects of group [F(1,
22) = 67.74, p < 0.0001], and time [F(6, 132) = 8.923, p < 0.0001], but no significant interaction
[F(6, 132) = 0.9468, p = 0.4640]. For IASC mice Fisher’s LSD test showed significant
differences in total consumption compared to baseline from test day 2 through test day 7 (p <
.05). For IAMC mice Fisher’s LSD test showed significant differences in total consumption
compared to baseline from test day 1 through test day 7 (p < .01). Fisher’s LSD test revealed
significant differences in total consumption between IAMC and IASC mice for baseline and at
all test days (p < .0001).
In C57BL/6J mice IAA also produced significantly increased total ethanol preference when a
single concentration (15%) or multiple concentrations (7.5%, 15%, and 30%) were offered (see
Figure 4.6). Comparison of single-concentration (IASC) and multiple concentration (IAMC)
mice using two-way ANOVA with repeated measures revealed significant effects of group [F(1,
22) = 6.942, p= 0.0151], and time [F(6, 132) = 6.423, p < 0.0001], but no significant interaction
[F(6, 132) = 0.4946, p = 0.8115]. For IASC and IAMC mice Fisher’s LSD test showed
significant differences in total consumption compared to baseline on all test days except test day
3 (p < .05). Fisher’s LSD test revealed significant differences in total consumption between
IAMC and IASC mice for baseline and on test days 1, 2, 4, 6, and 7. (p < .05).
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Figure 4.5. Total ethanol consumption in mice offered intermittent access to water, and to
either a single concentration (15%) or multiple concentrations (7.5, 15, and 30%) of ethanol.
CAS and CAM indicate 7-day average consumption for mice offered continuous access to a
single concentration, or multiple concentrations, of ethanol, respectively. * : p < .05; two-way
ANOVA with repeated measures, Fisher’s LSD test for daily means compared to group
baseline.
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Figure 4.6. Total ethanol preference in mice offered intermittent access to water, and to either a
single concentration (15%) or multiple concentrations (7.5, 15, and 30%) of ethanol. CAS and
CAM indicate 7-day average preference for mice offered continuous access to a single
concentration, or multiple concentrations, of ethanol, respectively. * : p < .05; two-way
ANOVA with repeated measures, Fisher’s LSD test for daily means compared to group
baseline.
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15% alcohol consumption and preference
IAA produced significantly increased 15% ethanol consumption when a single concentration
(15%) or multiple concentrations (7.5%, 15%, and 30%) were offered (see Figure 4.7).
Comparison of single-concentration (IASC) and multiple concentration (IAMC) mice using twoway ANOVA revealed a trend toward a significant effect of group [F(1, 175) = 3.356, p =
0.0687], a significant effect of time [F(7, 175) = 4.515, p = 0.0001], and no significant
interaction [F(7, 175) = 0.5680, p = 0.7813]. Repeated measures could not be used due to
leakage of all 15% ethanol from the drinking tube for IASC mouse #9 on test day 5. For IASC
mice Fisher’s LSD test showed significant differences in 15% consumption compared to baseline
on test day 2 and from test day 4 through test day 7 (p < .05). For IAMC mice Fisher’s LSD test
showed significant differences in 15% consumption compared to baseline on test day 2 and from
test day 5 through test day 7 (p < .05). Fisher’s LSD test revealed significant differences in 15%
consumption between IAMC (9.26 g/kg) and IASC (13.37 g/kg) mice for test day 4 only (p =
.0410).
Differences were more apparent between IAMC and IASC mice for 15% ethanol preference, but
in IAMC mice this measurement is less meaningful, because it does not represent the totality of
ethanol consumed compared to water. In C57BL/6J mice IAA produced significantly increased
15% ethanol preference when a single concentration (15%) or multiple concentrations (7.5%,
15%, and 30%) were offered (see Figure 4.8). Comparison of single-concentration (IASC) and
multiple concentration (IAMC) mice using two-way ANOVA revealed a significant effect of
group [F(1, 175) = 29.21, p < 0.0001], a significant effect of time [F(7, 175) = 4.331, p =
0.0002], and no significant interaction [F(7, 175) = 0.2917, p = 0.9565]. Repeated measures
could not be used due to leakage of all 15% ethanol from the drinking tube for IASC mouse #9
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on test day 5. For IASC mice Fisher’s LSD test showed significant differences in 15% preference
compared to baseline on test day 2 and from test day 4 through test day 7 (p < .05). For IAMC
mice Fisher’s LSD test showed significant differences in 15% preference compared to baseline
on test day 1 and from test day 5 through test day 7 (p < .05). Fisher’s LSD test revealed
significant differences in 15% preference between IAMC and IASC mice for baseline and test
days 2 through 4 (p < .05).
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Figure 4.7. 15% ethanol consumption in mice offered intermittent access to water, and to either
a single concentration (15%) or multiple concentrations (7.5, 15, and 30%) of ethanol. CAS and
CAM indicate 7-day average 15% consumption for mice offered continuous access to a single
concentration, or multiple concentrations, of ethanol, respectively. * : p < .05; two-way
ANOVA with repeated measures, Fisher’s LSD test for daily means compared to group
baseline.

101

Figure 4.8. 15% ethanol preference in mice offered intermittent access to water, and to either a
single concentration (15%) or multiple concentrations (7.5, 15, and 30%) of ethanol. CAS and
CAM indicate 7-day average 15% preference for mice offered continuous access to a single
concentration, or multiple concentrations, of ethanol, respectively. * : p < .05; two-way
ANOVA with repeated measures, Fisher’s LSD test for daily means compared to group
baseline.
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Intermittent alcohol access vs. continuous alcohol access
Escalation in alcohol intake for the IA group was confirmed using one-way ANOVA with
repeated measures. For IA mice each test day was compared to the baseline period, which was
defined as the final 7 days of continuous access in these mice. For CA mice drinking data was
analyzed for stability from day 11 through 17 of the 25-day drinking period, to confirm a lack of
elevation in intake due to CA. Drinking data for CA mice was collected beginning on day 42 of
the study, and was collected through day 66, which in the IA mice corresponded to the period
beginning 3 days prior to IA test day 4 and ending on IA test day 7. Drinking data for all IASC
and IAMC were thus compared to the time-matched corresponding data for CASC and CAMC
mice using unpaired two-tailed Student’s t-test with a significance threshold of p < .05.
No differences were observed between IASC baseline consumption and preference and CASC
baseline consumption and preference (unpaired two-tailed t-test, p < .05). Similarly, no
differences were observed between IAMC and CAMC mice for baseline consumption or
preference of total ethanol, or for any single ethanol concentration (unpaired two-tailed t-test, p <
.05) (see Figure 4.9).
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Figure 4.9. Baseline drinking in IA groups compared to corresponding CA groups for single
concentration and multiple concentration drinking. For IA mice the baseline period was defined
as the final 7 days of continuous access in these mice, and for CA mice drinking data was
analyzed for stability from day 11 through 17 of the 25-day drinking period. No significant
differences were found, which showed that IA mice did not show significantly different
drinking behavior compared to CA mice prior to IA.
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IASC drinking vs. CASC drinking
For IASC mice one-way ANOVA with repeated measures showed a significant effect of
treatment on ethanol consumption [F(7, 77) = 8.850, p < 0.0001]. Consumption was elevated
compared to baseline on test day 2 through test day 7 (Fisher’s LSD, p < .05)(see Figure 4.10A).
For ethanol preference in IASC mice there was a significant effect of treatment [F(7, 77) =
6.527, p < 0.0001], and preference was elevated on all test days except for test day 3 (Fisher’s
LSD, p < .05) (see Figure 4.10B). For CASC mice one-way ANOVA with repeated measures
showed no significant differences over time in consumption [F(6, 66) = 1.695, p = .1361] or
preference [F(6, 66) = 1.359, p = .2445](see Figures 4.10C, 4.10D). Comparison of timematched daily intake between IASC and CASC mice showed significant differences on all IA
test days for consumption and preference (Student’s t-test, p < .05).
IAMC drinking vs. CAMC drinking
For IAMC mice one-way ANOVA with repeated measures showed a significant effect of
treatment on total ethanol consumption [F(7, 77) = 9.956, p < 0.0001] and preference [F(7, 77) =
6.538, p < 0.0001]. Consumption was significantly elevated compared to baseline on all test
days, and preference was significantly elevated on all test days except for test day 3 (Fisher’s
LSD test, p < .05)(see Figures 4.11A, 4.11B). No significant changes in total ethanol
consumption [F(6, 66) = 1.157, p = 0.3403] or preference [F(6, 66) = 0.2036, p = 0.9745] over
time were observed in CA mice (see Figures 4.11C, 4.11D). Comparison of time-matched daily
intake between IAMC and CAMC mice showed significant differences on all IA test days for
total consumption and total preference (Student’s t-test, p < .05).
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Figure 4.10. Alcohol consumption (A, C) and preference (B, D) over time for mice offered a
single concentration (15%) of ethanol under IA (IASC) and CA (CASC) conditions. Data were
analyzed using one-way ANOVA with repeated measures and Fisher’s LSD test to compare
daily drinking within groups. * : p < .05; Fisher’s LSD test.
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Figure 4.11. Total alcohol consumption (A, C) and preference (B, D) over time for mice
offered multiple concentrations (7.5, 15, and 30%) of ethanol under IA (IAMC) and CA
(CAMC) conditions. Data were analyzed using one-way ANOVA with repeated measures and
Fisher’s LSD test to compare daily drinking within groups. * : p < .05; Fisher’s LSD test.
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ANOVA with repeated measures in IAMC showed that consumption [F(7, 77) = 4.499, p =
0.0003] and preference [F(7, 77) = 3.841, p = 0.0012] for 15% ethanol was significantly elevated
over time. Consumption of 15% ethanol was significantly elevated on test days 1, 2, 5, 6, and 7
(Fisher’s LSD, p < .05) (see Figures 4.12A, 4.12B). Preference for 15% ethanol was significantly
elevated on test day 1 and test days 5 through 7 (Fisher’s LSD, p < .05). For CA mice ANOVA
without repeated measures was used due to missing data for subject 8 on day 4 of the analyzed
period. No significant changes in 15% ethanol consumption [F(6, 76) = .2440, p = 0.9603] or
preference [F(6, 76) = 0.3206, p = 0.9243] over time were observed in CA mice (see Figures
12C, 12D). Comparison of time-matched daily intake between IAMC and CAMC mice showed
significant differences on all IA test days for 15% consumption and 15% preference (Student’s ttest, p < .05).
For 30% ethanol one-way ANOVA with repeated measures in IAMC showed that consumption
[F(7, 77) = 1.338, p = 0.2440] and preference [F(7, 77) = 0.6428, p = 0.7192] were not altered
over time by IAA (see Figures 4.13A, 4.13B). No significant changes in 30% ethanol
consumption [F(6, 66) = .9547, p = 0.4627] or preference [F(6, 66) = 0.4724, p = 0.8264] over
time were observed in CA mice (see Figures 13C, 13D). Comparison of time-matched daily
intake between IAMC and CAMC mice showed significant differences for 30% consumption
and 30% preference on IA test day 4 only (Student’s t-test, p < .05).
For 7.5% ethanol one-way ANOVA with repeated measures in IAMC showed no changes over
time in consumption [F(7, 77) = 1.529, p = 0.1702] or preference [F(7, 77) = 1.764, p = 0.1068]
(see Figures 14A, 14B). Similarly, no changes were observed in CAMC mice for 7.5% ethanol
consumption [F(6, 66) = 1.760, p = 0.1210] or preference [F(6, 66) = 1.347, p = 0.2491] (see
Figures 4.14C, 4.14D). Comparison of time-matched daily intake between IAMC and CAMC
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mice showed significant differences for 7.5% consumption on IA test day 1, and for 7.5%
preference on IA test days 1 and 4 (Student’s t-test, p < .05).
Quantitative real-time PCR
Of the five mRNA transcripts examined using qPCR, only two were found to be significantly
regulated across groups (see Figure 15). Smarca4 transcript was found to be significantly
increased in CA mice compared to IA and H2O mice [F(2, 21) = 9.039, p = 0.0015; Tukey posttest: p < .05]. Cacna1g transcript was found to be significantly decreased in CA mice compared
to IA and H2O mice [F(2, 21) = 6.302, p = 0.0072; Tukey post-test: p < .05]. Abundance of
Cacna1d [F(2, 21) = 2.174, p = 0.1386], Kif5c [F(2, 21) = 2.518, p = 0.1046], and Gria1 [F(2,
21) = 1.737, p = 0.2004] did not differ between groups.
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Figure 4.12. 15% alcohol consumption (A, C) and preference (B, D) over time for mice offered
multiple concentrations (7.5, 15, and 30%) of ethanol under IA (IAMC) and CA (CAMC)
conditions. Data were analyzed using one-way ANOVA with repeated measures and Fisher’s
LSD test to compare daily drinking within groups. * : p < .05; Fisher’s LSD test.
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Figure 4.13. 30% alcohol consumption (A, C) and preference (B, D) over time for mice offered
multiple concentrations (7.5, 15, and 30%) of ethanol under IA (IAMC) and CA (CAMC)
conditions. Data were analyzed using one-way ANOVA with repeated measures and Fisher’s
LSD test to compare daily drinking within groups. * : p < .05; Fisher’s LSD test.
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Figure 4.14. 7.5% alcohol consumption (A, C) and preference (B, D) over time for mice offered
multiple concentrations (7.5, 15, and 30%) of ethanol under IA (IAMC) and CA (CAMC)
conditions. Data were analyzed using one-way ANOVA with repeated measures and Fisher’s
LSD test to compare daily drinking within groups. * : p < .05; Fisher’s LSD test.
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Figure 4.15. Gene expression determined by quantitative real-time PCR across groups of
C57BL/6NCrl mice allowed access to water or to 15% alcohol on a continuous access (CA) or 1day-per-week intermittent access (IA) schedule. Data were normalized to low-variance
transcripts using Genorm, and analyzed using ANOVA with repeated measures followed by
Tukey post-hoc test. * : p < .05 for significant difference compared to H2O and IA groups.

113

Discussion
Intermittent alcohol access with 15% alcohol induces significantly elevated consumption and
preference for the drug over water in C57BL/6NCrl and C57BL/6J mice, in accordance with
hypotheses. This is the first demonstration of IAA in the C57BL/6NCrl mouse, and establishes
the efficacy of repeated scheduled abstinence to elevate consumption and preference in this
strain. This result is important because conflicting evidence exists regarding the utility of alcohol
deprivation in this strain for increasing alcohol intake; some studies show that single and
repetitive 4-day deprivation periods have no effect (Tomie et al., 2013; Wolstenholme et al.,
2011), and others have found significant increases in consumption and reference upon
reinstatement (Khisti et al., 2006b).
Similarly, for the C57BL/6J strain this result confirms that IAA produces elevated consumption
and preference, in agreement with previous studies. This result confirms the effect observed in
two other publications reporting 1-day-per-week IAA in the C57BL/6J strain (Melendez et al.,
2006a; Rosenwasser et al., 2013). All other IAA publications in mice and rats use every-otherday IAA (Adermark et al., 2011; Ahmadiantehrani et al., 2013; Barak et al., 2011; Carnicella et
al., 2009a; Chappell et al., 2013; Cippitelli et al., 2012; Crabbe et al., 2012; Daoura et al., 2011;
Daoura and Nylander, 2011; Dawson et al., 2013; Egecioglu et al., 2013; George et al., 2012;
Hargreaves et al., 2009a; Hopf et al., 2011; Hwa et al., 2011; Hwa et al., 2013; Lee et al., 2013;
Li et al., 2010a; Li et al., 2012a; Li et al., 2012b; Li et al., 2011b; Loi et al., 2010; Melendez,
2011; Moorman and Aston-Jones, 2009b; Nielsen et al., 2012; Obara et al., 2009a; OsterndorffKahanek et al., 2013; Palm et al., 2011; Sabino et al., 2013; Sajja and Rahman, 2013; Shirazi et
al., 2013; Simms et al., 2010; Simms et al., 2013; Simms et al., 2008; Stuber et al., 2008; Wen et
al., 2012; Yardley et al., 2012).
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The magnitude and immediacy of increases in drinking behavior are similar within rodent strains
across studies, but varied greatly between strains. Interestingly, the effects of IAA on
consumption were similar in relative magnitude for the two strains in this study: the
C57BL/6NCrl mice increased from approximately 3 g/kg/day to 6 g/kg/day, and the C57BL/6J
increased from approximately 8 g/kg/day to 15 g/kg/day. This result suggests that IAA is useful
in rodents regardless of initial ethanol consumption, and should allow for experimental
dissection of factors that contribute to baseline drinking and development of maladaptive
drinking, which may be distinct, at least within C57BL/6 strains. This type of study is important
for understanding the consequences of binge-drinking and intermittent ethanol exposure in
humans, which differ in initial sensitivity to and intake of alcohol, and in propensity to develop
AUDs (King et al., 2013; Rohsenow et al., 2012; Schuckit et al., 2013).
Study of alcohol-related behavior in C57BL/6NCrl mice is relatively limited, and generally
involves comparisons to the alcohol-preferring C57BL/6J strain, which shows greater alcohol
consumption and preference, reduced effect of alcohol deprivation, and less ethanol-induced
dopamine release in the ventral striatum (Khisti et al., 2006b; Mulligan et al., 2008b;
Ramachandra et al., 2007a). In pair-housed C57BL/6NCrl mice alcohol deprivation produces no
effects on drinking, but in mice housed alone the procedure produces increases of 50% or more,
which suggests that increases in drinking produced by alcohol deprivation in this strain is
dependent on stress induced by social isolation (Khisti et al., 2006b; Tomie et al., 2013).
Other direct behavioral comparisons between C57BL/6NCrl and C57BL/6J mice show
behavioral differences with some relevance to alcohol drinking and other alcohol-related
behaviors. In contextual fear-conditioning C57BL/6NCrl mice show more conditioned freezing,
and this difference is maintained in an altered context (Bryant et al., 2008; Radulovic et al.,
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1998). Stressors such as maternal separation also potentiate conditioned fear responses and
alcohol drinking, and these differences are associated with altered mesocortical glutamate and
GABA receptor expression (Romano-Lopez et al., 2012; Wilber et al., 2009). Interestingly,
C57BL/6J mice show better motor coordination than C57BL/6NCrl mice in the Rota-rod task,
which raises the possibility that ataxia due to alcohol intake influence consumption in these
strains (Bryant et al., 2008). Mice are prey animals, and any action that increases likelihood of
predation, such as reduced motor control, would be expected to be avoided by the animal.
Mice from the C57BL/6J strain significantly increase alcohol consumption and preference when
offered multiple concentrations of alcohol, compared to a single concentration of alcohol. This
observation is consistent with other studies that show that choice of alcohol concentrations
elevates intake, although most such studies report results in rats, and mouse studies are rare (Bell
et al., 2003; Bell et al., 2004c; Holter et al., 1998; Melendez et al., 2006a; Rodd-Henricks et al.,
2001a; Serra et al., 2003b; Vengeliene et al., 2005; Wolffgramm and Heyne, 1995). Despite a
doubling in consumption, this level of alcohol drinking does not represent an upper limit on
consumption for the strain, because intermittent access significantly increases overall
consumption and preference.
Interestingly, only consumption and preference for 15% alcohol increase over time in response to
IAA in mice offered access to 7.5%, 15%, and 30% ethanol. Consumption of 30% ethanol is
approximately equivalent to that of 15% ethanol at the beginning of IAA procedures, and it does
not change over time. Consumption of 7.5% ethanol accounts for a trivial fraction (< 10%) of
total intake and similarly does not change over time. While these results agree with others
showing that choice of alcohol concentration greatly enhances drinking, they differ in that
deprivation causes a shift to higher concentrations of alcohol (Siegmund et al., 2005a; Spanagel
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and Holter, 1999). It is unclear why no such shift was seen in the current study, but other studies
used slightly different access schedules. In rats multiple concentration drinking occured over a
period of months, punctuated by 3-day deprivations, the first of which shifted concentration
preference. In mice weekly access was begun only after an initial 2-week deprivation period,
which delayed escalation. It therefore seems that the length of baseline drinking and of initial
deprivation has lasting effects on the manifestation of the increased drinking, and further
experimentation should address the neuromolecular correlates of these differences in the
mesolimbocortical dopaminergic circuitry. Furthermore, these results indicate that offering a
single alcohol concentration may skew results and mask significant effects of experimental
manipulations, which may be specific to particular concentrations. Furthermore, multiple
concentrations greatly enhance the validity of animal models for representing drinking in
humans, who generally have some choice in the strength of alcohol they consume.
In the C57BL/6NCrl strain ethanol intake is at least partially determined by epigenetic influences
on gene expression, and thus changes in gene expression associated with altered drinking
behavior produced by IAA can illuminate the particular neuromolecular mediators of the
behavior. The nucleus accumbens is of particular interest in the context of alcohol craving and
addition, because it is known that changes in functioning and gene expression in this region
contribute to changes in motivated behavior for reward, including drugs (Barrot et al., 2002;
Bauer et al., 2013; Carlezonjr and Thomas, 2009; Li et al., 2011c; McBride et al., 2009). Results
for transcriptional regulation in nucleus accumbens of IAA mice compared to water drinking
mice do not resemble results for single-deprivation mice compared to water drinking mice, and
this result is unexpected. For the transcripts measured in C57BL/6NCrl mice regulation in
nucleus accumbens due to continuous alcohol access is similar to that observed in abstinent mice
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after a single 4-day deprivation period, when compared to water drinking controls. In contrast,
no significant differences are apparent between IA and H2O groups for any measured transcript.
It is therefore hypothesized that gene expression differences observed after alcohol deprivation
are a result of previous alcohol exposure that are in the process of diminishing, and thus are
apparent after 4 days, but not 6 days, of abstinence.
These results show that alcohol exposure regulates gene expression in a transient manner that is
no longer apparent after several days of abstinence, when no differences are observed between
IA and H2O mice. This is intriguing given the divergent drinking behavior observed in ethanolnaïve water drinkers and IAA mice when exposed to alcohol, and may indicate that alcoholinduced transcriptional changes have propagated to the functional protein level, where they exert
control over neuronal function and drinking behavior. It is therefore important to study acute
transcriptional regulation induced by alcohol drinking as a control group in any studies
examining gene expression associated with abstinence and relapse behavior, because changes
that are important mediators of behavior may no longer be apparent in deprived mice. To
confirm this hypothesis, future studies will address the correlations between alcohol-induced
transcription and protein translation and abundance over time.
These results establish the utility of the one-day-per-week IAA model to produce significantly
elevated alcohol consumption and preference in C57BL/6NCrl mice, which drink less alcohol
than the commonly-used C57BL/6J strain, for which the effectiveness of one-day-per-week IAA
was also confirmed. Furthermore, the use of multiple alcohol concentrations (7.5%, 15%, 30%
v/v) produces significantly elevated consumption and preference under continuous access and
intermittent access schedules. In the multiple concentration model escalation due to intermittent
access occurs for consumption and preference of 15% alcohol, while intake of 7.5% alcohol and
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30% alcohol remain unchanged. After six cycles of IAA and six days of abstinence,
transcriptional regulation in nucleus accumbens of C57BL/6NCrl mice compared to waterdrinking control mice does not resemble that observed in 4-day-abstinent mice compared to their
own controls. Future studies will determine the persistence of alcohol-responsive regional gene
expression in abstinent animals, and the contribution of this transcriptional regulation to bingelike drinking behavior. The results reported herein provide important direction for the study of
the development of binge-like drinking in rodent strains with dissimilar genetic backgrounds and
alcohol-related behaviors, which is a powerful tool for deciphering the neurobiology of alcohol
craving, and the genetic and environmental factors that influence heavy drinking behavior and
the transition to alcoholism.
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Chapter 5. Nucleus accumbens transcriptional regulation in the intermittent
alcohol access model: differential expression and weighted gene co-expression
networks

Introduction
Current therapeutic strategies are not effective in the long term for the majority of alcoholics,
because the neurobiology that mediates the development and maintenance of maladaptive
drinking behavior characteristic of the disease is not well understood. Both the transition to
alcoholism and attempts at abstinence are characterized by episodes of binge-like drinking, in
which blood alcohol concentrations of greater than 80 mg/dl are achieved through consumption
of several drinks in a short period of time (Fillmore and Jude, 2011). In general, alcoholics
consume greater amounts of ethanol than non-alcoholics, and in those trying to quit drinking a
pattern of cyclic withdrawal and relapse is often observed. Animal models that produce this type
of binge-like relapse drinking are crucial to the understanding of alcohol-related behavior, but
progress in this area has been slowed by the dearth of preclinical models that produce such
intake.
In the past decade models have been developed that produce elevated alcohol consumption
and/or binge-like drinking in rodents, with or without induction of dependence (Becker, 2013;
Crabbe et al., 2011). These models vary in effectiveness and validity, but the most successful
have been the chronic intermittent ethanol (CIE) vapor chamber model, the drinking-in-the-dark
(DID) model, and the intermittent alcohol access (IAA) model (Crabbe et al., 2009; Iancu et al.,
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2013; Lopez et al., 2011; Rhodes et al., 2005; Simms et al., 2008; Sparta et al., 2008). Of these
models the IAA procedure appears to be the most valid for comparison to human alcoholism, in
that it requires the least intrusive experimental manipulation and is the only procedure in which
all alcohol exposure is voluntary (Wise, 1973).
The CIE model makes use of the alcohol dehydrogenase inhibitor pyrazole and extensive
exposures to stressful vapor chambers for daily sessions of 14 hours or more (Knapp and Breese,
2012). In addition to its actions on alcohol dehydrogenase, which cause greatly elevate blood
ethanol concentrations, pyrazole is an NMDA receptor agonist and has some agonist activity at
acetylcholine receptors (Pereira et al., 1992). The DID model elevates drinking through limited
access of two to four hours, in which only solutions containing alcohol are offered (Rhodes et al.,
2005). While the DID and CIE models produce binge-like drinking behavior, human alcoholics
do not generally use pyrazole in conjunction with drinking, or drink in limited-access scenarios
in which water is unavailable. Although inhaled alcohol, for example the “vapor-tini” has
increased in popularity in recent years, it remains a relatively rare method of administration.
Thus, while the CIE and DID models reliably produce binge-like drinking behavior, limitations
in validity undermine the meaningfulness of conclusions drawn through their use. In contrast, the
IAA model uses only repeated scheduled abstinence periods of 1 to 6 days to produce elevated
alcohol consumption and binge-like drinking in rodents (Melendez, 2011; Simms et al., 2008).
IAA drinking occurs in 24h voluntary access periods in the home cage, in which food and water
are always available, and gradual escalation in drinking occurs over time, eventually leading to
binge-like consumption and near-total preference (Hwa et al., 2011). While the IAA model is not
thought of as one that produces dependence per se, extended cycles of IAA over weeks and
months produce inflexible drinking behavior and handling-induced convulsions, which are
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thought to be signs of addiction and dependence, and it is therefore thought to model the
transition from controlled to compulsive behavior (Hopf et al., 2010; Loi et al., 2010).
The validity of the model to represent human alcohol-related behavior is further supported by
pharmacological studies that have identified the molecular mediators of its effects on drinking
behavior, which are similar to results from human studies. IAA drinking and drinking in humans
are attenuated by acamprosate, naltrexone, and drugs that interfere with the functioning of the
corticotropin releasing hormone (CRH) system (Daoura and Nylander, 2011; Hwa et al., 2013;
Sabino et al., 2013; Simms et al., 2008).
Because IAA is a valid and reliable model of binge-drinking and the transition to alcoholism,
much study in recent years has been devoted to understanding the behavior. However, relatively
few studies have examined regional changes in transcription in the brain produced by IAA, and
their contribution to escalation in drinking. Consistent findings have been that gene expression
associated with IAA is distinct from that induced by continuous access drinking and other
models of binge-drinking, and that transcriptional regulation is necessary for induction of bingelike drinking (Ahmadiantehrani et al., 2013; Lee et al., 2013; Obara et al., 2009a; OsterndorffKahanek et al., 2013). IAA drinking is associated with subregion-specific accumulation of
ΔFosB in nucleus accumbens, striatum, and prefrontal cortex, which indicates that it shares some
common molecular mechanisms with motivated behavior for other drugs of abuse (Li et al.,
2010a; Sajja and Rahman, 2013). Crucially, ΔFosB accumulation and binge-like drinking
produced by IAA are attenuated by naltrexone and nAChR antagonist cytisine, showing that
changes in gene expression associated with the procedure are directly related to the changes in
behavior it produces (Li et al., 2010a; Sajja and Rahman, 2013).
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The role of transcriptional regulation in binge-drinking produced by IAA is further supported by
studies showing that transcript coding glial cell line-derived neurotrophic factor (GDNF) in the
VTA is increased by alcohol drinking, and decreased by 24h of abstinence during IAA
procedures. Neuronal GDNF signaling activates CREB-mediated gene transcription, and plays a
role in the differentiation and maintenance of dopaminergic neurons (Hayashi et al., 2000;
Jongen et al., 2005). Intra-VTA GDNF reverses the reduction of NAc dopamine associated with
24h withdrawal, and attenuates binge-like alcohol consumption (Ahmadiantehrani et al., 2013;
Barak et al., 2011; Carnicella et al., 2009a). Furthermore, increased cAMP signaling reduces
IAA drinking, likely through activation of CREB-mediated transcription, which is known to
modulate addictive behavior (Wen et al., 2012). Retinoic acid signaling is deficient in the brain
of alcoholics, and this transcriptional pathway is also implicated in PFC dopamine receptor
regulation associated with binge-like drinking in IAA, but not in the DID model (OsterndorffKahanek et al., 2013).
Finally, epigenetic regulation of gene expression contributing to changes in drinking behavior is
suggested by the strong influence of early-life environment and experience on escalation of
intake. Maternal separation and adolescent social isolation produce stress and persistent changes
in gene expression through modulation of epigenetic processes, and these manipulations also
increase drinking in the IAA model. In addition to increasing drinking behavior, these early life
stressors increase the efficacy of naltrexone to attenuate binge-like drinking, and induce anxietylike behavior (Chappell et al., 2013; Daoura and Nylander, 2011). Abundance of genes involved
in epigenetic processes is correlated with alcohol intake across individual mice within the
C57BL/NCrl inbred strain, and histone deacetylase inhibitor Trichostatin A induces gradual
increases in drinking over time (Wolstenholme et al., 2011).
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Because IAA is a valid model for binge-drinking and the transition to alcoholism, and changes in
gene expression in mesolimbic dopaminergic pathway brain regions are crucial to its effects,
genomic investigation was performed to examine the nucleus accumbens transcriptome of
C57BL/6J mice allowed intermittent or continuous access to alcohol, with the goal of identifying
important genes and gene networks involved in maladaptive alcohol-related behavior. Along
with water-drinking control mice, alcohol-drinking mice were subjected to microarray analysis to
identify differentially-expressed genes across group, and weighted gene co-expression analysis
(WGCNA) was used to generate gene networks associated with alcohol drinking behavior across
individuals within each group. Network topology was compared across group networks to
identify global changes in gene co-expression relationships, and expression of network clusters
(modules) were correlated with drinking behavior. Regulated transcripts and modules were
interrogated for functional roles in the cell and published evidence for involvement in ethanolrelated behavioral phenotypes. Finally, behaviorally relevant genes and modules were compared
to published literature for association with alcohol-related gene sets and phenotypes.
It was hypothesized that differentially expressed genes would be identified via LIMMA for all
group-wise comparisons, and that WGCNA would identify group differences in global
transcriptome connectivity (network-level differences), as well as local co-expression networks
(module-level differences). Furthermore, it was hypothesized that modules significantly
associated with drinking behavior would not be preserved between IAA and CA mice. Finally, it
was hypothesized that gene ontology and transcription factor binding site analysis would
implicate regulation of gene expression via deltaFosB, CREB, and epigenetic processes in the
control of drinking behavior.

Materials and Methods
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Animals
Subjects were the same cohort of C57BL/6J mice from The Jackson Laboratory (Bar Harbor,
ME) used for IAA behavioral studies in Chapter 4. For microarray studies only the 24 mice
offered multiple concentrations of alcohol concurrently (7.5, 15, 30%) and the water-drinking
(H2O) control mice were used. All mice were individually housed and allowed 30 days to
habituate to the animal facility. Intermittent access (IA) mice drank continuously for 17 days as a
baseline access period, followed by 7 cycles of IAA, in which 24h alcohol access periods were
separated by 6 days of abstinence. IA mice were sacrificed in the afternoon on the 7th day
following the 7th and final 24h alcohol access period, to correspond to the period just before
ethanol would have been reintroduced for the 8th access session. Continuous access (CA) mice
were sacrificed in the afternoon on the 25th consecutive day of alcohol access, to closely match
total days of access to the IA mice, who received 24 days of access. For LIMMA and WGCNA
analyses consumption and preference measurements for total, 15%, and 30% alcohol intake were
considered. Intake of 7.5% alcohol was not considered due to trivial consumption and lack of
changes over time.
Dissection and tissue preparation
Brains were dissected according to published procedures ((Kerns, 2005), (see supplementary
materials) and nucleus accumbens was collected and frozen in 1.5 mL sterile microcentrifuge
tubes in liquid nitrogen. Following collection tissue was stored at -80° C until RNA was
extracted.
RNA extraction and quality control
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Frozen tissue was homogenized in STAT-60 (Tel-test, Inc., Friendswood, TX) and processed by
chloroform extraction and column purification using the Qiagen RNeasy kit (Qiagen N.V.,
Hilden, Germany) (see supplementary materials).
Extracted total RNA was subjected to quality control measures for purity and degradation using
UV spectrophotometry and Bio-Rad Experion Automated Electrophoresis System (Bio-Rad,
Hercules, CA). RNA samples were accepted for further analysis conditional on 260/280 ratio
greater than 2.0, and RNA Quality Index (RQI) greater than 8.0.
Microarray hybridization and scanning
Affymetrix Mouse Gene 1.0 ST microarrays were used for all samples (Affymetrix, Santa Clara,
CA). For hybridization and scanning steps processing groups were subjected to supervised
randomization to minimize batch effects that act as confounding variables when batches and
experimental groups correspond. Total RNA was processed according to manufacturer’s
instructions using the Ambion WT expression kit (Life Technologies, Carlsbad, CA), followed
by the Affymetrix GeneChip WT Terminal Labeling and Controls Kit, and the Affymetrix
GeneChip Hybridization, Wash, and Stain Kit (Affymetrix, Santa Clara, CA).All samples were
hybridized to oligonucleotide arrays overnight for 16 hours, and scanned according to
manufacturer’s instructions.
Expression data processing
Raw data was analyzed using Affymetrix Expression Console software and transformed using
the Robust Multichip Average (RMA) method to summarize probeset-level expression data.
RMA expression data was exported as tab-delimited text files and processed using Microsoft
Excel software to exclude probesets for which no sample registered RMA > 3 (Microsoft,
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Redmond, WA). This step was performed to exclude probesets for which expression was not in
the reliable linear range for measurement. Filtered data was further adjusted using the ComBat
method to reduce the influence of hybridization batch effects that may have been introduced as a
consequence of processing order. The resulting expression-filtered and ComBat adjusted
expression data was used for all further analysis.
Differential expression analysis with LIMMA
Filtered and adjusted RMA expression data was subjected to multi-class LIMMA analysis across
the IA, CA, and H2O groups to identify probesets with significantly different abundance across
groups. LIMMA fits a linear model to the expression of each gene, and compares models
between groups of samples to identify significantly different genes. Multi-class LIMMA returns
an F-statistic for each probeset that is similar in meaning to that returned by ANOVA; it
indicates whether any of the group-wise differences are significant. Multi-class LIMMA results
across groups were filtered for F < 0.05. Also returned are p-values for significant differences in
probeset expression for each pair-wise group comparison, and FDR-adjusted p-values to correct
for false-positive results due to multiple comparisons. The FDR-adjusted p-value is computed
using the method of Benjamini and Hochberg, and indicates the expected proportion of false
discoveries in the group of genes filtered for adjusted p-value below that threshold. For example,
in the group of genes selected for adjusted p-value < .05 for IAA vs CA differential expression it
is expected that 5% of results will be false-positives. This adjustment is strict, but necessary
given that tests will be performed for 35, 466 probesets. However, to reveal small differences
that may inform hypothesis generation, but not be apparent with FDR adjustment, raw p-values
may be analyzed to determine differential expression, with the caveat that expected false-positive
ratio for a given p-value threshold is equal to that proportion of the total probesets analyzed. For
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example if 35,466 probesets are tested for differential expression using a raw p-value threshold
of p < .01, then 1% or 355 of the identified probesets are expected to be false-positive results.
Differential expression testing between groups using FDR-adjusted p-value < 0.05 was used to
obtain groups of significantly regulated genes for IA vs.CA and CA vs. H2O, but not for IA vs.
H2O. A raw p-value filter of p < 0.01 was applied to IA vs. H2O LIMMA results to identify
differential expression.
Weighted Gene Correlation Network Analysis (WGCNA)
WGCNA is used to analyze correlation patterns in genes across microarray samples, and to
identify clusters of highly correlated genes, known as modules, which are gene co-expression
networks. Modules can be associated with phenotypic data to provide powerful insight into the
connections between gene expression and behavior. WGCNA produces networks that are
approximately scale-free, which are characterized by highly connected nodes at multiple levels,
and a high level of fault tolerance that preserves network function despite node failure or
removal. Another relevant characteristic of scale-free networks is that clustering coefficient
decreases following a power law as the node degree increases; that is, low-degree nodes tend to
be clustered in tightly interconnected “neighborhoods” that are connected to one another by
network hubs. Network analysis methods such as WGCNA that assume scale independence are
particularly useful, because many complex biological, social, and technological networks have
characteristics of scale-free networks, including yeast protein interactions and metabolic
networks (Albert, 2005).
Expression in particular modules can be summarized numerically by a single value called a
module eigengene (ME, or first principal component), which allows for module expression to be
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correlated with phenotypic data such as behavior to give an association score and eigengene
significance (ES). Within each module individual probesets can also be analyzed for correlation
with phenotypic data, which yields a gene score (GS), and for intra-modular connectivity via
intra-modular expression correlation, which is represented by a module membership score
(MM). Values for ES, GS, and MM range from -1 to 1 and are derived by Pearson correlation
analysis, which also gives a p-value for significance of relationship. While connectivity varies
across modules and hub genes, genes with the highest MM scores within each module are
considered to be highly connected hub genes for those modules. Each probeset can be assigned
to one module only, although MM for other modules may also reach significance (p < .05).
The meaningfulness of a module is indicated by the correlation between GS and MM; that is,
modular genes with the most intra-modular connectivity are also the most well-correlated with
drinking behavior, showing that module expression is likely associated with behavior.
Determining whether GS and ES relationships are causal, consequential, or merely correlational
can be inferred somewhat through study of module genes in the context of published literature,
but only determined with confidence through in vivo functional verification. There is no standard
accepted criterion for GS/MM correlation threshold for meaningfulness, but in general the
majority of modules are significantly correlated at p < 0.2 (Pearson correlation). For all module
sets generated herein 4 network module definitions were considered at deepSplit values of 0
through 3, and the value that gave the greatest percentage of modules with GS/MM Pearson
correlations was chosen. The IA and H2O network module sets were generated with deepSplit =
1, and the CA network was generated with deepSplit = 2.
Modules can be analyzed for significant enrichment for any list of genes, which allows for
interrogation of factors relevant to biological function. Of particular interest is module over129

representation of genes that are differentially expressed between groups according to LIMMA
analysis in modules associated with drinking, because these genes are likely primary mediators
of the effects of IAA on behavior. Enrichment analysis also allows for the examination of
module overlap across group networks, to study module preservation under different
experimental conditions, and differences in the relationship between preserved modules and
drinking behavior. Module enrichments were determined by hypergeometric test for probesetlevel overlap, with resulting p-values subjected to Bonferroni correction for multiple
comparisons.
Filtered and adjusted RMA expression data was subjected to WGCNA analysis in the IA, CA,
and H2O groups to identify gene co-expression networks associated with drinking behavior in
each group (for detailed methods see supplementary materials). Expression and phenotype data
for each group was analyzed separately to produce gene co-expression networks and modules,
and to correlate modules with behavior. In IA and CA mice modules were correlated with
alcohol drinking behavior, and with 5-day average water consumption in H2O mice. Modules in
each group were analyzed for statistically significant over-representation of modules in other
groups, differentially expressed genes from LIMMA, cell-type specific markers (Cahoy et al.,
2008), gene ontology term members, miRNA targets (microRNA.org database, August 2010
release), and transcription factor binding sites. For phenotype analysis BXD nucleus accumbens
mRNA expression was correlated with BXD published phenotypes.
The cell-type marker list was converted to Affymetrix Mouse Gene 1.0 ST probeIDs, and
trimmed to remove genes with no such ID, to ensure proper matching and a valid background
gene set for statistical comparison. The final cell-type marker list contained 5382 total entries.
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Gene ontology analysis
Gene sets obtained by LIMMA and WGCNA were subjected to gene ontology (GO) analysis to
illuminate biological relevance and regulation mechanisms. Analysis was performed using the
GOrilla Gene Ontology Enrichment Analysis And Visualization Tool (http://cblgorilla.cs.technion.ac.il/) to identify over-represented GO terms for biological process, molecular
function, and cellular component (Eden et al., 2009). All p-values were corrected for multiple
comparisons within the software using a specialized method developed by the authors for use
with the Gorilla tool (Eden et al., 2007). Gene symbol lists for annotated probesets were input as
test sets, and the background set was the gene symbol list from the subset of annotated probesets
in the 35, 467 probesets used for LIMMA and WGCNA analyses. For LIMMA sets, Hierarchical
charts with terms shaded by significance were output to visualize relationships between overrepresented terms.
Transcription factor binding site analysis
Transcription factor binding site analysis was performed using the Promoter Analysis and
Interaction Network Toolset (PAINT) (Vadigepalli et al., 2003). PAINT was used to search for
consensus binding sites for transcription factors in promoter regions of gene sets, and to identify
significantly over- or under-represented sites, which provide mechanistic information about
transcriptional regulation. Gene sets were input using Affymetrix Mouse Gene 1.0 ST gene-level
probeset IDs, and regions within 2000 base pairs of the transcription start site were considered
for analysis. The TRANSFAC Pro v 2009.4 database was used for transcription factor binding
site identification. For all analyses the false discovery rate (FDR) threshold was 0.30.

Results
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Differences in gene expression between IA, CA, and H2O groups
Differential gene expression among groups was determined using multi-class LIMMA
procedures and Benjamini-Hochberg FDR multiple comparison correction applied to RMA
expression data. The set of 3521 probesets with F < .05 across groups (referred to as the
AcrossGroup gene set) were filtered for FDR-adjusted p-value < .05 for pairwise comparisons
between groups (see Table 1, Supplementary Table 1). The group-wise comparison process
identified 683 probesets (521 upregulated in IA vs. CA, 162 downregulated in IA vs. CA)
differentially expressed between IAA and CA mice, and 343 probesets (106 upregulated in CA
vs. H2O, 237 downregulated in CA vs. H2O) differentially expressed between CA and H2O
mice (see Table 1, Supplementary Tables 2 and 3). No probesets were identified as significantly
different in abundance between IAA and H2O mice using FDR-adjusted p-values, but 202
probesets were identified using a raw p-value filter of p < .01 (161 upregulated in IA vs. H2O, 42
downregulated in IA vs. H2O) (see Table 1). Of the set of 3521 probesets with F < .05, 2817
were annotated and represented a known gene. Of the 683 probesets significantly different
between IAA and CA 661 were annotated, and of the 343 probesets significantly different
between CA and H2O groups 325 were annotated (see Table 1).
Table 5.1. Differential gene expression determined by multi-class LIMMA. Analysis was
performed using an F-statistic threshold of F < .05 to derive genes regulated across groups, and
FDR-adjusted p-value < .05 for comparisons between groups.
Comparison

Significant probesets

Annotated probesets

Upregulated

Downregulated

IA vs. CA

683

661

521

162

CA vs. H2O

343

325

106

237
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IA vs. H2O

0

0

N/A

N/A

Across groups

3521

2817

N/A

N/A

Sets of differentially expressed genes were subjected to gene ontology analysis to identify overrepresented GO terms for biological process (BP), molecular function (MF), and cellular
compartment (CC). Only annotated probesets with FDR-adjusted p-value < .05 were subjected to
gene ontology analysis. For the set of 2817 annotated probesets identified as significantly
regulated across groups GO analysis identified 214 BP terms, 60 MF terms, and 60 CC terms
(see Supplementary Tables 4, 5, and 6). For the set of 661 annotated probesets identified as
significantly regulated between IA and CA mice GO analysis identified 110 BP terms, 36 MF
terms, and 28 CC terms (see Supplementary Table 7). For the set of 325 annotated probesets
identified as significantly regulated between CA and H2O mice GO analysis identified 5 BP
terms, 18 MF terms, and 7 CC terms (see Supplementary Table 8).
For each gene set GO results across function, process, and compartment converged on key areas
that provide insight into function. For the AcrossGroup gene set terms converged on areas
related to glutamatergic and GABAergic neurotransmission, and neuroplasticity through
axonal/dendritic remodeling and control of neurogenesis, differentiation, and cell death.
Regulation of MAPK cascade, Wnt signaling, syntaxin binding, cadherin binding, and ion
homeostasis for calcium, sodium, and potassium are also implicated by over-represented GO
terms in the AcrossGroup set (see supplementary Tables 4, 5, and 6, Supplementary Figure 1).
For the gene set regulated between IA and CA mice terms were related primarily to calcium and
potassium ion transport and homeostasis, as well as regulation of cell-cell adhesion and synaptic
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plasticity (see Supplementary Table 7, Supplementary Figure 2). For the gene set regulated
between CA and H2O mice terms were related primarily to potassium ion channel activity,
calcium ion binding, and cell adhesion (see Supplementary Table 8, Supplementary Figure 3).
Gene sets with FDR-adjusted p-values < .05 for IAA vs. CA and CA vs. H2O were subjected to
transcription factor binding site analysis to identify mechanisms of transcriptional regulation for
genes induced by continuous alcohol access and intermittent alcohol access. After multiple
comparison correction 40 significantly over-represented transcription factor binding sites were
identified in genes differentially expressed between IAA and CA mice, and no factors were
identified for genes significant for CA compared to H2O mice (see Table 5.2). Interrogation of
significant gene lists from LIMMA identified several differentially regulated transcripts coding
for over-represented transcription factors, transcription factor binding proteins, or regulators of
transcription factor activation (see Table 5.3).
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Table 5.2. Transcription factor binding site analysis in genes differentially expressed between
IAA and CA nucleus accumbens. Binding sites are reported with FDR-adjusted p-value.
TRE/External Group
AP-2/V$AP2_Q6
AP-2/V$AP2_Q6_01
AP-2alpha/V$AP2ALPHA_01
AP-4/V$AP4_01
ATF6/V$ATF6_01
Bach2/V$BACH2_01
CKROX/V$CKROX_Q2
CP2/LBP-1c/LSF/V$CP2_02
CREB/V$CREB_02
E2F/V$E2F_03
E2F/V$E2F_Q6_01
ER/V$ER_Q6
ETF/V$ETF_Q6
Hand1:E47/V$HAND1E47_01
HIC1/V$HIC1_02
HIF1/V$HIF1_Q3
Ikaros/V$IK_Q5
Kid3/V$KID3_01
KROX/V$KROX_Q6
LRF/V$LRF_Q2
MAZ/V$MAZ_Q6
MyoD/V$MYOD_Q6_01
myogenin / NF-1/V$MYOGNF1_01
NF-Y/V$NFY_Q6_01
Pax-3/V$PAX3_B

Corrected p-value
p < .0001
0.0148
0.0011
0.0633
0.0867
0.1419
p < .0001
p < .0001
0.0015
p < .0001
0.0009
0.1100
p < .0001
0.0645
p < .0001
0.0867
0.1419
0.0224
p < .0001
0.0466
p < .0001
0.0442
0.0001
0.2314
0.0301
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PPARalpha:RXRalpha/V$PPARA_01
RFX/V$RFX_Q6
RFX1/V$RFX1_02
SF1/V$SF1_Q6_01
Sp1/V$SP1_Q2_01
Sp3/V$SP3_Q3
SREBP/V$SREBP_Q3
SREBP/V$SREBP_Q6
STAT1/V$STAT1_01
Tax/CREB/V$TAXCREB_01
VDR/V$VDR_Q3
v-Myb/V$VMYB_02
WT1/V$WT1_Q6
ZF5/V$ZF5_B
ZNF219/V$ZNF219_01

0.1409
0.0184
0.1409
0.0141
p < .0001
0.2247
0.0531
0.0184
0.0689
0.2342
0.0689
p < .0001
p < .0001
p < .0001
p < .0001
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Table 5.3. Significantly over-represented transcription factors with factor, binding protein, or
direct mediator of action regulated across groups (LIMMA, F < .05 and/or adjusted p-value <
.05)

TF

Related
genes

F-value

CP2

Tcfcp2l1

1.46E-03

CKROX

Zbtb7b

CREB

Adj. p-value,
IAA vs. CA

log fold change,
IAA vs. CA

adj-p-value,
CA vs. H2O

log fold change,
CA vs. H2O

0.039

-0.13

0.234

0.12

7.78E-03

0.920

0.02

0.124

-0.13

Creb5

2.43E-02

0.528

0.07

0.247

-0.12

CREB

Creb3l2

1.71E-02

0.680

0.04

0.176

-0.10

E2F

E2f1

1.11E-04

0.008

0.19

0.085

-0.17

ER

Esrrg

5.28E-03

0.294

0.07

0.120

-0.12

PPARα:RXRα

Rdh10

1.99E-04

0.057

-0.15

0.025

0.22

PPARα:RXRα

Rbp1

4.93E-04

0.030

-0.17

0.097

0.18
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WGCNA network properties
For each group expression data was analyzed for network scale independence, and mean,
median, and maximum probeset connectivity was calculated for a range of soft-thresholding
powers (see Table 5.4). This step is performed to determine the power to be used in the
adjacency function for network construction (see supplementary materials for details). Scale
independence is a measure of the degree to which the network resembles an ideal scale-free
network, and ranges from 0 to 1. Connectivity (k) measures the degree of correlation of probeset
gene expression values with other probeset expression values, or the degree to which expression
patterns are correlated across probesets.
By examining these properties across a range of soft-thresholding powers, conclusions can be
drawn regarding changes in network topology and connectivity associated with experimental
treatment. For each network soft-thresholding powers were chosen based on the range of scale
independence produced. For the IA and CA networks the lowest soft-thresholding power was
chosen that achieved scale independence greater than 0.7, and for the H2O network the lowest
lowest soft-thresholding power greater than or equal to 6 was chosen that achieved scale
independence greater than 0.8. These criteria were adapted from the procedure of (Zhang and
Horvath, 2005).
Some conclusions were drawn from group differences in the relationships among softthresholding power, scale independence, and connectivity measurements. For all softthresholding powers the H2O network, which represents an alcohol-naïve NAc transcriptome,
was more scale-independent than IA or CA networks, and had greater mean, median, and
maximum gene connectivity. Comparison of CA and H2O networks at the default soft-
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thresholding power value of 6 showed that alcohol drinking fragmented gene co-expression
networks and altered clustering topology, as indicated by decreased connectivity measures and
scale independence at corresponding soft-thresholding powers. Abstinence during intermittent
access partially rescued overall connectivity deficits induced by alcohol drinking, but did not
restore scale independence (see Table 5.4).
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Table 5.4. Scale independence and connectivity (k) for networks across soft-thresholding powers.
Underlined values are those chosen for network construction in each group.
Intermittent access network

Constant access network

1

Scale
ind.
0.154

Mean
k
12300

Median
k
12400

Max
k
18600

Scale
ind.
0.0151

Mean
k
10200

Median
k
10000

Max
k
14600

Scale
ind.
0.214

Mean
k
14700

Medi
an k
14500

Max
k
19200

2

0.134

6060

5800

12200

0.207

4310

4140

8020

0.658

8400

8090

13100

3

0.476

3490

3110

8830

0.404

2180

2040

5010

0.795

5540

5170

9850

4

0.591

2200

1820

6710

0.531

1240

1120

3360

0.848

3960

3580

7820

5

0.651

1480

1120

5280

0.618

756

664

2370

0.87

2990

2630

6430

6

0.668

1040

728

4260

0.672

489

415

1740

0.886

2340

2000

5420

7

0.686

762

489

3500

0.713

331

272

1310

0.895

1890

1580

4650

8

0.695

571

340

2920

0.741

232

185

1010

0.902

1560

1270

4050

9

0.697

438

242

2470

0.765

167

129

788

0.905

1310

1050

3580

10

0.716

343

176

2110

0.784
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92.3

628

0.908

1110

877

3190

12

0.718

219

98.9

1570

0.804

71.7

50.5

424

0.907

839

640

2600

14

0.714

148

58.9

1210

0.815

44.4

29.6

299

0.908

656

487

2170

16

0.735

103

36.9

948

0.819

28.9

18.3

218

0.914

527

383

1840

18

0.744

74.4

24.1

757

0.829

19.6

11.7

164

0.914

433

309

1590

20

0.758

55

16.3

613

0.820

13.7

7.84
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0.913

362

254

1390

Power
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H2O network

Network construction and module eigengene significance
Network construction proceeded with the chosen soft-thresholding power, and for each network
a set of modules was selected from 4 candidate sets of modules that were derived through
adjustment of dynamic tree cut procedures (see supplementary methods). The IA network
produced 82 modules, the CA network produced 182 modules, and the H2O network produced
84 modules. Next eigengene significance for each module with behavior was determined via
Pearson correlation of drinking behavior with module eigengenes, with significance taken as p <
0.15. For the IA network Pearson correlation of module eigengenes with ethanol consumption
and preference (total, 15%, and 30%) at Test Day 7 was performed to generate ES values for
each module (see Supplementary Table 9). For the CA network Pearson correlation of module
eigengenes with ethanol consumption and preference (total, 15%, and 30%) on the penultimate
day of alcohol access (corresponding to IA Test Day 7) was performed to generate ES values for
each module (see Supplementary Table 10). For the H2O network Pearson correlation of module
eigengenes with 5-day average water intake was performed to generate ES values for each
module (see Supplementary Table 11). Calculation of ES yielded modules associated with
drinking behavior: 27 modules in the IAA network, 28 modules in the CA network, and 7
modules in the H2O network. Modules within each network were assigned a color label that was
unique within that network and used for identification in other analyses (see Figure 5.1).
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Figure 5.1. Gene co-expression networks generated by WGCNA for H2O (A), CA (B), and IA
(C) mice. For each network the expression dendrogram produced by hierarchical clustering is
presented above module definitions corresponding to dendrogram branches, which are indicated
by color. From left to right across dendrograms and module color graphs every pixel represents a
single probeset.
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Module preservation across networks
Modules within the IA, CA, and H2O networks were examined for significant overrepresentation of any modules from other networks using the hypergeometric test on probeset
level module overlaps, with p-values subjected to Bonferroni corrections for multiple
comparisons. Analysis found 69 of 182 CA modules significantly enriched for H2O modules
(38%), and 100 of 182 CA modules significantly enriched for IAA modules (55%). There were
31 of 82 IAA modules significantly enriched for H2O modules (38%), and 38 of 82 IAA
modules significantly enriched for CA modules (46%). In the H2O group 45 of 84 modules were
significantly enriched for CA modules (54%), and 41 of 84 modules were significantly enriched
for IAA modules (49%). Thus module preservation was greater between alcohol-exposed groups
than between either alcohol-exposed group and the H2O group, but only about half of the
modules in the IAA group correspond with modules in the CA group, and vice-versa.
When only modules with ES for drinking behavior were considered two significant overlaps
were identified for all group-wise module comparisons: the CA lightslateblue and IA salmon4
modules, and the IAA darkviolet and H2O palevioletred2 modules (see Tables 5.5 and 5.6). The
CA lightslateblue module is positively correlated with total consumption for the CA group, and
the IA salmon4 module is negatively correlated with total preference for the IA group. These
modules share six probesets, three of which code are for the same gene. Only Ptp4a3 (protein
tyrosine phosphatase 4a3) is significantly correlated with behavior in both groups, and that
correlation is both strong and in the opposite direction for each group: for IAA it is -0.74
(p=0.005), and for CA it is .68 (p=0.015). The IAA darkviolet and H palevioletred2 modules
share only Tmem49, which is significantly correlated with RE7_15c for the IAA group, but not
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with water consumption in the H2O group. No modules with ES for drinking behavior were
significantly preserved between H2O and CA networks (see Table 5.7).
Table 5.5. Module preservation between IA and CA networks for modules with behavioral
eigengene significance calculated by hypergeometric test of probeset level overlaps with
Bonferroni corrected p-values (p < .05).
IA module
turquoise
salmon4
yellow
paleturquoise
darkviolet
lightyellow
darkgreen
salmon4
blue
brown
green
red
salmon4
blue
brown
red
blue
brown
green
plum
greenyellow
skyblue
pink
turquoise
orangered4

CA module
bisque4
brown2
brown3
darkolivegreen
darkseagreen3
lavenderblush1
lightcyan
lightslateblue
lightsteelblue1
lightsteelblue1
lightsteelblue1
lightsteelblue1
magenta
pink
pink
pink
royalblue
royalblue
royalblue
royalblue2
saddlebrown
saddlebrown
salmon1
skyblue2
yellow

Corrected p-value
2.63E-08
4.96E-13
1.54E-04
6.57E-51
2.71E-02
5.30E-06
1.68E-02
7.45E-04
3.42E-14
2.05E-10
3.05E-02
4.33E-03
3.90E-06
3.24E-64
8.60E-77
4.26E-05
1.52E-12
4.16E-02
3.89E-08
2.55E-09
8.16E-05
8.55E-10
1.99E-03
7.24E-05
1.77E-04

144

Table 5.6. Module preservation between IA and H2O networks for modules with behavioral
eigengene significance calculated by hypergeometric test of probeset level overlaps with
Bonferroni corrected p-values (p < .05).
IA module

H2O module

Corrected p-value

darkviolet

palevioletred2

1.94E-02

lightyellow

blue

1.44E-02

midnightblue

thistle2

2.94E-02

paleturquoise

coral1

1.67E-12

paleturquoise

grey

2.04E-04

paleturquoise

paleturquoise

3.48E-03

salmon4

coral1

2.10E-13

salmon4

paleturquoise

1.16E-02

sienna3

turquoise

1.35E-02

turquoise

darkturquoise

2.23E-10

yellow

darkturquoise

5.27E-08

Table 5.7. Module preservation between CA and H2O networks for modules with behavioral
eigengene significance calculated by hypergeometric test of probeset level overlaps with
Bonferroni corrected p-values (p < .05).
CA module
blue
coral1
lightsteelblue1
lightsteelblue1
orangered1
pink
pink
pink
pink
powderblue
royalblue
royalblue
tan

H2O module
darkturquoise
greenyellow
lightsteelblue
turquoise
coral1
lightgreen
magenta
pink
turquoise
grey60
lightgreen
turquoise
navajowhite2

Corrected p-value
2.28E-02
3.09E-02
1.33E-14
1.47E-17
3.07E-03
5.35E-04
1.33E-06
2.53E-16
1.12E-115
3.35E-02
5.75E-05
1.55E-42
1.57E-02
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Module enrichment for cell-type specific markers
All modules were examined for enrichment for cell-type specific markers for neurons, astrocytes,
and microglia, to determine likely biological context for module functioning. Results for neuron
(8 IA modules, 8 CA modules, 11 H2O modules, see Table 5.8) and astrocyte (5 IA modules, 7
CA modules, 6 H2O modules, see Table 5.9) marker enrichment were similar across networks,
but for oligodendrocyte markers there were 7 enriched IA modules, 12 enriched CA modules,
and only 1 enriched H2O module (see Table 5.10). Few modules enriched for cell-type specific
markers had ES for drinking behavior. The IA salmon4 module was enriched for neuron
markers, and no other IA module with ES for behavior was enriched for any cell-type. In the CA
network the saddlebrown and royalblue modules were enriched for neuron markers, royalblue,
lightsteelblue1, and pink were enriched for oligodendrocyte markers, and lightsteelblue1 was
enriched for astrocyte markers. No H2O modules with ES were enriched in cell-type specific
markers.
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Table 5.8. Neuron cell-type specific marker enrichment in modules identified in IA, CA, and
H2O gene networks (hypergeometric test, Bonferroni correction, p < .05). Modules with
eigengene significance for drinking behavior are indicated with * (Pearson correlation, p < .10).
Module
tan
lightcyan
brown
blue
salmon4*
skyblue
greenyellow
darkred
magenta
tan
lightpink4
saddlebrown*
navajowhite2
skyblue
darkgoldenrod4
royalblue*
darkgrey
turquoise
floralwhite
royalblue
lightcyan
yellow
salmon4
magenta
firebrick4
grey60
darkslateblue

Cell type
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron
Neuron

Corrected p-value
7.89E-60
3.31E-20
7.58E-12
1.04E-11
1.81E-05
0.002
0.0029
0.0438
1.61E-86
1.55E-21
1.77E-08
1.86E-07
2.16E-06
0.0002
0.0315
0.0423
2.78E-16
2.90E-15
7.46E-07
8.91E-05
0.0002
0.0002
0.0016
0.0043
0.0076
0.0149
0.0202
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Network
IA
IA
IA
IA
IA
IA
IA
IA
CA
CA
CA
CA
CA
CA
CA
CA
H2O
H2O
H2O
H2O
H2O
H2O
H2O
H2O
H2O
H2O
H2O

Table 5.9. Oligodendrocyte cell-type specific marker enrichment in modules identified in IA,
CA, and H2O gene networks (hypergeometric test, Bonferroni correction, p < .05). Modules with
eigengene significance for drinking behavior are indiciated with * (Pearson correlation, p < .10).
Module
blue
brown
green
red
lightgreen
antiquewhite4
coral1
tan
green
royalblue*
yellow
skyblue3
skyblue
yellow3
lightsteelblue1*
firebrick4
pink*
magenta
orangered4
turquoise

Cell type
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte
Oligodendrocyte

Corrected p-value
6.65E-17
6.68E-12
2.76E-11
4.36E-05
0.0003
0.0035
0.0168
5.26E-11
7.43E-11
9.57E-07
1.06E-06
6.28E-06
6.87E-06
8.86E-05
0.0004
0.0015
0.0113
0.0128
0.0137
1.02E-17
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Network
IA
IA
IA
IA
IA
IA
IA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
CA
H2O

Table 5.10. Astrocyte cell-type specific marker enrichment in modules identified in IA, CA, and
H2O gene networks (hypergeometric test, Bonferroni correction, p < .05). Modules with
eigengene significance for drinking behavior are indiciated with * (Pearson correlation, p < .10).
Module
brown
darkslateblue
red
greenyellow
saddlebrown
yellow
green
lightpink4
lightsteelblue1*
lightblue3
plum2
darkgrey
lightsteelblue1
turquoise
darkorange
darkgreen
brown2
skyblue

Cell type
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte
Astrocyte

Corrected p-value
6.52E-18
4.09E-10
0.0009
0.0269
0.0276
2.24E-09
0.001
0.006
0.006
0.019
0.044
0.047
0.0002
0.0006
0.0154
0.0188
0.0317
0.0453
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Network
IA
IA
IA
IA
IA
CA
CA
CA
CA
CA
CA
CA
H2O
H2O
H2O
H2O
H2O
H2O

ES module enrichment for differentially expressed genes
Modules with eigengene significance for drinking behavior were examined for enrichment in
differentially expressed genes from multi-class LIMMA. Analyses were performed with the set
of regulated genes across groups with F < .05 (AcrossGroup), and the sets of genes with groupwise differences for IAA vs. CA, and CA vs. H2O. Among the IA modules with ES the grey
module was enriched for genes in the AcrossGroup set, and the salmon4 module was enriched
for genes in the AcrossGroup set and the and CA vs. H2O set (Bonferroni-corrected p < .05).
Among the CA modules with ES only the saddlebrown module was enriched for differentially
expressed genes, and the IAA vs. CA set and AcrossGroup set were over-represented
(Bonferroni-corrected p < .05).
ES module gene ontology analysis
Modules with eigengene significance for alcohol drinking behavior were examined for
enrichment in gene ontology terms for biological process (BP), molecular function (MF), and
cellular compartment (CC). GO terms were considered significant only after correction for
multiple comparisons (corrected p-value < .10).
Four IA network modules with ES for drinking behavior were significantly enriched for GO
terms: sienna3 (ES for total preference, Pearson: 0.565, p = 0.021), midnightblue (ES for 15%
consumption, Pearson: -0.741, p = 0.006), darkorange (ES for 15% consumption, Pearson: 0.652, p = 0.022), and lightyellow (ES for 15% consumption, Pearson: -0.601, p = 0.039) (see
Supplementary Table 12). For sienna3 only CC terms were identified, and indicated that genes in
cytoplasm, nucleus, and non-membrane-bound organelles were over-represented. For
midnightblue and lightyellow modules several BP and MF terms were identified, primarily due
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to the presence of several olfactory receptors and trace-amine-associated receptors in the
modules. As such, terms identified were involved in sensory perception of smell and G-protein
coupled receptor activity. For the darkorange module terms were involved in cellular response to
interferon-beta and defense response to virus, which indicated potential module involvement in
neuroimmune and neuroinflammatory processes.
Four CA network modules with ES for drinking behavior were significantly enriched for GO
terms: pink (ES for total consumption, Pearson: -0.524, p = 0.08), bisque4 (ES for total
consumption, Pearson: 0.488, p = 0.107), saddlebrown (ES for total preference, Pearson: -0.502,
p = 0.096), and blue4 (ES for 30% consumption, Pearson: 0.528, p = 0.078) (see Supplementary
Table 13). For the pink module terms were related to cellular metabolic processes: ubiquitinrelated protein metabolism and mRNA processing and splicing. GO terms for CC in the pink
module were consistent with cellular metabolic functioning, and indicated enrichment for genes
functioning in spliceosomal complex, transcription factor complexes TFTC and TFIID, and
ribonucleoprotein complex. For the bisque4 module terms were related to G-protein coupled
signaling, again primarily due to the presence of olfactory receptors. The saddlebrown module
was enriched for CC terms related to neuronal excitability and action potential transmission:
axolemma and voltage-gated potassium channel complex. Two significant terms in the blue4
module were related to fertilization processes, and thus likely not directly relevant to network
functioning in the nucleus accumbens.
ES module miRNA target enrichment
Modules with eigengene significance for drinking behavior were examined for enrichment in
miRNA targets to identify potential module regulation mechanisms (see supplementary Table
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14). Among the IA modules with ES for alcohol drinking behavior only sienna3 was enriched for
miRNA targets (see Table 5.11).
Table 5.11. miRNA target enrichment in sienna3 module from IA network. Hypergeometric test
with Bonferroni-corrected p-value < .05.
Target-enriched miRNA
miR-590-3p
miR-27b
miR-27a
miR-23b
miR-186
miR-494
miR-340-5p
miR-129-5p
miR-23a
miR-592
miR-9

Corrected p-values
3.55E-05
3.57E-04
6.04E-04
4.17E-03
4.22E-03
9.26E-03
9.94E-03
1.50E-02
1.70E-02
3.96E-02
4.68E-02

Among the CA modules with ES for alcohol drinking behavior the pink, royalblue, and
lightsteelblue1 modules were enriched for miRNA targets. The pink module was enriched for
targets of 100 miRNAs, the royalblue model was enriched for 65 miRNAs, and the
lightsteelblue1 module was enriched for 10 miRNAs (see supplementary Table 14). Targets for
61 miRNAs were found to be enriched in more than one CA module (see supplementary Table
14). Targets for nine miRNAs were found to be enriched in the IA sienna3 module and one or
more CA modules (see Table 5.12).
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Table 5.12. miRNA target enrichment in modules with IAA and CA ES.
miRNA
mmu-miR-129-5p__miRNA

mmu-miR-186__miRNA

mmu-miR-23a__miRNA

mmu-miR-23b__miRNA

mmu-miR-27a__miRNA

mmu-miR-27b__miRNA
mmu-miR-340-5p__miRNA

mmu-miR-494__miRNA

mmu-miR-590-3p__miRNA

Network
IAA
CA
CA
IAA
CA
CA
IAA
CA
CA
IAA
CA
CA
IAA
CA
CA
IAA
CA
IAA
CA
CA
CA
IAA
CA
CA
IAA
CA
CA
CA

Module
sienna3
pink
royalblue
sienna3
pink
royalblue
sienna3
pink
royalblue
sienna3
pink
royalblue
sienna3
pink
lightsteelblue1
sienna3
pink
sienna3
pink
royalblue
lightsteelblue1
sienna3
pink
royalblue
sienna3
pink
royalblue
lightsteelblue1
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Corrected
p-value
1.50E-02
2.43E-09
2.79E-06
4.22E-03
2.11E-13
8.73E-09
1.70E-02
3.02E-07
2.26E-03
4.17E-03
4.34E-08
8.21E-03
6.04E-04
1.43E-02
1.32E-02
3.57E-04
1.26E-02
9.94E-03
4.44E-15
1.13E-07
8.17E-03
9.26E-03
2.31E-12
1.33E-09
3.55E-05
5.79E-23
2.85E-12
2.11E-03

Transcription factor binding site analysis
Modules with eigengene significance for drinking behavior were examined for enrichment in
transcription factor binding sites (TFBS) in promoter regions to identify potential module
regulation mechanisms. TFBS results were combined with results from LIMMA for IAA vs. CA
differential gene expression to identify significantly regulated transcription factors in modules
with eigengene significance for drinking behavior. Consumption and preference ES modules
were considered together within each network and for each alcohol concentration (total, 15%,
30%). Targets for regulated transcription factors tended to be over-represented in modules for
with ES in either the IA network or the CA network, with the exceptions of targets with the
Pbx/V$PBX_Q3, Pbx-1/V$PBX1_03, and POU1F1/V$POU1F1_Q6 TFBS, which were
enriched in modules in both networks (see Table 5.13).
Table 5.13. Over-represented TFBS in modules with ES for drinking behavior across networks,
and for which transcription factor genes are differentially expressed between IA and CA mice
(multi-class LIMMA, F < .05, adjusted p-value < .05).
Log FC
IAA
TFBS
TF gene
from
CA
Pbx/V$PBX_Q3
Pknox2
0.22
Pbx-1/V$PBX1_03
Pbx1
-0.12
TBP/V$TBP_Q6
Tbpl1
-0.06
BRCA1:USF2/V$BRCA_01
Brca1
-0.04
POU1F1/V$POU1F1_Q6
Pou1f1
-0.09
E2F/V$E2F_01
E2f1
0.19
c-Maf/V$CMAF_01
Maf
0.06
0.14
PPARgamma:RXRalpha/V$PPARG_01 Pparg
Ppargc1a 0.09
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Network (ES behaviors)
IA and CA (total/15%/30%)
IA and CA (total/15%/30%)
IA only (15%/30%)
IA only (15%/30%)
IA (15%/30%), CA (15%)
CA only (total)
CA only (15%)
CA only (30%)

Discussion
In contrast to expected results, differential gene expression analysis with LIMMA identified
significant differences in expression between the IA and CA groups, and the CA and H2O
groups, but not between the IA and H2O groups. Transcription factor binding site analysis
implicated CREB-mediated transcription and retinoic acid signaling, among other mechanisms,
in the regulation of genes differentially expressed between IA and CA groups. Furthermore,
transcription factors or factor binding proteins for six over-represented sites, including CREB
and PPARalpha:RXRalpha, were differentially expressed among groups. Gene ontology analysis
of differentially expressed genes identified significantly over-represented terms in each set that
provide insight into function and cellular localization.
The WGCNA identified global differences in network topology and connectivity within the
nucleus accumbens transcriptome across groups. Gene co-expression modules were only
moderately preserved across groups, with the alcohol exposed groups more similar to each other
than to the H2O group. Only one set of preserved gene co-expression modules was associated
with ethanol drinking behavior in both alcohol exposed groups, and modules associated with
drinking behavior did not tend to be enriched in differentially expressed genes. Transcription
factor binding sites for AP-1 were over-represented among gene co-expression modules with ES
for drinking behavior in intermittent access mice, which implicated deltaFosB in the regulation
of those networks. Enrichment (gene ontology, cell-type specific marker) and regulation (TFBS,
miRNA) analysis identified several modules of particular interest with eigengene significance for
drinking behavior. In the IA network modules of interest were salmon4, sienna3, darkorange,
grey, midnightblue, and lightyellow. In the CA network modules of interest were saddlebrown,
pink, lightsteelblue1, royalblue, bisque4, and blue4 (see Table 5.14). The study of alcohol-related
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behavior will be informed by hub genes in modules of interest, differentially expressed
transcription factors, over-represented miRNAs, and GO processes/pathways, which represent
targets for future experimentation.
Table 5.14. Modules of interest from IA and CA WGCNA networks with eigengene significance
for drinking behavior (Pearson correlation, p < .10).
Network

Module

Eigengene/behavior
correlation

IA

salmon4

IA

grey

IA

sienna3

Total preference (.61)
15% consumption
(-.60), 15%
preference (-.64),
30% consumption
(.75), 30%
preference (.77)
Total preference
(.66), 15%
preference (.54)

IA

midnightblue

IA

darkorange

IA

lightyellow

CA

saddlebrown

CA

royalblue

CA

lightsteelblue1

CA

pink

CA

bisque4

CA

blue4

Cell-type
marker
enrichment
neuron

GO term enrichment

N/A

DE gene
enrichment
(LIMMA)
AcrossGroup,
CA vs. H2O
AcrossGroup

N/A

mIRNA
target
enriched
no

N/A

no

N/A

N/A

CC (cytoplasm, nucleus, nonmembrane-bound organelle)

yes

15% consumption
(-.74), 15%
preference (-.60),
30% consumption
(.63), 30%
preference (.68)
15% consumption
(-.65), 15%
preference (-.65)
15% consumption
(-.60), 15%
preference (-.54),
30% consumption
(.52), 30%
preference (.55)
Total preference (.50)

N/A

N/A

MF (perception of smell)

no

N/A

N/A

BP (neuroimmune/neuroinflammation)

no

N/A

N/A

BP/MF (perception of smell)

no

neuron

N/A

CC (axolemma, voltage-gated
potassium channel complex)

no

Total consumption
(-.49)
Total preference (.51), 15%
consumption (-.52),
15% preference (.52)
Total consumption
(-.52), total
preference (-.50),

neuron,
oligodendrocyte
oligodendrocyte,
astrocyte

N/A

N/A

yes

N/A

N/A

yes

oligodendrocyte

N/A

BP/MF (protein metabolism/mRNA
processing), CC (spliceosomal
complex, transcription factor
complexes TFTC/TFIID,
ribonucleoprotein complex)

yes

Total consumption
(.49)
30% consumption
(.53), 30%
preference (.59)

N/A

N/A

BP/MF (GPCR signaling)

no

N/A

N/A

BP (fertilization)

no
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Approximately 1% of measured transcripts in the nucleus accumbens (343 probesets) are
differentially expressed between continuous alcohol access mice and water drinking mice. Mice
had been drinking approximately 15 to 20 g/kg/day of alcohol for 25 days, so differentially
expressed genes represent long-term ethanol-responsive genes. Interestingly, these genes were
mostly downregulated (237 of 343), which differs from other studies, which have reported either
predominant upregulation or no bias (Bell et al., 2009; Kerns, 2005; Rodd et al., 2008). (Bell et
al., 2009; Kerns, 2005; Rodd et al., 2008). This disagreement could be caused by differences in
methodology; other NAc-specific studies have used experimenter administered alcohol or rats as
the animal model. An alternative explanation is that genes are transiently induced by alcohol
upon initial exposure, but that persistent exposure blunts the transcriptional response to alcohol,
such that fewer upregulated genes are observed. Furthermore, increased numbers of
downregulated genes may be due to homeostatic mechanisms triggered at the mRNA or protein
level by increased abundance after drinking. These homeostatic mechanisms would act to restore
normal functioning despite continued alcohol exposure by altering gene expression, through
processes such as regulation of miRNAs or transcription factors.
Differential expression analysis between IA and CA mice supports the hypothesis that the state
of the transcriptome during abstinence is partially, but not entirely, a product of the decay of
alcohol-responsive gene expression. Approximately 2% of measured genes (683 probesets) were
differentially expressed in IA mice compared to CA mice, and 76% of these were upregulated.
Of these genes, 241 are ethanol-responsive transcripts identified as differentially expressed
between H2O and CA groups, and every one of these genes is expressed in the opposite direction
for the two comparisons (see Supplementary Table 17). Of these 241 genes, 178 are down in CA
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mice compared to H2O mice, and up in IA mice compared to CA mice. Furthermore, the degree
of change for these genes in the two comparisons is extremely well correlated (Spearman
correlation: r = -.95, p < .0001) (see Figure 5.2). In other words, the majority (241 out of 343) of
genes regulated in nucleus accumbens by 25 days of alcohol drinking are regulated in the
opposite direction, and to nearly the same degree, after 6 cycles of IA and 6 days of abstinence.
Future studies should examine whether these genes are altered after the first deprivation period,
and whether alcohol drinking in IA mice restores expression of these genes to levels seen in CA
drinkers. In addition, a time-course study of gene expression during CA drinking over a period of
weeks would be useful, in that it would determine whether the unusual distribution of directional
changes in the present study was aberrant, and whether gene expression changes over time in
these mice, which show steady intake. A particularly useful study might be differential gene
expression in the nucleus accumbens transcriptome after 24 hours of alcohol drinking in naïve
mice compared IAA mice after several cycles of IA, because there is emerging evidence that
alcohol-responsive gene expression is directly related to the development of binge-like drinking
(Ahmadiantehrani et al., 2013).
Unexpectedly, there are no differentially expressed genes between the IA and H2O groups,
despite the reasonable assumption that IA mice would drink far more alcohol than H2O mice if
offered the opportunity. This drastic phenotypic difference likely indicates that changes in gene
expression caused by cycles of IAA have propagated to the functional protein level, at which
changes in neuronal function and behavior are mediated. It should also be mentioned that the fact
that genes are different between H2O and CA groups, and genes are different between CA and
IA groups, does not necessarily mean that one should expect differences between H2O and IA
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groups. Instead, this expectation stems from the robust transcriptional effects of alcohol,
combined with the high levels of intake displayed by IA mice on test days.
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Figure 5.2. Correlation of changes in gene expression for 241 transcripts identified by LIMMA
as differentially expressed for CA vs. H2O and IA vs. CA comparisons. (two-tailed Spearman
correlation, r = 0.9492, p < .0001)
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The lack of expression differences for IA vs. H2O could be due to the strict multiple comparison
correction to which raw p-values for group-wise differences were subjected during LIMMA, and
within-group variance that masks between-groups differences. By comparison, a raw p-value
cutoff of .05 gives 631 probesets differentially expressed between IA and H2O groups, and it is
therefore possible that subtle differences are present between H2O and IA groups that are below
the threshold of significance used in this study. Other potential explanations for this result are
that gene expression induced by a single day of alcohol drinking in nucleus accumbens is no
longer apparent after 6 days of abstinence, that repeated cycles of IAA have attenuated the
transcriptional response to ethanol, or a combination of these effects. Future studies will address
these issues in several ways. Transcription should be measured in IA mice immediately after
drinking, and during abstinence regulated genes should be compared to H2O and CA subjects at
the mRNA and protein level. In CA mice that drink long-term, time-course studies will address
the persistence of the transcriptional response to ethanol over time, and determine the utility of
the group as genomic controls for comparison. Finally, increased sample size and alternative
methods of assessing differential expression can be applied to further strengthen results and
conclusions drawn from studies of this nature.
Gene ontology results for differentially expressed genes identified over-represented terns
biological processes, molecular functions, and cellular compartment localization that provide
some insight into the functional consequences of regulation. The differentially expressed gene
sets are enriched in terms related to potassium ion channel activity, calcium ion binding, and cell
adhesion. Several terms in the H2O vs. CA set contain several genes coding for proteins
mediating the acute psychoactive effects of ethanol: GABA receptor subunits Gabra2 and
Gabrg3, glycine transporter Slc6a9, and ion channels for potassium, sodium, and calcium
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(Spanagel, 2009; Vengeliene et al., 2009). The terms related to cell adhesion are notable for the
presence of Mag and Mog, which are myelin-associated glycoproteins.
Alcohol is known to downregulate myelin-related genes, and to induce white-matter
degeneration in alcoholics through neuroinflammatory processes (Alfonso-Loeches et al., 2012;
Kril et al., 1997; Lewohl et al., 2005). Cell signaling via Wnt pathways and MAPK cascade are
also implicated by gene ontology terms, and ethanol is known to interact with both pathways
(Darlington et al., 2013; Vangipuram and Lyman, 2012).
The involvement of Wnt signaling is particularly intriguing, because it is upstream of other
implicated processes: gene expression, regulation of calcium, and alterations in cell cytoskeleton
and adhesion via MAPK cascade (Baarsma et al., 2013; Nusse, 2012). In addition, several Wntrelated genes, primarily frizzled-related proteins and frizzled homologs, are differentially
expressed among groups, and Frzb (frizzled-related protein, aka. secreted frizzled-related protein
3) is the 12th ranked gene in the IAA vs. CA set as ranked by log fold change. The gene Sfrp1
(secreted frizzled-related protein 1) is upregulated in CA vs. H2O, and downregulated in IAA vs.
CA, while Sfrp2 (secreted frizzled-related protein 2) is also down in IAA vs. CA. Frizzled
homologs 1, 2, and 3 (Fzd1, Fzd3, Fzd4) are receptors for the Wnt ligand, and are significantly
regulated in the AcrossGroup LIMMA set, being more abundant in CA mice than IA or H2O
mice. However, pair-wise differences for these genes were not significant after multiple
comparison correction. The secreted frizzled-related proteins (SFRPs) bind Wnt and decrease
pathway signaling, which alters gene expression; downregulation of these genes is associated
with development of several types of cancer (Finch et al., 1997; Zhao et al., 2007). Thus, Wnt
signaling seems to be altered by CA alcohol drinking, and increased expression of SFRPs may
represent homeostatic mechanisms acting to regulate this change. Discernment of the exact
162

manner of regulation, and the particular Wnt pathways involved, will require further study,
including measurement of protein abundance.
Transcription factor binding site analysis identified regulation mechanisms for differentially
expressed genes among groups. Factors or factor binding proteins for six over-represented
transcription factors were differentially expressed. Of particular interest are genes related to
retinoic acid signaling and CREB-mediated transcription. Alcohol interferes with retinoic acid
synthesis and impairs retinoic acid signaling, which alters gene expression and is associated with
development of hepatic cancer, through MAPK signaling and AP-1-mediated transcription
(Poschl et al., 2004; Wang, 2003). Furthermore, genes associated with retinoic acid and MAPK
signaling are regulated in hippocampus of C57BL/6J mice during ethanol withdrawal (Daniels
and Buck, 2002). Gene expression mediated by the CREB (cAMP response element binding
protein) transcription factor is extensively implicated in gene expression related to consumption
of abused substances and stress, and relevant targets include stress hormone CRF/CRH, opioid
peptide precursor dynorphin, and BDNF (brain derived neurotrophic factor) (Briand and Blendy,
2010; McCarthy et al., 2012; Pandey, 2004a; Robison and Nestler, 2011). Each of the overrepresented transcription factors represents a target of interest to interfere with ethanolresponsive gene expression, with the goal of interfering with transcription associated with the
development of binge-like drinking behavior. The congruence between the neurobiological
effects of alcohol and the changes in gene expression revealed by LIMMA support the notion
that genomic changes measured in the present study are a reliable basis on which to draw other
conclusions.
Calculating scale independence and connectivity prior to WGCNA revealed differences in
network topology and transcript co-expression across group networks. Continuous access alcohol
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drinking for 25 days decreased scale-independence and gene connectivity, and thus fragmented
gene co-expression networks operating in the nucleus accumbens of naïve mice. Consistent with
recovery of normal transcriptome expression in IA shown by LIMMA, abstinence partially
restores deficits in mean, median, and maximum gene connectivity associated with CA drinking,
but did not restore scale independence, which is indicative of a less fault-tolerant network in
which hub gene connectivity is particular reduced. These results may indicate less coordinated
signaling and gene regulatory mechanisms operating in neurons in general during drinking, amd
future study should examine particularly well-connected hub gene identity, and regulation of
connectivity due to alcohol exposure over time. Of particular interest is the process of
distinguishing those hub genes that do or do not recover connectivity during abstinence, which
could lead to heretofore unknown players in alterations in cell signaling. Genes of this type
would not necessarily show up in differential expression analyses; because while connectivity is
altered, expression may not necessarily be changed as well. There is some recent supporting
evidence for this approach, as well data showing that gene network fragmentation leads to
maladaptive alcohol behavior, but this result comes from naïve mice bred for high drinking
(HDID-1 and HDID-2 strains from the Crabbe laboratory), rather than alcohol-exposed animals
(Iancu et al., 2013).
In general overlap across networks for modules from WGCNA is moderate, and supports the
notion that alcohol exposure alters global patterns of gene expression. When analyzing these
results it should be noted that the groups represent a progression of experimental conditions; all
mice began the study as naïve mice with water only, then some subject were allowed continuous
access drinking, and a subset of these were allowed to progress to intermittent drinking. In the
CA network only 38% of modules (69 of 182) are enriched for H2O modules, indicating that
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gene co-expression relationships are altered by drinking. Interestingly, 38% of IAA modules (31
of 82) are enriched for H2O modules, indicating that six days of abstinence has not restored
connectivity. Future studies should examine if this is an effect of the previous six weekly cycles
of IAA, by determining whether a single six day abstinence period after CA drinking is sufficient
to restore connectivity. The IAA and CA networks were moderately preserved (CA enriched for
IA: 55%, IA enriched for CA: 46%), indicating that module identities were more similar to each
other than to the H2O network. This is fascinating in light of differential expression results,
which show more differences for IA vs. CA than for CA vs. H2O, and no differences for IA vs.
H2O. These results indicate that while abstinence certainly reverses some ethanol-responsive
gene expression, connectivity deficits and hub gene function are not restored, and these
processes should be further studied for specific hub genes and gene networks.
When only modules with eigengene significance for drinking behavior were considered,
differences between groups were even more stark; only two pairs of preserved modules with
behavioral significance were identified. For modules with ES for alcohol drinking, only the CA
lightslateblue and IAA salmon4 modules were preserved across networks. The CA lightslateblue
module expression is correlated with total consumption for the CA group, and the IAA salmon4
module is negatively correlated with total preference for the IAA group. These modules share 6
probesets, 3 of which code for the same gene. Interestingly, only protein tyrosine phosphatase
4a3 (Ptp4a3) is significantly correlated with behavior in both groups, and that correlation is both
strong and in the opposite direction (IAA: r = -0.74, CA: r = .68; Pearson correlation, p < .05).
The function of Ptp4a3 is not particular well characterized, but it seems to be membrane-bound
and involved in calcium mobilization and cell growth, and high levels are associated with risk for
some types of cancer (Laurent et al., 2011; Matter et al., 2001; Wang et al., 2002).
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The only other pair of modules with behavioral significance in both groups is the IAA
darkviolet/H2O palevioletred2 set. These modules share only Tmem49, which is significantly
correlated with 15% consumption for the IAA group, but not with water consumption in the H2O
group. These results suggest that gene co-expression patterns associated with drinking behavior
share almost no similarity between groups, and highlight the differences in the molecular basis of
alcohol intake under continuous access and intermittent access conditions.
Within each group gene network modules of interest are identified based on eigengene
significance, gene ontology, cell-type marker enrichment, differential gene expression
enrichment, and miRNA enrichment, and genes in these modules are targets for future study (see
Table 14). Of particular interest are highly connected hub genes identified on the basis of module
membership, which is a “fuzzy” measurement of intramodular connectivity (Zhang and Horvath,
2005). For each module of interest, the top 15 hub genes are reported, several are known to be
involved in alcohol-related behavior or directly related processes (see Supplementary Table 14,
Supplementary Table 15).
Hub genes for the IA salmon4 module include Htr1a (serotonin receptor 1a), agonists at which
increase ethanol intake, and Grm2 (glutamate receptor, metabotropic 2), which participates in
CREB/AP-1 mediated transcriptional regulation downstream of glutamate activity (Tomkins et
al., 1994; Wang et al., 2007). In the IA sienna3 module ubiquitin ligase Nedd4 (neural precursor
cell expressed, developmentally down-regulated 4) is the 6th ranked hub gene, and is known to be
involved in regulation of sodium, potassium, and calcium channels (Krzystanek et al., 2012;
Snyder et al., 2002; Zhang et al., 2010). Our laboratory recently showed that ethanol upregulates
Sgk1 (Serum/glucocorticoid regulated kinase 1) in PFC through activation of the hypothalamicpituitary-adrenal (HPA) axis (Costin et al., 2013a). SGK1 phosphorylates NEDD4, which
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decreases its activity and leads to increases in sodium and potassium channel abundance in the
cell membrane (Schuetz et al., 2008). The sienna3module may thus be involved in regulation of
ion channel abundance and nucleus accumbens excitability as a result of ethanol activation of the
HPA axis. Involvement in neuroinflammatory and neurodegenerative processes, particularly
regulation of myelin, is indicated for the IA midnightblue module due to the presence of Tlr4
(toll-like receptor 4), which is known to be involved in demyelination in chronic alcohol abuse,
and Il6r (interleukin 6 receptor), which is involved in immune regulation (Alfonso-Loeches et
al., 2010; Alfonso-Loeches et al., 2012; Wang et al., 2008b).
In the CA network the lightsteelblue1 module is enriched in targets for several miRNAs, and is
no notable for the presence of Tgfbr1 (transforming growth factor , beta receptor 1), which may
mediate the effects of chloride intracellular proteins (CLICs) on alcohol-related behaviors
through phosphorylation of SMAD proteins, which can modulate miRNA- regulated gene
expression (Bhandari et al., 2012; Davis et al., 2008). The lightsteelblue1 module also contains
the hub gene Rgs5 (regulator of G-protein signaling 5), which reduces signaling through G-alpha
subunits (Zhou et al., 2001). RGS family proteins influence mu-opioid receptor signaling and
morphine reward behaviors (Traynor, 2012). Furthermore, mRNAs coding for RGS proteins are
decreased in brains of human alcoholics, and SNPs in the RGS4 gene are associated with risk for
alcoholism in European Caucasians (Ho et al., 2010). The CA saddlebrown module is
particularly notable for being enriched in neuron-specific cell-type markers, and the presence of
hub genes Kcnip2 (Kv channel-interacting protein 2) and Adora2a (adenosine A2a receptor).
Adenosine receptors are known to be involved in ethanol-related behaviors and the physiological
effects of the drug, and in particular decreased ADORA2A function in the striatum is associated
with ethanol-seeking behaviors, and decreased CREB-mediate transcription (Chiang et al., 2013;
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Nam et al., 2013a; Nam et al., 2013b). The KCNIP2 protein acts as a calcium-sensing modulator
of voltage-gated potassium channels, where it acts to modulate neuronal excitability (Wang et
al., 2013). In the light of studies showing that SK potassium channel (a calcium-activated
potassium channel) inhibitors reduce IA alcohol intake, the connection between intracellular
calcium/potassium regulation in striatum and the development of binge-drinking should be
further explored (Hopf et al., 2011).
The present study illuminates the transcriptional consequences of alcohol drinking on continuous
access and intermittent access schedules in C57BL/6J mice, and provides several genes,
pathways, and gene networks associated with alcohol-related behavior that represent targets for
future study, with the goal of improving understanding alcoholism and therapeutic intervention.
Some limitations should be considered when interpreting the reported results. Any conclusions
drawn must take into account that only the nucleus accumbens was studied, and in only one
inbred strain. Alcohol-responsive gene expression tends to be region-specific, so the study of
more regions in the same manner reported herein will be particularly useful in deciphering the
connection between gene expression and addictive behavior. The C57BL/6J is an inbred strain,
and shows relatively high alcohol consumption compared to other strains. The effects of IAA
vary from strain to strain in mice and rodents, and future studies should address whether
transcription during CA and IA drinking similarly vary, and the connections between regulated
transcripts and behavior.
The data reported also represents only one time point for both CA and IA mice, which limits the
conclusions that can be drawn. Future studies should examine gene expression at other time
points during access, for example to compare the first cycle of IA to the last, and IA gene
expression directly following alcohol consumption. Nevertheless, the results reported herein
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provide novel insight into the connection between escalations in alcohol drinking and
transcriptional regulation in the nucleus accumbens, and provide direction for future study.
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Chapter 6. Mu-opioid receptor-selective antagonist NAQ selectively reduces
high concentration alcohol consumption and delays the effects of intermittent
alcohol access

Introduction
Nearly 4% of people in the United States are estimated to be afflicted with alcohol use disorders
(AUDs), such as alcohol abuse or dependence. In the United States alone, the total cost to society
related to alcohol use and abuse amounted to 2.7% of yearly GDP (Rehm et al., 2009). However,
despite this high prevalence and cost, only three medications have been approved by the FDA to
treat alcohol dependence: disulfiram, acamprosate, and naltrexone. Although these drugs are
modestly effective in some patients, none are effective in all patients, and long-term efficacy
remains limited (Anton et al., 2006; Bouza et al., 2004; Yancey and Lumbad, 2011). Naltrexone
is modestly effective at reduction of heavy relapse drinking, but only marginally effective at
enhancing abstinence (Garbutt, 2010). Acamprosate is most effective for abstinent alcoholics for
whom relief craving is a key factor in relapse, but seems to only be effective in the long-term for
20-30% of patients (Kiefer and Mann, 2010). Thus new treatment strategies for AUDs are
needed, and several neurotransmitter systems are under active investigation as therapeutic
vectors, including the GABAergic signaling, endogenous opioid signaling, the endocannabinoid
system, the corticotropin releasing factor (CRF) system, nicotinic acetylcholine receptors, and
others (Leggio et al., 2010; Litten et al., 2012; Rosner et al., 2010).
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Studies have shown that various neurotransmitter systems, neuromodulators, and intracellular
signaling pathways are involved in alcohol dependence (Vengeliene et al., 2008). The
endogenous opioid system appears to be involved in the reinforcing effects of alcohol, through
its interactions with mesolimbic dopaminergic reward pathways and glutamate, gammaaminobutyric acid (GABA), serotonin, endocannabinoid, and glycine neurotransmitter systems
(Johnson, 2008). There are three main subtypes of opioid receptors, designated as the µ opioid
receptor (MOR), the κ opioid receptor (KOR), and the δ opioid receptor (DOR), respectively.
Naltrexone is a nonselective opioid receptor antagonist with greatest affinity for MOR (Ki: 0.1 to
2.0 nm), but also blocks KOR (Ki: 0.5 nm) and DOR (Ki: 8.0 nm). The three main opioid
receptors subtypes, as well as the nociceptin/orphanin FQ receptor and the sigma receptor, which
are similar in structure to opioid receptors, have been studied in the context of alcohol-related
behaviors and therapies for alcoholism (Murphy, 2010; Robson et al., 2012; Soyka and Rosner,
2010).
Animal and human studies suggest a crucial role for the MOR in alcoholism, as MOR agonists
and antagonists oppositely modulate ethanol consumption (Hyytiä and Sinclair, 1993; Zhang and
Kelley, 2002). Furthermore, MOR knockout mice consume less ethanol than wild-type
littermates, and do not develop ethanol place preference (Hall et al., 2001; Roberts et al., 2000b).
In humans naltrexone attenuates the stimulating and reinforcing effects of alcohol, and enhances
the sedative effects.(Davidson et al., 1999; Drobes et al., 2004; McCaul et al., 2000; Swift et al.,
1994). Naltrexone decreases alcohol-related cue activation of the ventral striatum in alcohol
dependent subjects, and increases activity in cortical regions during decision making tasks in
abstinent alcoholics (Boettiger et al., 2009; Myrick et al., 2008).
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However, despite preclinical and clinical evidence for involvement of the endogenous opioid
system in alcohol reward and addiction, meta-analyses have shown that naltrexone is only
moderately effective at reducing heavy binge drinking, and effectiveness is extremely variable
across studies (Garbutt, 2010; Johnson, 2008). Several factors have been shown to be predictive
of good patient response to naltrexone: high craving for alcohol, use of other drugs, early age of
onset of alcoholism, and a family history of alcoholism (Monterosso et al., 2001; Rubio et al.,
2005). The latter two factors in particular indicate that genetic background is a primary influence
on the role of the endogenous opioid system in ethanol-related behaviors. Consistent with this
notion, poor compliance and treatment success rates have limited the clinical usefulness of oral
naltrexone in many patients, with the notable exception of carriers particular single nucleotide
polymorphisms (SNPs) in the mu opioid gene (Chamorro et al., 2012; Chen et al., 2012; Oslin et
al., 2003; Ray et al., 2012). A different SNP in MOR has recently been shown to mediate some
alcohol-related phenotypes in Rhesus macaques (Barr, 2013). Interestingly, psychological
variables also play a role in patient response to naltrexone. Significant differences between
naltrexone and placebo effectiveness were observed in Type A personalities, but not Type B
personalities (Bogenschutz et al., 2009). Differences in hedonic processing indicated by
preference for sweet substances have also been shown to be a predictive phenotype for
naltrexone effectiveness (Garbutt et al., 2009).
Thus it is clear that signaling by endogenous opioids, in particular through MOR, is involved in
alcohol-related behavior and alcoholism, yet naltrexone shows limited effectiveness in a subset
of alcoholics. It is therefore important to determine the relative importance of opioid receptor
subtypes in alcohol-related behaviors, to determine what patients can benefit from naltrexone,
and where to target novel and more selective therapeutic ligands. Study of the role of MOR in
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alcohol-related behaviors has been limited because small molecule mu-selective antagonists have
been unavailable, and studies using bioactive peptides are relatively difficult and expensive.
Novel MOR selective antagonists are thus a high priority target in drug development, both for
the treatment of AUDs and understanding of the role of signaling through the MOR in behavior.
NAQ, an isoquinoline substituted 6α-naltrexamine derivative, was recently reported to be a
highly selective MOR ligand (Ki ratios δ/µ ≈ 241, κ/µ ≈ 48) (Li et al., 2009b; Mitra et al., 2011;
Yuan et al., 2013; Yuan et al., 2011; Zaidi et al., 2013). NAQ was determined to be a low
efficacy competitive antagonist at MOR compared to DAMGO in the 35S-GTP[γS]-binding
assay, and in the warm-water tail immersion test NAQ was found to be a potent blocker of
morphine antinociception (AD50 = 0.45 mg/kg). Interestingly, NAQ showed much lower
efficacy in morphine dependent mice, in which it failed to fully block the receptor even at doses
up to 100 mg/kg, as measured by somatic signs of withdrawal. Naltrexone at 1 mg/kg produced
significantly more escape jumps and wet dog shakes than vehicle, but NAQ at 10 mg/kg
produced no escape jumps and only modest wet dog shakes (Yuan et al., 2011). NAQ has not
been studied in the context of alcohol-related behavior, but its molecular selectivity and
behavioral profile make it a useful tool for study of the role of MOR in alcohol-related behavior,
and a candidate drug for the prevention of relapse in alcoholism.
Taken together this evidence suggested further exploration of the potential for NAQ to alter
alcohol-related behaviors, and differences in the efficacy of NAQ compared to naltrexone. Thus,
studies were conducted to evaluate the effects of NAQ compared to naltrexone on voluntary
ethanol consumption in C57BL/6J mice using a multiple concentration 3-bottle choice model
(water, 15% ethanol, and 30% ethanol v/v) under continuous access and every-other-day
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intermittent access (IAA) conditions. NAQ was also evaluated for changes in taste preference for
bitter (quinine) and sweet (saccharin) solutions.

Materials and Methods

Animals
For experiments 1 and 2, C57BL/6J mice (N = 40) were purchased from Jackson Laboratories
(Bar Harbor, ME) at 8 to 9 weeks of age and housed 1 mouse per cage at 23 ± 1 °C on a 12 h
light/dark cycle (lights off at 6 pm). Experiments 3 and 4 were performed on a new group of 32
C57BL/6J mice of the same age, from the same supplier, and housed under identical conditions.
Food (Harlan Teklad #7912; Madison, WI) and water were available ad libitum. Cages and
bedding were changed weekly. Mice were allowed to habituate to the animal facility for one
week prior to experiments. Procedures adhered to the National Institute of Health (NIH) Guide
for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care
and Use Committee of Virginia Commonwealth University.
Drugs
NAQ was synthesized as described by Li and Zhang (2009). For all studies NAQ was first
dissolved in DI water to produce a stock solution that was diluted to the proper concentration as
needed. Prior to administration sodium chloride was added for a final concentration of 0.9%. For
all studies a 0.9% saline solution prepared from DI water and sodium chloride was used as
vehicle. All injections were administered to the intra-peritoneal cavity at a volume of 1 mL per
100 g of animal weight. Ethanol solutions (15% and 30% v/v) were prepared by diluting 200-
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proof absolute anhydrous ethanol (Pharmco-Aaper , Brookfield, CT) with tap water. Saccharin
and quinine hydrochloride (Sigma-Aldrich, St. Louis, MO) were dissolved in tap water.
Three-bottle choice drinking
All mice were allowed access to tap water and ethanol in tap water at concentrations of 15% and
30% (v/v) for 24 hours/day on access days. Fluids were measured daily to the nearest 0.1 mL and
replaced at 4pm, 2 hours before the onset of the dark cycle. All injections occurred once per day
after drinking measurements were taken and before drinking tubes were replaced. Injections
were prepared outside the drinking facility to minimize experimenter/animal interaction and
abstinence time.
For experiment 1 (constant access with drug administration) mice were allowed to drink for 14
days without interruption to establish baseline levels of consumption and preference for water
and each ethanol concentration. After this baseline period mice were assigned to 3 groups,
balanced for total ethanol consumption and preference such that no significant group differences
were present (1-way ANOVA). All mice were injected with saline for 2 days to habituate them
to the stress of injections, followed by 3 days of vehicle, 1.0 mg/kg NAQ, or 1.0 mg/kg
naltrexone, with alcohol and water consumption measured daily. Mice were then allowed access
to water only for 14 days prior to experiment 2.
For experiment 2 (intermittent access) the 3-bottle choice model was again used, but in this
experiment mice were only allowed access to ethanol for 24 hours on Monday, Wednesday, and
Friday of each week for 4 weeks (12 days of access). No drugs were administered during this
experiment.
Taste preference
175

For experiment 3 (NAQ effects on quinine and saccharin taste preference), 32 mice were allowed
access to 30 µM quinine and tap water for 4 days. After a day of access to water only, mice were
given 350 µM saccharin and tap water for 4 days. For both solutions consumption was measured
to the nearest mL and expressed in µg/kg/day. Preference was calculated as mL of adulterated
solution divided by total fluid intake. Saccharin and quinine were dissolved in the same tap water
used for ethanol solutions.
Statistics
Data were expressed as mean ± SEM. Analysis was performed in Graphpad Prism version 6.01.
Analysis of consumption and preference data was performed separately for 15% ethanol, 30%
ethanol, and total ethanol (15% and 30% combined). For all experiments two-way analysis of
variance (ANOVA) was conducted to independently compare ethanol consumption and
preference across treatment groups over time, and repeated-measures ANOVA was conducted
within each treatment group to identify significant effects of treatment over time. Dunnett’s
multiple comparisons tests were performed to identify significant group differences on particular
days.
For experiment 1 subject #17 failed to habituate to the stress of injection as measured by
recovery to pre-injection intake levels and was excluded from analysis after analysis of baseline
consumption using Chauvenet’s criterion determined it to be a statistical outlier (Gad and Weil,
1988). For experiment 2 only two-way ANOVA tests were conducted with repeated-measures.
Significant effects from either test were subjected to Dunnett’s test to compare individual test
days to baseline for each treatment group. Tubes with no liquid remaining to measure after 24
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hours were not included in calculations, and any mouse with data of this type was excluded from
repeated-measures tests due to this missing data.

Results
Experiment 1: NAQ effects on continuous alcohol consumption
In experiment 1 two-way ANOVA did not identify significant effects of treatment on total
consumption or total preference (p = 0.10, 0.89 respectively). Repeated-measures ANOVA
within each group showed that NAQ significantly reduced total ethanol consumption on both test
days at p < .05 compared to baseline [F(2,24) = 5.150, p = 0.013; Dunnett’s post-test p < 0.05].
In contrast, a significant reduction in total ethanol consumption was seen only on test day 1 for
naltrexone [F(2,22) = 3.932, p = 0.034; Dunnett’s post-test p < 0.05]. NAQ failed to significantly
decrease total preference compared to baseline on either test day [F(2,24) = 1.338), whereas
naltrexone reduced total preference on test day 1 only [F(2,22) = 5.805, p = 0.009; Dunnett’s
post-test p < 0.05]. Saline treatment had no effect on total consumption or preference (see Figure
1). NAQ and naltrexone failed to significantly alter consumption or preference for 15% ethanol
(see Figure 6.1).
For 30% ethanol consumption [F(2,99) = 3.236, p = .043] and preference [F(2,99) = 3.676, p =
.028], two-way ANOVA identified a significant effect of treatment, but no interaction, and
Dunnett’s tests did not identify any means significantly different from baseline for any group on
any test day . However, within-groups repeated-measures ANOVA revealed that NAQ treatment
significantly decreased consumption [F(2, 22) = 6.518, p = .006] and preference [F(2, 22) =
6.649, p = .005] for 30% ethanol compared to baseline on both test days. NTX treatment did not
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produce significant changes in consumption [F(2, 22) = 2.620, p = .095] or preference [F(2,22) =
2.151, p = .140] for 30% ethanol, but a trend towards significance was observed.
Water intake and total fluid intake were examined to determine whether observed decreases in
ethanol consumption and preference were explained by non-selective decreases in total fluid
intake. Two- way ANOVA across groups, repeated-measures ANOVA within groups, and
ANOVA on each day were performed on both measurements, and no significant differences
were found (data not shown).
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Figure 6.1. Consumption and preference for total ethanol, 15% ethanol, and 30% ethanol from
experiment 1, with baseline in white, test day 1 in gray, test day 2 in black. Within-group
repeated-measures ANOVA for total ethanol, two-way ANOVA between groups
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Experiment 2: Effect of NAQ pre-treatment on drinking produced by IAA
In experiment 2 no drugs were administered and groups were identical to experiment 1.
Following 14 days of abstinence mice were allowed access to 15% ethanol and 30% ethanol on
Mondays, Wednesdays, and Fridays for 4 weeks. The baseline for all comparisons was day 1 of
IAA, on which the groups did not differ significantly in any preference or consumption
measurement (One-way ANOVA, data not shown).
For total ethanol consumption no significant effects were identified with two-way ANOVA with
repeated measures. However, repeated-measures one-way ANOVA within groups revealed a
significant effect of treatment over time for total ethanol consumption in the NAQ group
[F(11,143) = 4.340, p < .0001], the NTX group [F(11, 132) = 3.332, p = .0004], and the saline
group [F(11, 132) = 4.602, p < .0001]. For consumption data Dunnett’s test indicated significant
differences from baseline for the saline group at day 10 only (see Figure 6.2). No significant
differences in consumption were identified using Dunnett’s test for the NAQ and NTX group on
any day compared to day 1 of IAA.
For total ethanol preference no significant effects were identified with two-way ANOVA with
repeated measures, but one-way ANOVA with repeated measures identified significant changes
over time for mice treated with NAQ [F(11,143) = 6.393, p < .0001], NTX [F(11, 132) = 5.316,
p < .0001], and saline [F(11,132) = 4.065, p < .0001]. For total ethanol preference Dunnett’s test
with a significance threshold of p < .05 indicated a delayed effect of IAA in the NAQ- and NTXtreated groups compared to the saline-treated group. The saline-treated group showed
significantly increased preference on day 2 compared to day 1, and preference was significantly
elevated compared to day 1 on all subsequent access days, with the exception of day 5. In
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contrast, total ethanol preference of the NAQ group did not differ significantly from day 1 until
day 4 (Monday of week 2) and was elevated from days 6 through 12, while in the NTX group
this measurement only differed significantly from baseline on days 6 through 12 (see Figure 6.2).
For 15% ethanol alone repeated-measures ANOVA showed significant changes in consumption
and preference over time for all groups, although the patterns of intake differed markedly
between groups (see Figure 6.3). In NAQ-treated mice consumption [F(11,143) = 5.950, p <
.0001] and preference [F(11,143) = 5.088, p < .0001] were significantly elevated compared to
day 1 by day 4, and remained so from days 6 through 12, with the exception of consumption on
day 9. In NTX-treated mice consumption [F(11, 132) = 4.316, p < .0001] was significantly
different from day 1 on days 8, 10 and 12, while preference [F(11, 132) = 3.452, p = .0003] was
significantly different on days 8, 10 and 11. In saline-treated mice gradual increases in
consumption [F(11, 132) = 2.217, p = .0170] led to significant differences on day 12 only, while
preference [F(11, 132) = 2.376, p = .0103] was significantly increased from days 2 through 4 and
on days 8, 11, and 12.
For 30% ethanol alone repeated-measures ANOVA showed significant changes in consumption
of saline-treated mice [F(11, 99) = 2.091, p = .0277], but not for mice treated with NAQ [F(11,
121) = 1.139, p = .3372] or NTX [F(11, 110) = 1.201, p = .2946] (see Figure 6.4). For 30%
ethanol preference saline mice showed a trend toward significant changes over time [F(11, 99) =
1.698, p = .0848], and no differences were observed for mice treated with NAQ [F(11, 121) =
.8457, p = .5951] or NTX [F(11, 110) = .6089, p = .8179]. Dunnett’s test did not identify
significant differences between day 1 and any subsequent access day for any measurement in any
group (data not shown).
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Figure 6.2. Consumption (A) and preference (B) for total ethanol from experiment 2, withingroup repeated-measures ANOVA, Dunnett’s test compared to IAA day 1: * p < 0.05.
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Figure 6.3. Consumption (A) and preference (B) for 15% ethanol from experiment 2, withingroup repeated-measures ANOVA, Dunnett’s test compared to IAA day 1: * p < 0.05.
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Figure 6.4. Consumption (A) and preference (B) for 30% ethanol from experiment 2, withingroup repeated-measures ANOVA, Dunnett’s test compared to IAA day 1: * p < 0.05.
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Experiment 3: Effects of NAQ on consumption and preference of quinine and saccharin
No group differences in quinine consumption [treatment: F(1, 119) = .2745, p = .6013] or
preference [treatment: F(1, 119) = .9495, p = .3318] were observed with 2-way ANOVA (see
Figure 5). For saccharin consumption 2-way ANOVA identified a significant effect of treatment
[F(1, 120) = 12.74, p = 0.0005] and time [F(3, 120) = 15.70, p < 0.0001], but no interaction [F
(3, 120) = 0.5491, p = 0.6497]. Dunnett’s test identified a significant difference on saccharin
consumption between saline-treated and NAQ-treated mice at day 1 only (p = .0364) (see Figure
6.4). For saccharin preference 2-way ANOVA identified a significant effect of treatment [F(1,
120) = 9.865, p = 0.0021], but not of time [F(3, 120) = .7542, p = .5220], and no interaction was
observed [F (3, 120) = 0.2063, p = 0.8919] (see Figure 6.5).
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Figure 6.5. Effects of 5 mg/kg NAQ on 30 µM quinine consumption (A) and preference (B), and
350 µM saccharin consumption (C) and preference (D). Dunnett’s test for saline vs NAQ: * p <
0.05.
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Discussion
NAQ and naltrexone decrease continuous access ethanol consumption primarily by decreasing
consumption of 30% ethanol, while leaving consumption of 15% ethanol unchanged. The effects
of the two drugs on total consumption and preference are similar in magnitude, but not in
duration, which indicates that tolerance to NAQ may develop more slowly than tolerance to
naltrexone. However, only one dose of each drug was used, and both dose and treatment regimen
would need to be optimized for particular behaviors to determine maximal effects and any
advantages of one over the other. Thus, further study is needed to characterize tolerance to NAQ:
drinking experiments to examine behavioral tolerance for different dosing regimens over time,
and molecular experiments to determine the degree to which chronic exposure induces MOR
desensitization and downregulation. Slower development of tolerance to NAQ would be a clear
advantage over naltrexone in the clinical setting.
The selectivity of NAQ for high concentration alcohol compared to naltrexone is also an
intriguing result, though difficult to interpret. While NAQ produces a significant decrease in
consumption and preference of 30% ethanol, NTX does not, which indicates that selective MOR
antagonism is more selective for reducing intake of high concentration ethanol. In this context
high concentration is relative only to the other alcohol concentration offered, but few studies in
the literature have offered concentrations greater than 30% (v/v), and this approaches the 40%
alcohol content (80 proof) of most hard liquor consumed by humans. While some humans sip
alcohol at this concentration in a controlled manner, it is also the quickest way to achieve high
blood alcohol concentrations and the psychoactive effects of alcohol. As in humans, it seems
probable that the decision to consume high concentration alcohol in mice reflects greater
motivation for the psychoactive effects of ethanol than does consumption of low concentrations,
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because these effects are reached more quickly, yet require drinking a more bitter and aversive
substance. More study is needed to determine the motivational correlates of high concentration
vs. medium concentration drinking in animals, but attenuation of this kind of drinking in mice
may indicate particular effectiveness in control of heavy drinking in humans.
Furthermore, MOR antagonism is sufficient to selectively decrease 30% intake, while
nonselective opioid receptor antagonism by naltrexone produces only a trend in this direction.
This suggests the possibility that naltrexone action at other opioid receptor subtypes may be
counter-productive to the reduction of consumption, although this effect could be due to an
insufficient number of subjects to identify significance, or use of a dose of naltrexone that does
not produce optimal attenuation of 30% alcohol intake. Future studies will address these
methodological issues, as well as use DOR and KOR selective opioid receptor ligands in
conjunction with naltrexone and NAQ to determine the role of each receptor subtype.
In the intermittent access model, scheduled abstinence produced an immediate significant
increase in total ethanol preference in saline-treated mice, but in NAQ- and naltrexone-treated
mice this effect did not manifest until the second week of intermittent access. Thus nonselective
and mu-selective opioid antagonists selectively decreased intake of high concentration alcohol,
and effects on intake persisted through 2 weeks of abstinence, after which the induction of bingelike drinking by intermittent access was delayed compared to saline-treated mice. These effects
are consistent with the effects of naltrexone in humans, in which the drug is modestly effective at
reducing heavy relapse binge drinking (Garbutt, 2010). The examination of this effect of pretreatment was not the stated goal of the study in which it was discovered, and the 2 week
abstinence period was intended to be a “wash-out” period, after which IAA would be used to
escalate drinking, and NAQ and naltrexone would be tested for reduction of binge-like drinking.
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Naltrexone and NAQ did not acutely alter binge-drinking after establishment, but when
segregated by treatment from the previous experiment significant differences were observed
between saline- and antagonist-treated groups. The nature of the molecular mediators of this
effect of opioid antagonist pre-treatment are not apparent from the studies reported here-in, and
future experiments will determine whether MOR receptor regulation or some downstream
mechanism is responsible. Dopaminergic signaling in the mesolimbic reward pathways are
controlled partially by opioidergic tone, and long-term antagonism at MOR may induce
secondary adaptations in dopaminergic signaling or other related processes that lead to altered
behavior. The persistence of antagonist treatment in attenuating drinking behavior is surprising,
but encouraging as a factor in clinical treatment of alcoholism, where patient compliance can
have a negative impact on treatment success.
NAQ does not alter taste preference for bitter solutions, which showed that its negative effects on
alcohol intake are not produced through sensitization to bitter tastes. This control is particularly
important because NAQ was selective for 30% alcohol over 15% alcohol, which is an effect that
would also be produced by sensitization to bitter tastes. Changes in saccharin intake were
minimal and transient, but may indicate that NAQ temporarily decreased consumption of
sweetened solutions, either through decreased novelty-seeking or reduced reinforcing effects of
sweet tastes. Given the persistent nature of attenuation in drinking by NAQ shown in the IAA
experiments, this is likely an effect with minimal clinical relevance. However, further study is
needed to explore the selectivity of NAQ for ethanol compared to other reinforcers, and to
further dissect the effect of the drug on alcohol reward. Further preclinical study toward this end
using operant self-administration with progressive ratio breakpoint measurement and conditioned
place preference will measure the reinforcing and rewarding properties of the drug, respectively.
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Evidence for effects of NAQ on cue- and stress-induced reinstatement will also be crucial
support for the advancement of the drug to clinical trials in the future.
Taken together these results indicate that selective MOR antagonism is sufficient to reduce
consumption of high concentration alcohol and attenuate relapse drinking behavior, and that
NAQ represents a potential drug for use in the prevention of relapse in alcoholics that may have
advantages over naltrexone.
The use of concurrent multiple ethanol concentrations in this study is an extension of the work of
several laboratories in mice and rats that have shown that this type of access produces greater
intake and allows for the expression of individual subject preference in concentrations, which are
masked by the presentation of a single concentration of ethanol only (Melendez et al., 2006b;
Rodd-Henricks et al., 2001b; Wolffgramm and Heyne, 1995). This model also allows for
discernment of drug effects not possible in a binary-choice, single-concentration model, such as
the selectivity for the higher-concentration alcohol solution seen in this study. However,
interpretation of this type of behavior is limited, and more study is needed to determine the
factors that cause a mouse to choose high or low alcohol concentrations. Because naltrexone also
showed this property, albeit in a non-significant trend, it represents a factor that may be
predictive for success in treating alcoholism, to which acamprosate, baclofen, and other drugs
thought to have this potential should be subjected.
The authors are aware of only one other study using concurrent multiple ethanol concentrations
in an IAA model with mice, and in that study C57BL/6J mice were allowed access to 7.5%,
15%, and 30% alcohol on only one day per week, after a baseline drinking period and 2 weeks of
abstinence (Melendez et al., 2006b). In that study the effects of intermittent access differed
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markedly from those reported here, despite similar baseline consumption of 15% and 30%
ethanol. By the end of IAA procedures mice showed greatly elevated consumption of 30%
ethanol, but not 15% ethanol, while in the present study IAA primarily increased intake of 15%
ethanol. This effect is seen across groups, and may be a result of stress due to injection, a shorter
baseline access period (2 weeks vs. 6 weeks), the absence of 7.5% ethanol solution, or general
environmental differences. Whatever the cause, the results of the present study do not support the
notion that binge-like drinking produced by IAA is selective for higher concentrations of alcohol.
The apparent delay in the effects of IAA in mice treated with NAQ and naltrexone compared to
saline-treated mice shows that these drugs have long-lasting behavioral effects that may persist
for weeks after cessation of treatment. Experiments of this type may represent a useful test for
preclinical testing of drugs with potential in treating alcoholism. The analogous situation in
human alcoholism treatment is that of a patient taking naltrexone while drinking and successfully
transitioning to abstinence, followed by cessation of naltrexone treatment and re-exposure to
alcohol. Further study should examine this effect in alcohol-dependent mice during withdrawal,
and aim to determine whether it is a result of pairing the drug with alcohol, or if treatment in the
absence of alcohol is sufficient to reduce future consumption. These results can inform the
manner in which drug treatment and behavioral therapy are managed in abstinent alcoholics and
those trying to cease drinking.
The similar, but not identical, effects of NAQ and naltrexone on alcohol intake may be explained
in part by the differing pharmacodynamic and pharmacokinetic properties of the drugs.
Interestingly, while effects on alcohol drinking are similar between the two drugs, drastic
differences in withdrawal-induced behaviors are observed in chronic morphine-exposed mice
administered NAQ and naltrexone at the same doses used in this study (Yuan et al., 2011). Even
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at a dose of 100 mg/kg NAQ fails to produce half of the number of escape jumps or wet-dog
shakes as 1 mg/kg naltrexone. These differences may be explained by dissimilarities between
NAQ and naltrexone in metabolism and in action at the three primary opioid receptor subtypes.
In vitro studies show the absorption of the two drugs to be very similar, but hepatic clearance of
naltrexone is approximately 50-fold greater than that of NAQ in human liver microsomes, and
the unbound fraction of NAQ in human plasma is less than 3%, compared to 72-79% for
naltrexone. NAQ lacks the ketone moiety exploited by aldo-keto reductase enzymes for
naltrexone metabolism to 6β-naltrexol, which is followed by glucuronidation, and thus NAQ is
not found to be detectably glucuronidated, and its primary oxidative metabolite is the Ndealkylated product (Mitra et al., 2011). Interestingly, this sets NAQ apart from naltrexone and
other structurally similar compounds. Morphine and buprenorphine undergo N-dealkylation,
although their primary route of metabolism is glucuronidation (Kobayashi et al., 1998; Projean et
al., 2003). In contrast, naltrexone does not undergo N-dealkylation in vivo. More research into
the pharmacological properties of NAQ and its metabolites is needed to identify whether these
factors contribute to the differences seen in the behavioral effects produced by NAQ and
naltrexone (Yuan et al., 2011).
In addition to MOR, evidence suggests that DOR is also involved in alcohol consumption
(Roberts et al., 2001). Recently published work by van Rijn et al. demonstrates that DOR-1
selective agonist TAN-67 reduces ethanol consumption by enhancing the rewarding properties of
lower doses of ethanol , and chronic ethanol exposure increases the potency of some DOR
selective ligands in the spinal cord of mice (van Rijn et al., 2012a, b). NAQ is a partial DOR
agonist with moderate efficacy (% Emax of SNC80 = 53.4 ± 5.4 %) while naltrexone produces
little activation at the DOR (% Emax of SNC80 = 3.99 ± 1.32 %), and this difference may
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partially underlie the selectivity of NAQ for high-concentration ethanol consumption compared
to naltrexone (Yuan et al., 2011).
Differing action at the KOR likely also contributes to the differences in effect seen in this study
between NAQ and naltrexone. The KOR antagonist norBNI selectively attenuates ethanol selfadministration in ethanol-dependent rats (Nealey et al., 2011). In addition, KOR antagonist
JDTic decreases alcohol self-administration and cue-induced reinstatement of alcohol seeking
when administered 2 h prior to testing (Schank et al., 2012). In contrast, KOR agonist CI-977
potentiates ethanol intake and preference in long-term ethanol-experienced rats (Hölter et al.,
2000). Naltrexone binds to the KOR with 5 times the affinity of NAQ and also produces greater
KOR activation (NAQ, % Emax of U50,488H = 13.1 ± 2.0 %, EC50 = 10.9 ± 7.9 nM;
naltrexone, % Emax of U50,488H = 17.6 ± 1.0 %, EC50 = 4.0 ± 1.6 nM), which could produce
behavioral effects in opposition to those produced by MOR antagonism/partial agonism on
ethanol consumption (Li et al., 2009a).
In these studies NAQ shows similar efficacy to naltrexone in the reduction of ethanol intake and
in the delay of escalated intake due to intermittent access, and is thus a promising candidate for
therapeutic intervention in alcoholism and deserving of further study. Some potential advantages
over naltrexone were identified that should be explored: greater selectivity for highconcentration ethanol and slower development of tolerance. Some of these effects are likely due
to differences in pharmacodynamics and pharmacokinetics, and may represent advantages over
naltrexone in a clinical setting. Studies examining NAQ in morphine withdrawal have shown
striking differences compared to naltrexone, but the drug has only begun to be examined in the
context of alcohol-related behaviors, and its effects in the IAA model, other models of increased
craving such as drinking-in-the-dark, and other related behaviors should be further explored.
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Chapter 7. General discussion, limitations, and future directions

The studies herein report observations on the behavioral and genomic aspects of scheduled
alcohol abstinence procedures in C57BL/6 mice, which produce binge-like and inflexible ethanol
drinking behavior. These results are important because scheduled alcohol deprivation methods,
which include the intermittent alcohol access (IAA) and alcohol deprivation effect (ADE)
models, are thought to produce behavioral and neuromolecular adaptations that are similar to
those occurring with binge drinking and the transition to alcoholism in humans (REF). Thus,
insights gained through the preclinical study of the IAA and ADE models, including
environmental factors that modulate their effects, and changes in brain gene expression
associated with changes in behavior they produce, inform the study of motivated behavior for
abused substances and the search for better treatments for alcoholism.
Accordingly, within are provided genes, cell signaling pathways, and gene networks acting in
midbrain, striatum, and prefrontal cortex, that merit further preclinical study to determine
relevance to the development of binge-like drinking behavior due to scheduled abstinence.
Furthermore, methodological recommendations are made to maximize the utility of such
preclinical models for representing maladaptive drinking behavior characteristic of alcohol use
disorders. Finally, specific research goals and plans are provided to confirm the results reported
and further understanding of binge-like drinking and the development of alcoholism.

Alcohol deprivation effect studies
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Genomic analysis of transcriptional regulation induced by the ethanol deprivation effect reveals
that differences in gene expression produced by abstinence are most severe in the nucleus
accumbens (NAc), compared to the prefrontal cortex (PFC) and ventral midbrain (VMB).
Interestingly, the directionality of changes induced by the four-day deprivation period also varies
among regions: more mRNA transcripts are downregulated than upregulated in NAc and PFC,
but in VMB all regulated transcripts are reduced in abundance. Thus the NAc seems to be a
primary site of neuroplasticity occurring with alcohol deprivation.
There is little overlap in regulated transcripts between any two of the three regions studied, and
no genes are altered by alcohol deprivation in all three. Despite the lack of overlapping genes,
some biological themes were common to more than one region, and represent areas for further
study: PI3K signaling, hormone signaling, regulation of cell fate, regulation of neuronal
connectivity, and mRNA transcription and processing. In the NAc in particular, several signaling
pathways and biological processes with known relevance to alcoholism and alcohol-related
behavior are over-represented in regulated genes: myelination, CRF/CRH signaling, regulation
of protein ubiquitination and degradation, extensive regulation of ion channels for sodium,
calcium, and potassium. In addition, regulation of glutamate and GABA receptor populations
and ligand transport are implicated by genes regulated during alcohol deprivation in nucleus
accumbens.
During alcohol deprivation some gene regulation mechanisms are common across regions, but
the nucleus accumbens gene set contains the majority of over-represented transcription factor
binding sites in gene promoter regions. In all regions studied epigenetic processes involving
histone acetylation and chromatin remodeling are clearly implicated in gene regulation during
deprivation. In the NAc the functioning of Smarca4, also known as Brg1, is of particular interest,
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because it is a calcium-responsive helicase that acts in several chromatin modifying complexes,
regulates Fos gene transcription, and is increased nearly 2-fold by alcohol deprivation (Murphy
et al., 1999; Qiu and Ghosh, 2008; Trotter, 2007). Interference with BRG1 function or associated
complexes represents a direct mechanism for interference in ethanol-responsive transcription,
which could interfere with neuroplasticity and changes in behavior. Future studies should
attempt to address the involvement of BRG1 in transcriptional regulation in NAc during alcohol
drinking. In particular, conditional BRG1 knockout mice would allow for the inactivation of the
gene at particular time-points during drinking behavior, to determine the connection between
gene regulation and alcohol intake.
It is not surprising that CREB binding sites are over-represented in genes regulated by alcohol
deprivation, considering the well-established role of CREB-mediated gene expression in the
regulation of addictive behavior, but this does indicate some similarity in underlying regulation
mechanisms for gene regulation induced by alcohol deprivation and craving for other drugs of
abuse. Interestingly, regulation of transcripts through miRNA is also implicated in the
deprivation-regulated genes, which lends to support to the notion that alcohol deprivation is a
valid model for the development of alcoholism, because miRNA alterations are a signature
characteristic of the alcoholic brain (Bahi and Dreyer, 2013; Lewohl et al., 2011; Nunez and
Mayfield, 2012).
Ion channel regulation seems to play a role in neuroplasticity occurring with scheduled alcohol
deprivation. Transcripts coding for six voltage-gated calcium channel subunits (Cacna1a,
Cacna1d, Cacna1g, Cacna2d1, Cacnb2, and Cacnb4) are upregulated by ethanol deprivation,
and thus calcium channel blockers should be explored for efficacy in reducing maladaptive
drinking produced by alcohol deprivation. Differential expression results from IAA mice also
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contain an unusually large number of calcium channels, as indicated by significant overrepresentation of calcium ion-related gene ontology terms. Ethanol inhibits N- and P/Q-type
calcium channels, and there is some evidence for efficacy of T-type and N-type calcium channel
blockers to alter other alcohol-related behaviors, but not in the context of scheduled abstinence
(McMahon et al., 2000; Newton et al., 2008; Solem et al., 1997). This finding is particularly
intriguing in light of the recent landmark study showing that the anti-craving effects of
acamprosate are mediated by increased calcium, and that in patients taking the drug positive
outcomes such as time to relapse are correlated with plasma calcium levels (Spanagel et al.,
2013).
Taken together with the efficacy of acamprosate in the ADE and IAA models, and the regulation
of calcium channels and related genes in the ADE and IAA results, calcium deficits are
implicated as a primary mediator of ethanol intake in scheduled deprivation models. Further
studies should examine whether dietary calcium supplementation is sufficient to reduce bingelike drinking in the intermittent access model, i.e. are calcium carbonate antacids a treatment for
alcoholism? It is also not yet clear by what mechanisms plasma calcium regulates drinking
behavior, and whether this effect is CNS-mediated. These questions will be answered by
measuring calcium levels in plasma and in brain regions associated with ethanol drinking
behavior at several time points before, during, and after drinking on different access schedules.
Calcium levels should be correlated with ethanol drinking and dopamine release, and changes in
gene expression and protein abundance for voltage-gated calcium channels and other calciumrelated genes measured.

Intermittent alcohol access
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While the alcohol deprivation effect is a well-characterized model, it does not produce binge-like
drinking in which blood ethanol concentrations reach levels greater than 80 mg/dl, and
furthermore proved to be an extremely unreliable model in the Miles laboratory. With the
publication of two seminal papers in 2006 and 2008, it became clear that cycles of abstinence on
the proper schedule, in the form of repeated deprivations or intermittent access, was a better
model for increasing alcohol intake, and a more valid model of maladaptive drinking in humans
(Melendez et al., 2006a; Simms et al., 2008). Thus all other studies reported herein make use of
the intermittent alcohol access (IAA) model, either in the form of once-per-week or every-otherday 24-hour access periods.
The transition from the Alcohol Deprivation Effect (ADE) model to the Intermittent Alcohol
Access (IAA) model merits some explanation. The project assigned to me upon my arrival in the
Miles Laboratory in 2007 was concerned with regional transcriptional regulation induced by the
ADE. The laboratory had recently published on characterization of ADE behavior in C57BL/6J
and C57BL/6NCrl mouse strains, and had determined that the C57BL/6NCrl strain was more
amenable to the production of the ADE, despite drinking less alcohol than the closely-related
C57BL/6J strain (Khisti, 2006). The first task I performed was to attempt to repeat the ADE
procedure, with the objective of obtaining tissue samples for measurement of mRNA abundance
using microarray and PCR methods. Unfortunately, I was unable to reproduce the effect using
C57BL/6NCrl mice. Meanwhile, Melendez showed a result (2006) in which repeated one-dayper-week deprivation periods with multiple alcohol concentrations were used to induce an ADE
in C57BL/6J mice. Our technician, Nathan Bruce, achieved significantly elevated intake using
the Melendez procedure in a pilot study with C57BL/6NCrl mice (data not shown), and I adopted
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this method for all further scheduled deprivation studies: first with C57BL/6NCrl mice, and later
with C57BL/6J mice.
Goals for these studies are to determine the utility of the commonly used C57BL/6J and
C57BL/6NCrl inbred strains in the IAA model, to determine the effect of providing a choice in
alcohol concentrations on alcohol intake, to identify changes in the nucleus accumbens
transcriptome associated with the development of binge-like drinking behavior, and to interfere
with that development via targeted pharmacological manipulation. For all but the final
pharmacological studies the one-per-week model was used, because at the time they were
performed the utility of this model had been demonstrated in mice, but the every-other-day
model had not (Melendez, 2011). With the confirmation of the usefulness of the every-other-day
IAA model, which produces binge-like drinking and had been well-characterized in rats, this
procedure was adopted, and used for studies with the mu-opioid selective antagonist NAQ.
Furthermore, the every-other-day IAA model produces handling-induced seizures during
withdrawal, which has not been demonstrated for the more sporadic version (Hwa et al., 2011).
By comparison, the once-per-week procedure has been far less studied (Melendez et al., 2006a;
Rosenwasser et al., 2013).
Initial IAA experiments establish for the first time the effectiveness of the IAA procedure in
C57BL/6NCrl mice from Charles River Laboratories, which drink less ethanol than the closely
related C57BL/6J strain, but do not show differences in initial alcohol sensitivity, acute
functional tolerance to alcohol, or ethanol-induced loss of righting reflex (Mulligan et al., 2008a;
Mulligan et al., 2005). These strains show differences in the effectiveness of a 4-day alcohol
deprivation period to induce escalation in intake; the C57BL/6NCrl strain shows significant
increases in consumption and preference upon reinstatement of access, while the C57BL/6J mice
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do not (Khisti et al., 2006b). However, these results show that intermittent access on a once-perweek or every-other-day schedule increases alcohol intake in the C57BL/6J strain, and thus the
lack of an alcohol deprivation effect was not a result of a “ceiling effect”, as posited in the
mentioned study. The result reported herein confirms the utility of scheduled abstinence for
inducing increased consumption in C57BL/6NCrl mice, and further use of these mice in this
context would be useful as a contrast to the well-characterized C57BL/6J strain.
There are several potential explanations for the differences in effectiveness of each scheduled
deprivation model across the C57BL/6 sub-strains, and further experimentation in this area could
be useful because the relative similarity of the strains makes it easier to highlight those
differences which may be especially important for determining relapse behavior. The length of
the deprivation period could be a crucial factor in determining efficacy of IAA in C57BL/6J
mice; abstinence of one to two days, or six days, increases consumption and preference in these
mice, but abstinence of four days does not. The C57BL/6NCrl strain shows less ethanol-induced
dopamine release in ventral striatum than the C57BL/6J strain, which suggests differing effects
of ethanol on the function of dopaminergic neurons in the ventral tegmental area, where it
stimulates dopamine release in the nucleus accumbens (Ramachandra et al., 2007b). The use of
in vivo microdialysis in both strains to measure dopamine levels in the NAc at different timepoints during drinking would be informative, particularly in light of the conflicting relationship
between ethanol preference and dopamine release in the literature (Spanagel, 2009).
There is evidence that these strains differ in expression of dozens of genes across brain regions,
some of which are associated with alcohol preference and alcohol phenotypes (Mulligan et al.,
2008a). Thus measurement of mRNA and protein abundance of primary ethanol targets and
ethanol-responsive genes in the VTA and NAc, particularly at the 4-day abstinence time-point
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when relapse behavior differs, could identify targets with particular behavioral relevance for
further study. Because expression differences between the strains are minimal, there is a greater
chance of finding a significant association between expression and behavior than with more
distantly-related strains (Mulligan et al., 2008a).
There is also some evidence that C57BL/6NCrl mice are more fearful than C57BL/6J mice, and
more susceptible to environmental stressors, and that the effects of alcohol deprivation may be
dependent on social isolation stress (Tomie et al., 2013). These strains thus offer an opportunity
to gain insight into the role of anxiety and stress in escalating drinking behavior (Bryant et al.,
2008; Radulovic et al., 1998). Different stressors, such as foot-shock, yohimbine, or social stress
will likely produce differing effects on drinking in these strains, and the effects of treatments
such as naltrexone to reduce intake could inform the management of alcoholism in humans, in
which the disease is often comorbid with PTSD or other anxiety disorders (Brady and Back,
2012; McCarthy and Petrakis, 2010). It would also be informative to study the development of
binge-like drinking in the C57BL/6J mouse under group-housed conditions, to determine if the
effects of IAA in these mice are similarly dependent on social stress. If the effects of scheduled
alcohol deprivation are dependent on social stress, the scope of validity of the model could be
narrowed, in that results might only be relevant to the development of alcoholism when there is a
component of social stress involved.
Several other experimental parameters, such as the alcohol concentration used, could be
responsible for the differences in the two strains across experiments. For example, it may be that
a 4-day deprivation period is sufficient to escalate drinking in C57BL/6J mice if a choice in
ethanol concentrations is offered, so more direct comparison is needed to establish that
differences in the effects of abstinence are not a result of intended or unintended environmental
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differences. Our laboratory has observed that voluntary ethanol drinking behavior is extremely
sensitive to environmental change; and unintended environmental differences that alter drinking
behavior can be as subtle as changes in bedding from wood-chip to corn cob based products. It is
therefore crucial to measure drinking behavior in both strains at the same time, and in the same
facility.
After establishing that IAA increases ethanol consumption and preference in C57BL/6NCrl
mice, studies focused on the C57BL/6J mouse as an experimental model, because it drinks more
alcohol, and this is also a characteristic of humans with a predisposition for development of
alcohol use disorders, compared to the general population (Schuckit et al., 2006; Schuckit et al.,
2013). Consistent with published literature, the presentation of multiple ethanol concentrations
led to greatly increased consumption and preference (Rodd-Henricks et al., 2001a; Vengeliene et
al., 2005; Wolffgramm, 1990). Interestingly, IAA did not cause a shift to high concentration
alcohol, as seen in other studies, and this may be due to subtle differences in baseline drinking
and abstinence schedule. Future studies should address the effect of a longer baseline access
period, potentially on the order of months, on the subsequent escalation of drinking behavior.
Study of the neuromolecular correlates of these differences in behavior will illuminate the
mechanisms by which different aspects of maladaptive drinking are mediated.
The statistical methodology used to analyze repeated deprivation drinking data merits some
discussion with regard to rationale. The most proper and stringent method for establishing
significant differences between experimental groups (to reject the null hypothesis that the groups
do not differ) is the 2-way ANOVA with repeated measures, which takes into account the
continuous access (CA) and intermittent access (IA) data, as well as the persistence of subject
identity over time. As with any ANOVA, post-hoc tests are used to establish significant
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differences between any two group means, for example between CA and IA groups on
reinstatment day 7. However, with a 2-way ANOVA of this type there is a concern that the test
will fail to reject a null hypothesis which is in fact false, i.e. type II error or false negative. This
concern arises from the relatively high degree of individual variation in drinking data within a
group of mice of a size that is feasible for experimentation (typically 6 to 20 mice). The variance
in such data, which is remarkable even within a single subject from day to day, leads to high
standard deviation relative to the group mean, and it is thus difficult to establish significant
differences in means between two groups of mice.
A suboptimal, yet valid, solution to this difficulty is to use one-way ANOVA with repeated
measures within the IA and CA groups, followed by post-hoc tests, to examine differences
between baseline drinking and subsequent access days. For the IA mice the intermittent access
procedure is expected to produce significantly elevated consumption and preference, as
inidicated by positive post-hoc results, and for the CA mice it is expected that no differences
from baseline will be observed. These methods establish the efficacy of intermittent alcohol
access to elevate alcohol intake, the lack of change over time that is typically observed with
continuous access. To establish groupwise differences between IA and CA groups using 2-way
ANOVA it is expected that groups sizes larger than those used in the present studies (N = 12)
will be necessary, although differences from group to group and experiment to experiment
preclude effective power analysis to determine ideal group size. Preliminary power analyses
imply that groups of 20-25 mice may be required, which are at the limits of feasability given
current techniques (data not shown). To remedy this problem, new methods for collecting
drinking data may be needed, such as automated data collection using tube weight and

203

lickometers, which also provide advantages in temporal resolution and minimized experimentersubject interaction.
Gene expression in the nucleus accumbens associated with intermittent access over a period of 7
weeks differs markedly from that observed after a single 4-day deprivation, and the magnitude of
differences makes it unlikely that basal transcriptional differences between the C57BL/6J mice
used for IAA and the C57BL/6NCrl mice used for EDE are responsible. In C57BL/NCrl EDE
mice more than 500 transcripts are different between deprived mice and water mice after 4 days
of abstinence, whereas no differences were observed with the same comparison in C57BL/6J
IAA mice after 6 days of abstinence. This discrepancy could be a result of the length of
abstinence or of different transcriptional responses to ethanol between the strains, which drink
markedly different amounts of alcohol. Future studies should address whether time of
deprivation or ethanol-responsive gene expression differences are responsible.
The nucleus accumbens was chosen as the first region to examine in the IAA genomics
experiments because the EDE results showed far more transcript regulation in this region than in
prefrontal cortex or ventral midbrain. Furthermore, this region is known to be of central
importance in drug-related behavior, and multiple neurotransmitter systems are involved at
different stages of drug use. Dopamine release from the VTA signals drug availability and
triggers initial consumption behavior, while dysregulation of glutamatergic signaling during
abstinence leads to elevated signaling to the region from the PFC, and this is thought to
contribute to relapse behavior (Kalivas and Volkow, 2011; Quintero, 2013). Changes in the NAc
regional transcriptome are likely to signal alterations in function that underlie alcohol use during
relapse, and detailed knowledge of these changes will inform the study of the molecular
mechanisms of addictive behavior, and the search for intervention strategies. For these reasons
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the nucleus accumbens was chosen as the first region to examine using microarrays, but data
from other regions, such as PFC, VTA, and amygdala are also of interest. As methods for
dissection improve it will also become more feasible to examine subregions in these areas, for
example to distinguish the nucleus accumbens core from shell, which will allow for even finer
understanding down to the level of small neuronal populations.

Further insight into the nature of neuromolecular changes important for escalation of drinking
behavior during IAA is offered by the studies with NAQ and naltrexone, in which the drug
attenuates escalation two weeks after the cessation of treatment. This effect may potentially be
explained by long-lasting changes in endogenous opioid neurotransmission engendered by
repeated administration of mu-opioid selective and non-selective antagonists (Madia et al., 2012;
Virk and Williams, 2008). The transient efficacy of the drugs to reduce drinking behavior hints
that daily administration may not be the ideal treatment regimen for these drugs, at least at the
doses tested. By the third day of naltrexone treatment the drug no longer reduced drinking
behavior, and in other studies a similar effect was seen with NAQ after approximately 5 days
(data not shown). It seems likely that repeated administration of the drug has altered abundance
and expression of opioid receptors or downstream cell signaling components; mu-opioid receptor
in the case of NAQ, and potentially mu-, delta-, and kappa-opioid receptors for naltrexone.
The choice to test a selective mu-opioid antagonist (NAQ) in the context of IAA merits some
brief discussion. In fact the choice was not made from the genomic results from the IAA or ADE
models, but instead was a natural avenue of research stemming from the availablity of a novel
compound that shared a mechanism of action with naltrexone, which is approved by the FDA for
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treatment of relapse in alcohol use disorders. This compound was produced by Dr. Yan Zhang in
the Department of Medicinal Chemistry in the VCU School of Pharmacy, and some preliminary
behavioral work had been done with regard to somatic signs of morphine withdrawal, but the
effects of the compound on alcohol drinking were unknown. This compound was of particular
interest because non-peptidyl mu-opioid receptor selective antagonists had not been previously
synthesized, and being restricted to peptides greatly impairs the feasability of pharmacological
experimentation, due to the impermeability of the blood brain barrier. Given that naltrexone is
the only compound approved by the FDA for alcoholism with a clearly understood mechanism of
action (relatively nonselective opioid receptor antagonism), it followed that a selective small
molecule mu-opioid receptor antagonist such as NAQ represented a high priority target for
preclinical experimentation in the context of alcohol drinking and relapse-like behavior. Thus,
the studies with NAQ were initiated, and eventually lead to the results reported herein.
A role for mu-opioid receptor regulation in the intermittent access model is supported by the
observation the Oprm1 transcript is upregulated by continuous access drinking, and
downregulated during intermittent access. Protein measurements will determine if these changes
are translated into alterations in receptor abundance, and thus illuminate the precise implications
of changes in mu opioid receptor in NAc on drinking behavior. Interestingly, the severity of
alcohol craving in alcohol-dependent human beings is correlated to the degree to which
abstinence increases mu-opioid receptor abundance in the NAc, and thus persistent
downregulation due to antagonist treatment may be responsible for the attenuation in escalation
due to IAA in treated mice (Heinz et al., 2005).
Beyond craving, altered mu-opioid receptor populations in NAc could also alter consumption
after initiation, because ethanol and other drugs of abuse elevate extracellular levels of
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endorphins in the NAc, the function of which would be impaired by a reduced receptor
population (Olive et al., 2001). Furthermore, mu-opioid receptor knockout mice do not selfadminister alcohol, which suggests that it may be more important than delta- or kappa-opioid
receptors for determining intake, and lends support to the notion that NAQ may be a better drug
than the non-selective antagonist naltrexone for reducing relapse (Mendez and Morales-Mulia,
2008). Given the clear potential of NAQ as a therapy for alcoholism, extensive future study
should be devoted to further exploring its potential in preclinical models.
After effective dosing and treatment regimens are established in voluntary drinking models, the
effects of the drug on operant self-administration should be examined; in particular it should be
determined whether NAQ treatment of pretreatment alters progressive ratio breakpoints and
reinstatement of responding due to cues or stressors. A hybrid IAA self-administration model has
been demonstrated that would be particularly useful, in addition to non-deprived operant selfadministration studies (Hopf et al., 2010). Behavioral studies of this type should be conducted in
concert with neuromolecular studies to determine the efficacy of NAQ compared to naltrexone.
For example, it should be determined whether NAQ directly reduces extracellular dopamine in
the nucleus accumbens, and whether it produces desensitization or downregulation of opioid
receptor populations.

Limitations
Several factors limit the scope and generalizability of the results reported herein to the human
disease of human alcoholism, but offer opportunities for future study. First, results are reported
in only two strains of mice, and although this progenitor separation occurred more than 60 years
ago, the strains are still relatively similar in alcohol-related behavior and gene expression. While
this offers the opportunity to home in on important neuromolecular and transcriptional mediators
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of behavior in the absence of noise, the degree to which results can be generalized to other rodent
strains, and to humans, is unclear. Some effects of alcohol, such as dopamine release in the NAc,
are fairly stable across genetic backgrounds, while others, such as ethanol-responsive gene
expression, are not. While the IAA model has been studied in several rodent strains, in most only
the sub-optimal single concentration model has been applied. Of particular interest are the ways
in which multiple alcohol concentrations effect baseline drinking, and how IAA alters preference
among these concentrations. Even within a single inbred strain intermittent access results vary
across laboratories, so the efficacy of the model in different rodent strains with divergent
alcohol-related behavior must be confirmed (Crabbe et al., 2012; Hwa et al., 2011).
Second, in all reported studies mice are housed alone, and there is some evidence that in
C57BL/6NCrl mice escalation due to IAA is dependent on stress produced by social isolation
(Khisti et al., 2006b; Tomie et al., 2013). If this holds true for other strains it would limit the
generalizability of results to human alcoholics; and may limit the scope to those who drink alone,
or in which alcoholism is comorbid with anxiety disorders, such as PTSD. While this would
reduce the validity of the model as a general representation of alcoholism, it would still be useful
for study of drinking due to, or despite, anxiety and stress. A simple method for reducing stress
due to social isolation is the use of clear plastic dividers to separate the home-cage into areas in
which the drinking of a single mouse can be measured, but still allow for some minimal level of
interaction. More sophisticated methods are possible, but expense limits their utility. For
example, group-housed mice can be tagged with radio transmitters that identify each mouse as it
approaches the drinking apparatus.
Third, drinking under intermittent access schedules is generally measured over the entire 24 hour
access period, which may not provide the most useful description of drinking behavior. Under
208

normal conditions rodents, which are nocturnal, tend to drink during the dark cycle, and in
particular immediately after lights off for a short period, which is followed by food consumption,
and then a longer period of drinking (Boyle et al., 1997; Gill et al., 1986). Intake decreases as the
night progresses, and in the second half of the dark cycle little alcohol is consumed. In rats in
which maladaptive drinking has been produced through alcohol deprivation, temporal patterns of
drinking are markedly altered; most rats show high levels of consumption during the light cycle,
with little difference from the dark cycle (Holter et al., 1998). These differences likely reflect
alterations in circadian rhythm that are at least partially mediated by changes in clock genes,
which are posited to play a role in addiction processes and depression (Perreau-Lenz et al.,
2007).
Therefore measurements of drinking behavior and gene expression at a finer temporal resolution
would allow for finer dissection of the connection between transcription and behavior, and for
the study of expression of immediate early genes, which mediate later gene expression. The use
of lickometers that directly measure when a rodent is drinking is a fairly inexpensive solution to
the measurement of drinking behavior on a sub-day time scale, and all future intermittent access
studies should make use of this modification, if possible (Griffin et al., 2007). The measurement
of global gene expression on this scale is more difficult, primarily because of the high cost of
microarrays, but quantitative real-time PCR can be used to measure transcript abundance of
specific genes based on genomic results from 24-hour drinker samples.
Fourth, gene expression results are limited by the use of mice as an experimental model, and the
dissection methods utilized. In mice the consistent and accurate dissection of the nucleus
accumbens from whole brain is difficult, and the separation of the core and shell subregions is
not feasible. Thus, reported gene expression results collapse expression in the nucleus
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accumbens core and shell, but expression changes associated with intermittent access can be
subregion specific within the NAc, prefrontal cortex, and amygdala (Gilpin et al., 2012; Li et al.,
2010b; Li et al., 2012b). Improved dissection techniques, including laser capture
microdissection, will allow for more detailed study of changes in gene expression associated
with continuous access and intermittent access drinking using genomic methods (Chimge et al.,
2007).
As with all gene expression studies in animal models, the generalizability of results to humans is
limited to a degree because of differences in the genome. While 99% of mouse genes have
human homologues, non-coding putative regulatory regions show a far lower level of
conservation (Mouse Genome Sequencing et al., 2002). Although expensive, the use of nonhuman primates for studies such as these would allow for better comparisons with the human
condition. In particular, results can be compared to the growing body of data describing
neuromolecular adaptations in post-mortem brain tissue of alcohol dependent humans, and these
results would support the use of the model in rodents.
Fifth, the results for intermittent alcohol access behavior and transcription reported here were
obtained using the once-per-week access model. While this model produces immediate
significant increases in alcohol consumption and preference, it is not the form of the model
which has begun to emerge as the consensus procedure in the literature. The every-other-day
model has seen substantially more research effort in recent years, and the degree to which results
are generalizable between models is unclear. No studies have directly compared the every-otherday, no baseline, single concentration model to the once-per-week, extended baseline, multiple
concentration model, although the behavioral changes produced by the two schedules seem to be
similar across laboratories. The degree to which continuous access prior to deprivation
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contributes to subsequent escalation of intake is unclear, and it may be that each model is useful
for describing a particular aspect of alcohol-related behavior. It should be noted that in our
laboratory the initial presentation of alcohol is accompanied by what is believed to be a “novelty
effect”, in which mice drink markedly more alcohol on the first access day than on subsequent
days, and stable intake is often not reached for several days, or even weeks. It is unclear whether
this initial, transient increase in drinking has a correlate in the no-baseline model, because
subjects are never allowed continuous access under which drinking can stabilize.
It may be that every-other-day drinking maintains and exacerbates this otherwise transient
increase in drinking, and that once-per-week access mediates its effects through the same
mechanisms. Because the state of the brain differs greatly upon the start of intermittent access
(naïve mouse vs. alcohol-drinking mouse), it is an intriguing possibility that the neuromolecular
substrates involved in the escalation of drinking behavior differ between the two models. Future
studies should address the utility of the every-other-day schedule after a continuous access
baseline period, and of the once-per-week schedule in alcohol-naïve animals, and compare the
transcriptional response in these mice to naïve mice on the first alcohol access day.
An issue not addressed in the literature is that with scheduled deprivation procedures, such as the
IAA and EDE models, abstinence is involuntary, and if the transcriptional response to alcohol
differs between voluntary and involuntary drug taking, then it is likely that voluntary and
involuntary abstinence also produce differing effects on neurobiology and subsequent drinking
behavior (Fernandez-Castillo et al., 2012; Tapocik et al., 2013). In humans abstinence is often,
but not always, voluntary, as negative social, economic, and physiological consequences of use
mount, and people attempt to quit drinking (A.P.A., 2000; Haeny et al., 2013). It may be that
wanting to stop drinking modulates the effects of abstinence on the brain in ways distinct from
211

involuntary situations, and that IAA is only a valid model for involuntary abstinence, such as
occurs upon hospitalization, imprisonment, lack of funds to buy alcohol, or other uncontrollable
environmental influence. Unfortunately, rodents do not have social and economic concerns that
modulate abuse behavior, and their limited cognition limits possibilities for inducing abstinence.
It is unclear how to convince a rodent that alcohol consumption is not in its best interests,
without the use of directly aversive stimuli such as foot-shock, or noxious tastes and smells,
which do not have a clear correlate in the human condition. One imperfect, yet seemingly valid,
method is the introduction of an alternative reinforcer concurrently with ethanol on reinstatement
test days, with the correlate to the human condition being positive life activities that are
neglected due to the desire to seek and consume alcohol instead. This behavior is a known
characteristic of abuse across psychoactive substances, but has not been explored in the context
of IAA. It is known that IAA produces an ethanol-selective increase in drinking that is inflexible
in the face of aversive influences on intake, but not whether it increases the relative reinforcing
value of alcohol compared to other rewarding stimuli. Potential alternative reinforcers include
sweetened solutions and foods, social interaction, wheel running, and sex. This reinforcer can be
offered concurrently with alcohol reinstatement following deprivation, using a design tailored to
the reinforcer. For something like sex, the option to drink alcohol would be removed upon the
animal choosing the alternate reinforcer, and the decision can be monitored over the course of
weekly cycles, which may eventually result in alcohol being chosen. For a rewarding activity
like social interaction or wheel running, it would be informative to measure the amount of time
that the animal devotes to either activity during ethanol access, which would be expected to
decrease with repeated cycles of deprivation.
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A further limitation of the drinking studies reported herein is the lack of measurement of blood
ethanol content (BEC), which is a direct measurement of alcohol intoxication, and be more
meaningful in the context of drinking behavior than once-per-day measurements of volume
consumed. Individual differences in consumption patterns and metabolism could lead to
differences in BEC, and thus to ethanol intoxication, that would be not be apparent from simple
24-hour measurements. Future studies of this nature should aim to include BEC measurements
when reporting drinking data, but care must be taken in the implementation of these procedures.
Blood collection from mice is stressful for the animal, and reduces subsequent drinking behavior.
In a repeated deprivation or intermittent access model this is a confounding influence, and it may
only be practical to collect blood on the final day of alcohol access, or to use a previously
implanted catheter system for easy access. This type of collection would likely be more feasible
in rats than in mice, due to the size of the blood vessels. A further difficulty to consider is the
timing of the blood collections. Rodents do not drink at a steady rate throughout the day, and the
collection of blood would be expected to preclude further drinking by the animal for that day at
least. Therefore to collect multiple time points and generate a meaningful picture of alcohol
intoxication during reinstatement days it would be necessary to drastically increase the number
of animals used; each time point would require an entirely separate group of continuous access
and intermittent access mice. Comparisons from reinstatement days to baseline drinking are also
possible, but necessitate the collection of blood during the baseline access period, which will
certainly interfere with drinking and prolong the time required for drinking to stabilize, and for
intermittent access to begin. Nevertheless, these measurements, along with other improvements
to drinking data collection, such as lickometers and remote data collection, should be
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implemented in future studies, to allow for better understanding of binge-like drinking behavior
induced by scheduled deprivation and its relevance to alcoholism.
Finally, with any comparison of measurements of protein or nucleotides in a tissue sample
collected from an animal, one must consider the influence of cell death caused by experimental
treatments. Tissue collection is based on a regional perimeter, and the cellular content of the
delineated area determines the results of abundance assays. For example, if continuous access
alcohol drinking is killing oligodendrocytes in the nucleus accumbens, then it would be expected
that expression of myelin-related genes decrease. However, without knowledge of the cell death
that may be occurring, it might instead be hypothesized that decreases in gene expression instead
indicate attenuated function of the myelin sheath, rather than outright destruction. In the same
way death of particular neuronal populations might skew results of particular neuronal
constituents. For example, if neurons containing D2 dopamine receptors are preferentially
destroyed by alcohol exposure the microarray results may show a decrease in transcript coding
for the receptor, which could otherwise be interpreted as a functional change in living cells. To
complicate matters further, a cellular loss may have secondary repercussions in other neurons
and glia that interfere with interpretation of results. For example, a preferential loss of
GABAergic interneurons may cause neurons they modulate to increase activity, and then to
compensate with homeostatic mechanisms that alter mRNA and protein abundance. These
changes may simply be a result of cell death, and not relevant to alcohol-related behavior under
conditions that do not destroy brain cells. To further explore these issues methods are available
to assay the health state of isolated cells, which should be applied to mice after continuous access
and intermittent access drinking, and will determine whether cell death plays a role in changes in
mRNA abundance associated with alcohol drinking and abstinence.
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Several avenues of molecular research will be useful for further characterizing the
neuromolecular correlates of alcohol drinking before and after scheduled deprivation, and the
intermittent alcohol access procedures described herein provide important methodological
guidelines for further study of the effects of scheduled alcohol deprivation in rodents as a model
of binge-drinking.

Transcriptional regulation mechanisms in NAc during drinking and scheduled deprivation
Despite the limitations outlined above, and although further study is needed to determine the
nature of alcohol-responsive gene expression on intermittent access and continuous access
schedules over time, some molecular mediators of transcriptional regulation that are likely to be
important can be identified for experimentation based on the present results.
The acquisition of alcohol reinforcement appears to be mediated by mesolimbic A10
dopaminergic neurons projecting from the ventral tegmental area to the nucleus accumbens, and
the degree of subsequent intake and preference is correlated with ethanol-induced increases in
extracellular dopamine in the NAc (Katner and Weiss, 2001). Furthermore, in humans ethanolevoked dopamine release in NAc is directly related to the degree of psychostimulation produced
by the drug (Boileau et al., 2003). Therefore ethanol-evoked dopamine release in the nucleus
accumbens, and changes in gene expression that alter the functioning of this region, are likely
important mediators of the development of maladaptive drinking in the intermittent access
model.
Modulation of gene expression by dopamine receptor activation is clearly involved in
transcriptional regulation occurring with continuous access and intermittent access alcohol
drinking. Dopamine receptors are G-protein coupled receptors that modulate gene expression
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through the action of Gα subunits on adenylyl cyclase, which alter cAMP concentrations and the
function of cAMP-dependent protein kinase (PKA). PKA and other kinases, such as
Ca2+/calmodulin-dependent protein kinase IV (CaMKIV), phosphorylate the transcription factor
cAMP response-element binding protein (CREB), which activates transcription of genes with
cAMP response elements in promoter regions. Dozens of CREB-mediated genes have been
identified, and include corticotrophin-releasing hormone (CRH), neuropeptide Y (NPY),
prodynorphin (PDYN), and brain-derived neurotropic factor (BDNF). Alcohol reduces CREB
function in the nucleus accumbens at least partially through activation of D2-like dopamine
receptors (D2-D4), which inhibit PKA function (Spanagel, 2009).
In the nucleus accumbens reduced CREB function seems to promote drug intake associated with
positive affective states, signaling mediators upstream of CREB are differentially expressed
(multi-class LIMMA, F < .05, BH-adjusted p-value < .30) between intermittent access mice and
continuous access mice from the cell membrane to the nucleus (Pandey, 2004a, b). For all of
these enzymes transcriptional regulation means that mechanistic roles can only be loosely
hypothesized; alterations in transcript abundance must be confirmed by quantitative PCR and
protein measurement, and function confirmed in vivo.
Transcript coding for the D3 dopamine receptor (Drd3), which inhibits adenylyl cyclase, is more
abundant in nucleus accumbens of CA mice than in IA or H2O mice, and this receptor is known
to play a role in alcohol intake following deprivation. In several lines of rats undergoing alcohol
drinking with repeated deprivations, DRD3 is upregulated in the striatum, and DRD3 antagonists
dose-dependently reduce drinking during alcohol reinstatement (Vengeliene et al., 2006).
Measurement of protein abundance will determine if changes in Drd3 mRNA in the present
experiments reflect changes in protein at the cell membrane, but it seems likely that continuous
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access drinking increased DRD3 abundance in nucleus accumbens, and that during deprivation
this upregulation in dopamine signaling promotes alcohol seeking through adenylyl cyclase
inhibition and reduced CREB-mediated transcription.
In support of this hypothesis, transcript for Adcy8 (adenylyl cyclase 8), a calcium/calmodulinsensitive form of the enzyme, is reduced by continuous access drinking, and recovered by
abstinence. The recovery of this gene expression may be promoted by homeostatic mechanisms
acting to restore adenylyl cyclase function in the face of inhibition by alcohol-induced
extracellular dopamine increases. In a similar vein, the downregulation of Ddc (dopa
decarboxylase) in intermittent access mice may be a result of decreased monoamine signaling
through dopamine and serotonin in the nucleus accumbens (Hodgetts and O'Keefe, 2006) . In
general, repeated activation of neuromolecular processes by alcohol induce changes that
gradually push the cell out of the normal boundaries of functioning, and thus promote alcohol
intake to restore normality.
Furthermore, several kinases downstream of calcium and cAMP with CREB phosphorylation
activity are regulated during intermittent access procedures (Pandey, 2004a). The classical
CREB-activation pathways are represented by apparent PKA subunit regulation, as transcripts
coding for Prkacb (protein kinase, cAMP dependent, catalytic, beta) and Prkar2b (protein
kinase, cAMP dependent regulatory, type II beta), are upregulated by continuous access
drinking. The regulation of Camk4 (calcium/calmodulin-dependent protein kinase IV) and
Camk1d (calcium/calmodulin-dependent protein kinase ID) are of particular interest, because
they are not altered by continuous access drinking, but are more abundant in abstinent mice after
intermittent access. The function of CAMK4 and CAMK1D could be particularly important for
CREB-mediated gene expression during abstinence that contributes to elevated drinking during
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relapse-like behavior. Furthermore, mRNA coding for Camk2b, Camk2n1, Camkk2, and
Rps6ka2 are all upregulated in intermittent access mice compared to continuous access mice, and
all phosphorylate CREB. Finally, Creb3l2 (cAMP responsive element binding protein 3-like 2)
and Creb5 (cAMP responsive element binding protein 5) are upregulated by continuous access
drinking, while Crem (cAMP responsive element modulator) is increased during abstinence from
intermittent access, as compared to both other groups.
The involvement of deltaFosB signaling in plasticity occurring with intermittent access is wellestablished, and so will not be mentioned in depth here, other than to mention that expression of
dozens of putative targets of deltaFosB transcriptional regulation are altered (McClung and
Nestler, 2003; Nestler et al., 2001; Robison and Nestler, 2011). These targets include AMPA1
glutamate receptor (Gria1), cyclin-dependent kinase 5 and regulatory subunits (Cdk5, Cdk5r1,
Cdk5r2), synaptotagmins (I, II, III, IV, V, VI, VII, XI), kinesins (1B, 1C, 3C, 5A, 5C, 7, 9, 13B),
and microtubule-associated proteins (1A, 1 light chain 3 alpha, 1 light chain 3 beta, 1B, 4, tau).
Interestingly, AP-1 mediated transcription (a dimer of Jun and Fos family proteins) is
downstream of retinoic acid signaling by way of the MAPK cascade, and genes involved in
retinoic acid are regulated among drinking groups in IAA studies. Regulated retinoic acid-related
genes include Rarb (retinoic acid receptor, beta), Rora (RAR-related orphan receptor alpha),
Rorb (RAR-related orphan receptor beta), Rarres2 (retinoic acid receptor responder (tazarotene
induced) 2), (Stra6), stimulated by retinoic acid gene 6, Rdh10 (retinol dehydrogenase 10 (alltrans)), and Rdh18 (retinol dehydrogenase 18). Regulated MAPK genes (Map3k10, Map3k11,
Mapk10, Mapk10, Mapk6, and Mapk8ip) are uniformly downregulated in abstinent intermittent
access mice compared to continuous access mice. Retinoic signaling is impaired in the brains of
alcoholics, but the connection to altered behavior through gene regulation has not been explored,
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and the intermittent access model represents a useful paradigm within which to study this
connection (Clugston and Blaner, 2012).
Of particular interest is the observation that Wnt signaling in the nucleus accumbens may play a
role in regulation of gene expression associated with alcohol drinking. Although alcohol
modulation of Wnt signaling has been described in brain (PFC, hippocampus, neural stem cells),
bone, and liver, alterations in Wnt signaling in the brain have not been directly associated with
regulation of drinking behavior. There are three well-characterized Wnt signaling pathways, in
addition to several that are less studied, through which Wnt ligand binding to Frizzled receptor
regulates cellular processes (Inoki et al., 2006; Ishitani et al., 2003; Nusse, 2012). The canonical
Wnt pathway modulates gene expression through β-catenin signaling, the noncanonical planar
call pathway regulates cytoskeleton structure, and the noncanonical Wnt/calcium pathway
regulates ER calcium release, which activates PKC, calcineurin, and CamKII. Given the apparent
roles of transcriptional regulation, calcium regulation, and axonal/dendritic remodeling in
neuroplasticity in the nucleus accumbens occurring with ethanol drinking and abstinence, the
Wnt pathways represent a high-priority target for future study in alcohol drinking behavior, and
binge-like drinking in particular.
Some evidence for a role of Wnt signaling in alcoholism comes from genetic studies in humans
and mice. A SNP in DKK2 (dickkopf 2 homolog), an antagonist of canonical Wnt signaling, is
significantly associated with alcohol-related harm in alcoholics (Kim, 2013). Furthermore, some
risk for alcoholism is found to be conferred by haplotypic variation in exon 3 of TTC12, a gene
about which very little is known, but which is similar to beta-catenin and may function in the
Wnt pathway (Yang, 2007). By analyzing hippocampal miRNA abundance across BXD strains,
it was found that microRNA miR-31 is associated with alcohol-related behaviors, and the
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expression correlates of this gene are enriched in genes involved in Wnt signaling, axon
guidance, and MAPK signaling (Parsons, 2012).
The most well-characterized effects of ethanol on Wnt signaling are in bone, where alcohol
suppresses the canonical Wnt/ β-catenin signaling pathway and disrupts gene expression
(Lauing, 2012). Serum levels of sclerostin, an endogenous Wnt antagonist, are raised in alcohol
patients, but sclerostin levels seem to be related to liver function, and are not correlated with
ethanol intake (Gonzalez-Reimers, 2013). In Sprague-Dawley rats experimenter-administered
chronic binge alcohol (i.p, 3 g/kg, 3 days/week, for 4 weeks) modulated canonical Wnt signaling
gene expression, as indicated by gene ontology analysis of microarray results from lumbar
vertebrae (Himes, 2008). In genes regulated by ethanol exposure in two models of alcohol liver
disease, genes related to Wnt signaling were upregulated (Bardag-Gorce, 2006).
The effects of ethanol on Wnt signaling are also well characterized with regard to fetal
neurodegeneration. There is clear evidence that the teratogenic effects of ethanol on
neurodevelopment in fetal alcohol syndrome are at least partially mediated through Wnt
signaling, both upstream and downstream of Wnt/Frizzled binding. Elevated calcium induced by
ethanol exposure activates CamKII, which phosphorylates β-catenin and prevents its
transcriptional activation, preventing trophic support of neural stem cells. Blocking calcium
increases prevents CamKII activation and prevents cell death (Flentke, 2013). Furthermore, in
human neural stem cells ethanol exposure regulates the expression of Wnt proteins, Wnt receptor
complex proteins, and cytoplasmic mediators of Wnt signaling (pGSK3β and β-catenin), but
there is conflicting evidence as to the direction of regulation that may reflect methodological
differences (Vangipuram, 2012; Choi, 2011).
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Analysis of differential expression in nucleus accumbens during the IAA model revealed that
Gsk3β is upregulated in intermittent access mice, compared to continuous access mice. The
identification of GSK3B as a hub gene in an ethanol-responsive gene co-expression network in
PFC of BXD mice offers further support for a role of Wnt signaling in alcohol-related behaviors
(Wolen, 2012), as does its identification as a gene with influence on alcohol dependence in a
recent multi-species gene ranking study (Zhao, 2012). Noncanonical Wnt signaling involving
GSK3B and other signaling mechanisms could also mediate gene regulation in the nucleus
accumbens. Wnt is capable of activating protein kinase mTOR through GSK3β inhibition via a
pathway that does not involve β-catenin (Inoki, 2006).
Wnt signaling in nucleus accumbens occurring in the IAA model may also involve the
noncanonical Wnt/calcium pathway, through which Wnt controls calcium release from the
endoplasmic reticulum. Calcium release activates CamKII, which phosphorylates nemo-like
kinase (NLK), which modulates gene expression (Ishitani, 2003). Transcripts coding for NLK, as
well as for CamKII regulatory and catalytic subunits, are downregulated in mice during
continuous access drinking, and upregulated in intermittent access mice during abstinence.
Activation of NLK acts as a negative feedback loop that attenuates canonical Wnt signaling via
β-catenin (Sugimura, 2010). Furthermore, in the nucleus accumbens Wnt signaling could be
connected to dopamine release through regulation of the activity of PKA, which phosphorylates
β-catenin, preventing its ubiquitination and degradation, and activating gene expression of
canonical Wnt targets (Hino, 2005).
Future studies should examine the role of Wnt signaling in nucleus accumbens for the
development of binge-like drinking behavior using the IAA model. Several approaches are
available to perturb the signaling pathway at multiple levels, including ligands, RNAi, and viral221

vector mediated over-expression. Studies of this type may point the way to the development of
more effective drugs for the prevention of relapse drinking in patients with alcohol use disorders.

Other likely nucleus accumbens adaptations of note for future study
Some other likely neuromolecular adaptations deserve mention. Abundance of Fa2hv (fatty acid
2-hydroxylase), the enzyme responsible for catabolism of the endogenous cannabinoid receptor
ligand anandamide, is significantly downregulated by continuous access drinking, and
upregulated during abstinence from intermittent access (Pacher and Kunos, 2013). This evidence
hints at alterations in anandamide in the nucleus accumbens, and thus altered cannabinoid
receptor activation. Thus there is some support for adaptation of the endocannabinoid system,
which has been postulated to play a role in alcohol drinking behavior, during intermittent access
(Pava and Woodward, 2012). Other endocannabinoid related genes coding for cannabinoid
receptors 1 and 2, cannabinoid-receptor interacting protein 1, and monoacylglycerol lipase, were
not regulated. These results are deserving of further exploration, because ethanol drinking
increases levels of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the nucleus
accumbens, but does not alter anandamide levels. Furthermore, infusion of cannabinoid receptor
antagonist rimonabant reduces self-administration of ethanol, but not of cocaine (Colombo et al.,
2007). Therefore alterations in endocannabinoid function play a role in ethanol seeking behavior,
and this connection should be explored in the intermittent access model, with a particular aim
toward exploring the potential for cannabinoid-based treatments for relapse. In particular,
interference with endocannabinoid metabolism represents a method for perturbing the system
without producing marijauana-like psychoactive effects (Blankman and Cravatt, 2013).
In both models of scheduled deprivation reported herein, gene regulation clearly points to
alterations in nucleus accumbens myelination, which would alter neuronal signaling and
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excitability within the region. Interestingly, in the IAA model significantly regulated myelinrelated genes are uniformly decreased by continuous access drinking, and all show significant
recovery after six cycles of intermittent access, to the point that no differences are seen between
IA mice and H2O mice. Regulation of seven myelin-related genes (Mag, Mbp, Mobp, Mog,
Omg, Opalin, and Pmp22) are significantly decreased by continuous access, and recovered by
intermittent access. Future study should examine myelin in the nucleus accumbens in IA and CA
mice, as well as the expression of myelin-related genes in IA mice immediately following bingelike alcohol drinking, to determine whether regulation of these genes is altered by scheduled
abstinence. It is currently unclear whether myelin deficits are recovered or exacerbated by
intermittent access, but this information will illuminate the connection between myelination and
the development of addictive behavior towards alcohol. Experimentation with the demyelinating
agent Cuprizone in the context of intermittent access would show the effects of progressive
degeneration of myelin in alcohol-seeking behaviors over time.
Neuroplasticity induced by ethanol over time is not well understood, but detailed study of the
nucleus accumbens and other interconnected reward related regions using scheduled deprivation
methods has revealed the involvement of molecular mediators with established roles in drug
addiction processes. In addition to identifying mechanisms of gene regulation, genomic
methodology identified differentially expressed genes and gene co-expression networks that are
associated with maladaptive changes in drinking behavior over time, and these represent targets
for preclinical study as potential therapeutic vectors for the treatment of relapse in alcoholdependent patients. Although studies of mRNA transcription are not perfect representations of
the functional changes occurring in neurons and glia, identification of functions and processes of
regulated genes provides important clues to the functional implications for regions in the
223

mesolimbocortical reward related pathways, and directions for future study of neuroplasticity
that leads to addiction. The weekly intermittent alcohol access procedure was shown to be an
effective and valid preclinical model in C57BL/6 mice that likely produces binge-like drinking
through mechanisms known to be involved in the pathology of alcoholism in humans, including
CREB- and deltaFosB-mediated transcription, miRNA regulation, and epigenetic modifications.
Finally, the compound NAQ, a novel small molecule mu-opioid receptor-selective antagonist,
was shown to be effective at reducing high concentration alcohol drinking and escalation of
intake due to intermittent access. NAQ shows similar efficacy to naltrexone, while showing
some evidence for advantages in tolerance and behavioral selectivity, and thus represents a
potential treatment for relapse in alcoholism that is deserving of further study. Future studies will
follow the guidelines and directions laid out within, and further examine the role of gene
expression in the nucleus accumbens and connected regions during intermittent and continuous
access to multiple alcohol concentrations. This line of research will advance basic understanding
of addictive behavior and of alcohol addiction.
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Appendix 1. Supplementary Materials Location
Supplementary materials for chapters 3 and 5, as well as annotated R code for WGCNA, can be
found at http://jonathanandrewwarner.com and on the Miles Laboratory Wiki, which can be
accessed through the VCU website or by contacting Dr. Michael Miles at mfmiles@vcu.edu.
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